生医学的応用を目指した温度応答型生分解性インジェクタブルポリマーの設計 by Yoshida Yasuyuki & 吉田 泰之
Design of temperature-responsive biodegradable
injectable polymers for biomedical
applications
著者 Yoshida Yasuyuki
発行年 2017-03-31
その他のタイトル 生医学的応用を目指した温度応答型生分解性インジ
ェクタブルポリマーの設計
学位授与機関 関西大学
学位授与番号 34416甲第635号
URL http://doi.org/10.32286/00000164
 1 
課程博士 
 
2017 年 3 月 
関西大学審査学位論文 
 
 
Design of temperature-responsive 
biodegradable injectable polymers for 
biomedical applications 
生医学的応用を目指した温度応答型生分解性 
インジェクタブルポリマーの設計 
 
研究科・専攻 :   理工学研究科・総合理工学専攻   
研究領域     :     生体材料化学             
学籍番号     :     14D6009       
氏名         :      吉田	 泰之       
 
        
 2 
博士論文要旨 
理工学研究科 総合理工学専攻  
                                                            ＜領域＞生体材料化学 
                                                           ＜学籍番号＞14D6009 
                                                          ＜氏名＞吉田	 泰之 
論題：Design of temperature-responsive biodegradable injectable polymers 
for biomedical applications 
（生医学的応用を目指した温度応答型生分解性インジェクタブルポリマーの設計） 
	 近年，温度や pH などの外部刺激に応答してゾル（液体）からゲルに転移するポリマーに
関する研究が盛んに行われている。このようなポリマー水溶液は，注射器で体内に容易に注
入可能であるため，インジェクタブルポリマ （ーIP）としての利用が期待されている。IP は，
体外では液体状態であるため容易に細胞（ES 細胞，iPS 細胞等）や薬物（生理活性ペプチ
ド，タンパク等）を懸濁・溶解することができ，in situ でそれらを内包したゲルを形成する
ため，再生医療用の組織再生用足場材料や薬物徐放デバイスへの応用が期待されている。さ
らに，開腹手術後の組織同士の癒着を防止する癒着防止膜，ガン近傍の血管を一定期間塞栓
してガンを死滅させる血管塞栓物質，内視鏡的粘膜剥離術時の膨隆材など，生医学的領域で
の応用展開が期待されている。こうした体内注入用の IP は，治療目的達成後に生体内で無
毒な成分に分解され，代謝・吸収される生体内分解吸収性高分子からなることが望まれる。
これまでに生分解性の IP の例として，疎水性セグメントに乳酸-グリコール酸共重合体 
(PLGA) ，親水性セグメントにポリエチレングリコール (PEG) を有する ABA 型トリブロ
ック共重合体 (PLGA-b-PEG-b-PLGA) などが報告されている。しかしながら，生分解性 IP
を臨床応用する上で解決すべき幾つかの課題がある。 
	 本論文ではこのような背景に基づき，生分解性 IP の疎水性セグメントとして脂肪族ポリ
エステルもしくはデプシペプチド-乳酸共重合体を有するブロック共重合体及びグラフト共
重合体を利用し，新規な生分解性 IP ヒドロゲルおよびその製剤の設計を行い，基礎的な検
討を行った結果についてまとめた。以下，本論文の内容を各章ごとに要約する。 
	 緒論（第一章）では，生分解性ポリマーと化学架橋型，物理架橋型ヒドロゲルの現在の研
究の趨勢やバイオマテリアルへの展開を紹介するとともに，生分解性 IP を臨床応用する上
で解決すべき課題や望まれる諸特性を示し，本研究で開発目標とする生分解性 IP 製剤の特
徴について述べた。第二章では，凍結乾燥による粉末化が可能で常温において容易に注射液
を調製可能な生分解性 IP 製剤を得ることを目的として，ポリマーの分子構造と添加剤につ
いて検討した結果について述べた。PCGA-b-PEG-b-PCGA（以下 tri-PCG）のカプロラクトン
とグリコール酸の組成比を変化させることにより融点を低下させ，凍結乾燥後の再分散性
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を高めるために適当な分子量の PEG を添加した結果，凍結乾燥後の粉末化が可能であり，
室温において約 20 秒程度で注射液を調製可能であった。さらに，得られた注射液は 37℃1
分でゲル化した。本研究で開発した IP 製剤は，注射液を臨床現場で常温において即時調製
可能であり，臨床使用における利便性は大きく向上したと言える 1)。第三章では，体内にお
いてゲル状態を維持する期間が調整可能な生分解性 IP ヒドロゲルを得ることを目的として，
ポリマーの分子構造と最適な架橋剤ついて検討した結果を述べた。Tri-PCG の両末端の水酸
基をスクシンイミド基に変換した両末端 OSu 化 PCGA-b-PEG-b-PCGA (Tri-PCG-SA-OSu) を
基材となる tri-PCG に添加した tri-PCG/tri-PCG-SA-OSu 混合ミセル水溶液と水溶性ポリアミ
ンを混合した製剤を開発した。この製剤では，温度上昇に伴うゲル化時に OSu 基と NH2 基
が反応して，ゲル内部に共有結合による化学架橋を生起させることに成功した。また，分子
量の異なる PLys や，PLys 以外の水溶性ポリアミンを添加した場合のゲル状態の維持期間に
ついても調査したところ，PLys5k 以外に, 末端にアミノ基を有する 4 分岐 PEG (4arm-PEG-
NH2) を添加した場合にも，同様の現象が認められた。さらに，PLys の添加量により，ゲル
状態の維持期間を 3-12 日まで調整可能であった 2)。第四章では，生体直交型（バイオオル
ソゴナル）な反応であるマイカル付加反応を利用した体内でのゲル状態の維持期間を調整
可能な生分解性 IP ヒドロゲルを得ることを目的として，tri-PCG の両末端の水酸基をアクリ
ロイル基に変換した両末端 Acryl 化 PCGA-b-PEG-b-PCGA (tri-PCG-Acryl) 水溶液と，疎水性
6 官能チオールである Dipentaerythritolhexakis (3-mercaptopropionate) (DPMP) を内包した tri-
PCG ミセル水溶液を混合した IP 製剤を開発した。この製剤は，温度上昇に伴いミセルが会
合して物理架橋形成によりゲル化が起こった際に，会合したミセル内部でマイケル付加反
応により共有結合が進行した。また tri-PCG-Acryl の含有率を変化させることにより，ゲル
状態の維持期間を 6-93 日まで調整可能であった。さらに，PEG を添加剤として用い，
PEG/DPMP/tri-PCG/tri-PCG-Acryl 混合液を調製した。混合液は，室温において 1 分以内で容
易に調製可能であり，得られたゲルは，加熱溶解して得られたポリマー水溶液と比較して，
同程度のゲル強度とゲル状態の維持期間を示した 3)。第五章では，ゲル化する pH 領域を簡
便に調整可能な温度応答型生分解性 IP 製剤を得ることを目的として，PCGA-b-PEG-b-PCGA
の両末端の水酸基を荷電基である COOH 基と NH2 基に変換したポリマー（tri-PCG-COOH, 
tri-PCG-NH2）を合成し，それらの温度応答性ゾル-ゲル転移挙動に及ぼす荷電基および pH
の影響について検討した。Tri-PCG-COOH, tri-PCG-NH2 をそれぞれ合成し，反対電荷を有す
る共重合体水溶液同士を混合した結果，単独溶液でのゾル-ゲル転移挙動とは異なる pH 領
域においてゲル化した。さらに，それらの混合比を変化させることにより，温度に応答して
ゲル化を示す pH 領域を簡便に調節できることが明らかとなった 4)。第六章では，様々な組
成を有する P(GD-DL-LA)-g-PEG) を合成し，PEG の分子量や導入率が温度応答性挙動に与
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える影響を明らかにした 5)。第七章では，水溶液低分子薬物の徐放化を目指し，PEG グラフ
ト化ポリ(DL-乳酸-デプシペプチド)ランダム共重合体 [poly(DL-lactide-r-depsipeptide)-g-PEG] 
(P(GD-DL-LA)-g-PEG)の側鎖の残存カルボキシル基にモデル薬物として水溶性の薬物である
レボフロキサシン (LEV) を結合したコンジュゲート [P(GD-DL-LA)-g-PEG/LEV] を合成し，
P(GD-DL-LA)-g-PEG/LEV の温度応答性ゾル-ゲル転移挙動やヒドロゲルからの薬物のリリー
ス挙動などに関して検討した結果について述べた。P(GD-DL-LA)-g-PEG/LEV 水溶液は温度
上昇に伴いゲルを形成し，37ºC における力学強度やゲル化温度は LEV を結合していない場
合と同程度の値であった。さらに，P(GD-DL-LA)-g-PEG/LEV ヒドロゲルは約 10 週間にわた
って持続的に LEV を放出し，LEV を直接内包した P(GD-DL-LA)-g-PEG ヒドロゲルに比べて
顕著にリリース速度を抑制できた 6)。 
	 結論（第八章）では，本研究で得られた知見や成果についてその内容を総括し，生分解性
ソフトバイオマテリアル分野に対する本研究の貢献とその意義を述べた。 
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1.1 Biodegradable polymers for biomedical application 
In these days, biomedical devices and materials used clinically with implanting inside 
of the body such as artificial organs have become more and more important to achieve 
better quality of life (QOL) for patients. Such biomaterials can be categorized into 
biodegradable and non-biodegradable materials. Non-biodegradable materials have been 
utilized in medical devices, which is desired to be stable and not depleted for long time 
such as an artificial heart, a hip joint and so on. On the other hand, biodegradable materials 
are expected to be utilized in medical devices only for temporal use. Among the 
biodegradable materials, biodegradable polymers are major and have been received much 
attention as biomedical and pharmaceutical applications 1-5 such as absorbable sutures, 
bine fixation materials, and drug delivery carriers etc., because these biodegradable 
polymers can be eliminated from the body after degradation. Many kinds of 
biodegradable polymers have been studied as biomedical materials. Biodegradable 
polymers can be further classified into natural and synthesis polymers. 
 
1.2 Biodegradable natural polymers  
Biodegradable natural polymers examples include proteins (polypeptides), nucleic 
acids, and polysaccharides. These polymers have amide, phosphodiester, and glycoside 
(ether) bonds, respectively, and can be enzymatically hydrolyzed. For example, 
extracellular matrix (ECM) of mammalian tissue is mainly composed of collagens 
(proteins), hyaluronic acid (HA) and chondroitin sulfate (polysaccharides). Collagen, 
denatured collagen (gelatin), and fibrin have been studied as cellular scaffolds for tissue 
engineering 6-10, drug releasing depots in drug delivery systems (DDS) 11-15 and so on, 
because these proteins exhibit good cellular attachment, proliferation properties and 
degradability. However, proteins usually have immunogenetic problems and also 
infectious problems by contamination of infectious species, such as bovine spongiform 
encephalopathy (BSE) and human immunodeficiency virus (HIV).  
   Polysaccharides, such as dextran, pullulan, chitin, chitosan, and hyaluronic acid, are 
also biodegradable natural polymers with many hydroxyl groups and show high 
hydrophilicity. Polysaccharides are highly stable under neutral condition, but can be 
degraded by enzymatic hydrolysis of the glucoside (ether) linkage. Some polysaccharides 
have various functional groups besides hydroxyl groups and display low immunogenicity 
and relatively good biocompatibility. Therefore, polysaccharides have been investigated 
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for biomedical application. For example, Akiyoshi and coworkers reported that 
cholesterol-modified polysaccharides form nano-meter sized hydrogel, nanogels, 
physically cross-linked by hydrophobic interaction of cholesterol groups 16-17. The 
nanogel can encapsulate hydrophilic drugs (protein, peptide) and also hydrophobic drugs, 
and be expected to be utilized as carriers for drug delivery systems.  
 
1.3 Biodegradable synthetic polymers 
   Biodegradable synthetic polymers have been extensively investigated as biomedical 
and pharmaceutical applications 1-15.  These polymers have hydrolytically or 
enzymatically labile chemical bonds in their back bone. Polyesters 18, polyamides 19, 
poly(ortho ester)s 20, polyanhydrides 21, polycarbonates 22, polyacetals 23, 
polyphosphazene 24 and polyphosphoesters 25 have been reported as examples of synthetic 
biodegradable polymers. These polymers exhibit spontaneous or enzymatic hydrolysis 
behavior in vivo and possess relativity good biocompatibility properties and has low 
immunogenicity. The degradation products can be metabolized or excreted from body via 
natural pathways and are non-toxic. Among them, aliphatic polyesters showed 
spontaneous (non-enzymatic) hydrolysis under physiological condtion, and already 
utilized as biodegradable medical devices. 
   Typical example of aliphatic polyesters are poly(lactic acid) (polylactide) (PLA) 26, 
poly(glycolic acid) (polyglycolide) (PGA) 27, poly(lactic acid-co-glycolic acid) (PLGA) 
28, poly(ε-caprolactone) (PCL) 29 and poly(caprolactone-co-glycolic acid) (PCGA) 30. 
PLA is one of the most popular aliphatic polyesters approved by Food and Drug 
administration (FDA) (USA) and has been used practically in clinical stage 1. PLA, PGA, 
other aliphatic polyesters, and their copolymers are usually synthesized by ring-opening 
polymerization (ROP) of lactide (LA), (the cyclic dimer of lactic acid, 2,6-dimiethyl-1,4-
dioxane-2,5-dione), glycolide (GA) (the cyclic dimer of glycolic acid, 1,4-dioxane-2,5-
dione), or/and other cyclic esters (lactones) in the presence of catalyst (typically tin 2-
ethylhexanoate [Sn(Oct)2]) or by direct polycondensation 31. PLA, PGA and their 
copolymer (PLGA) can be gradually degraded under physiological condition and 
degradation product (lactic acid and glycolic acid) can be metabolized4. Based on these 
factors, PLA and their copolymer have been utilized as implantable biomaterials, such as 
cellular scaffold for regenerative medicine 32-34, drug delivery devices 35-38, bone fixation 
materials 39-40, drug eluting stent (DES) 41-42, absorbable sutures 43-44 and so on. Using 
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PGA as cellular scaffold, Langer and Vacanti reported the formation cartilage-like cellular 
tissue with human ear-like shape under mice skin as a demonstration of scaffold guided 
tissue engineering in 1993 45.  
   Biodegradable aliphatic polyesters have also been used as nano- or macro-sized 
particle-type carriers for drug delivery system (DDS). Microspheres or nanospheres 
composed of PLA and PLGA are usually prepared by water-in-oil-in-water (W/O/W) 
double emulsion method to encapsulate hydrophilic drugs. Leuplin® produced by Takeda 
Pharmaceutical Co., Ltd. is a typical example of microsphere-type drug delivery devices, 
which is leuprorelin acetate as agonist of luteinzing hormone-releasing hormone (LH-
RH) encapsulated in a PLGA microsphere 46. The microsphere exhibited sustained release 
of the drug for 1 - 3 months in vivo 46.  
   Block copolymers consisting of a hydrophobic aliphatic polyester segment and a 
hydrophilic segment (typically PEG) can form nano-sized core-shell type polymeric 
micelles by self-assembly in water through non-covalent interaction such as hydrophobic 
interaction. Kataoka and coworkers reported that PEG-b-PLLA formed nanometer sized 
polymeric micelles having hydrophobic core and hydrophilic outer shell 47-48. Such 
copolymer micelles can encapsulate hydrophobic drugs in the hydrophobic cores by 
hydrophobic interaction. Therefore, copolymer micelles are expected to use for carriers 
for target delivery of an anti-tumor drugs because copolymer micelles can passively 
accumulate at tumor sites through well known the enhanced permeation and retention 
(EPR) effect 49. Kataoka reported that the block copolymer micelles composed of PEG-
b-PLLA showed effective accumulation into tumor and good therapeutic index against 
tumor bearing mices 50-51.  
 
1.4 Injectable hydrogel 
   Over the past decades, polymer hydrogels have been extensively investigated as 
implant biomedical materials 52-56. Because polymer hydrogels have a large amount of 
water and certain similarity with soft tissues and extracellular matrix (ECM). Hydrogels 
have been used as soft contact lens since 1960 57. The usage in biomedical applications 
has increased more and more, for example, cellular scaffolds for regenerative medicine 
58-61, drug delivery depots for sustained drug release 62-64, biosensor 65 and so on. These 
hydrogels has often been prepared by radical polymerization of water-soluble polymers 
bearing polymerizable (typically, acryloyl or methacryloyl) groups as prepolymers 65-66. 
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In a typical case, the solution of prepolymer containing photoinitiators are homo-
polymerized or copolymerized with comomoner upon UV irradiation to form hydrogel. 
However, such kind hydrogel needs surgical procedure to be implanted into the body. 
   Injectable polymer (IP) system, in situ gelation systems, is one of the candidates to 
solve the problems, and have been widely investigated in biomedical fields 67-70. IP 
solution can be mixed with living cells or drugs in a sol state at r.t. The obtained IP 
solution can easily be injected to the body by a syringe, and then becomes a hydrogel 
containing living cells or drugs at the injected site. Therefore, such IP systems are 
expected to be utilized as a scaffold for tissue engineering 58-61 or a drug delivery depot 
releasing drugs in a sustained manner 62-64. In situ gelation systems can be categorized 
into two groups, covalently (chemically) cross-linked systems and non-covalently 
(physically) cross-linked systems. 
 
1.5 Chemically cross-linked injectable polymer systems 
   Covalently (chemically) cross-linked systems can be further categorized into two 
groups, in situ polymerization systems and two solution mixing (coupling) systems. 
Typical in situ polymerization system can be prepared in the similar system described 
above. The hydrogel precursor solution containing a prepolymer and an initiator is 
injection to the desired site of the body by a syringe and the hydrogel can be formed after 
UV irradiation.  
   However, some of the hydrogels prepared by this method are not biodegradable. Only 
if a biodegradable polymer used as a backbone of prepolymer the obtained hydrogel is 
partially biodegradable. But, the polymerized chain produced is not biodegradable. 
Therefore, such gelation systems would have problems for long term toxicity and 
clearance from the body. In some cases, the hydrogels should be removed from the body 
by surgical operation to avoid unfavorable biological response. In addition, UV 
irradiation and photoinitiators may be potentially toxic. Thus, the scope of these gelation 
system as injectable hydrogels in biomedical applications are limited.  
   Another chemically cross-linked gelation system is two solution mixing coupling 
reaction system. In this system, two different multi-functional reactive polymer solutions 
reactive each other were mixed upon injection to form covalently cross-linked hydrogel. 
Coupling reaction reactions such as amine-succinimide reaction 66-67, Schiff’s base 
formation reaction (between amine and aldehyde) 68 and so on were reported for in situ 
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gelation. The coupling reaction proceed under physiological condition, and the obtained 
chemically cross-linked hydrogel has relatively low cytotoxicity. Sakai and coworkers 
reported that hydrogels prepared from 4-arm PEG-NH2 and 4-arm PEG-succinimide 
exhibited low cytotoxicity and high mechanical strength due to its homogeneous polymer 
networks 67. Recently, many researches on in situ gelation using click chemistry have 
been reported. The examples are Michael addition 68-80, copper(I)-catalyzed alkyne-azide 
cycloaddition 81-82, copper-free alkyne-azide cycloaddition, Diels-Alder cycloadditions, 
metal-free [3+2] cycloaddition 83-84 and oxime click 85.  
   Among them, Michael addition is a nucleophilic addition of a carbanion or a 
nucleophile such as thiol or amine groups to an α, β-unsaturated carbonyl compound. The 
reaction can proceed in highly selective manner under physiological condition (37℃, pH 
= 7.4), and is biorthogonal: no reaction with biological molecules. Thiol group has 
relatively lower pKa = ~ 8.0 compared with hydroxyl group and stronger nucleophilicity 
than amine groups 86. Michael addition reaction between thiol and maleimide 87, acryloyl 
88, mathacryloyl 89 and vinyl sulfone (VS) groups 86 were often reported. Elbert and 
coworkers reported that mixture solution of 4-arm PEG-acrylate and PEG-dithiol formed 
hydrogel through Michael-addition reaction 90. The obtained hydrogel exhibited relatively 
high mechanical strength and sustained release of drug from the hydrogel were also 
reported. They also reported enzymatically-degradable hydrogels fabricated between 4-
arm PEG-VS and oligopeptides containing bis-cysteine, matrix metalloproteinases 
(MMPs)-sensitive sequence and RGDS peptide as a cellular scaffold for regenerative 
medicine 86. 
 
1.6 Physically cross-linked stimuli-responsive injectable polymer systems 
   Recently there have been many reports on in situ gelation systems forming physically 
cross-linked hydrogels exhibiting sol-to-gel transition in response to external stimuli, 
such as temperature 91-93, pH, and ionic length 94-96. The physically cross-linked hydrogels 
are usually formed by hydrophobic interaction 97-99, ionic interaction 100-102, or 
stereocomplex formation 103-105. Among them, thermos-gelling polymers exhibiting a sol-
to-gel transition between room temperature (r.t.) and body temperature have been studied 
extensively as IP systems for biomedical applications. The driving force of the 
thermogelling system is usually hydrophobic interaction. Thermo-gelling systems have 
several advantages. These polymer solutions show rapid sol-to-gel transition in response 
 15 
to temperature changes (room temperature to body temperature) at the target site and 
without any toxic cross-linking agents and initiator. Sterilization of the polymer can easily 
be carried out by filtration of the polymer solution in a sol state before freeze-drying. 
Bioactive reagents, drugs or cells are mixed with IP solutions in a sol state before injection. 
Therefore, such thermo-gelling polymers are expected to utilize as injectable depot 
systems.  
   Some water-soluble polymers exhibit solubility changes in response to temperature. 
Poly(N-isopropylacrylamide) (PNIPAAm) is one of the well-known polymers exhibiting 
lower critical solution temperature (LCST) of 32℃ in water 106. The phase transition of 
PNIPAAm as increasing temperature changes occur elimination of hydrogen-bonded 
water molecules around amide groups and hydrophobic interaction of isopropyl groups 
of the N-isopropyl acryl amide, which drives coil-to-globule transition of the polymer. 
Okano and coworkers reported that cell-sheet engineering using PNIPAAm grafting 
culture dish for regenerative medicine 107. The LCST of PNIPAAm can be changed by 
copolymerization of NIPAAm with hydrophilic or hydrophobic monomers due to the 
change in hydrophilic/hydrophobic balance of the copolymer 108. Some researchers 
reported that amphiphilic block copolymer composed of PNIPAAM and hydrophilic 
polymers having various shapes, such as linear, graft and star shaped polymers, exhibiting 
sol-to-gel transition by micellar aggregation as the temperature increases 109-111. However, 
these thermo-gelling polymers based on PNIPAAm are basicaly not biodegradable. 
Therefore, biodegradable thermo-gelling polymer systems have been investigated for 
implantable biomedical materials For example, hyaluronic acid (HA)-g-PNIPAAm 
solution exhibited reversible sol-to-gel transition in response to temperature changes, and 
the obtained hydrogels could be degraded by enzymatic hydrolysis 112. Besides 
PNIPAAm-type temperature-responsive polymers, triblock copolymers of PEG and 
poly(propylene oxide) (PPG), PPG-b-PEG-b-PPG (commercial name is Pluronic or 
poloxamer)  in aqueous solution are well known to exhibit temperature-responsive sol-
to-gel transition on temperature increase 113-115. They have been studied as IP for drug 
delivery carriers and tissue engineering, however, there are several problems in usage as 
injectable hydrogels. Pluronic is not biodegradable, and the Pluronic gel implanted was 
eroded from the subcutaneous layer of mammals in relatively short period (< 1 day). 
   In 1997, Kim and coworkers reported that PEG-b-PLLA-b-PEG (BAB-type block 
copolymer) aqueous solution showed gel-to-sol transition as increasing temperature 88. 
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However, the gelation of this system occurred only when decreasing temperature. It was 
not convenient to be applied for medical use.  After the work, the temperature-
responsive phase transition behavior of PEG-b-PLGA-b-PEG with varying the molecular 
weights of PEG and PLGA were investigated 88. When the molecular weight of PEG was 
larger than 2,000, the PEG-b-PLGA-b-PEG aqueous solution exhibited gel-to-sol 
transition upon increase in temperature. But when the molecular weight of PEG was lower 
than 1,000, the polymer solution showed sol-to-gel transition upon increasing in 
temperature 116. After these pioneering works, many kinds of biodegradable IPs 
displaying sol-to-gel transition between r.t. and body temperature were developed. 
PLGA-b-PEG-b-PLGA (ABA-type block copolymneer) is one of the typical examples. 
The aqueous solution of PLGA-b-PEG-b-PLGA exhibited sol-to-gel transition upon 
increasing temperature similar to the PEG-b-PLGA-b-PEG (molecular weight of PEG < 
1,000), and are well-known as ReGel 94, 117-120. PLGA-b-PEG-b-PLGA can be synthesized 
by 1 step ring-opening copolymerization of lactide and glycolide in the presence of PEG 
as a macroinitiator. The synthesis of ABA-type block copolymer is relatively easier 
compared with the synthesis of BAB-type block copolymer. Moreover, these 
biodegradable IPs have an advantage in rapid gelation in response to temperature changes. 
ReGel/Paclitaxel system (OncoGel) provide a sustained release of paclitaxel from the 
hydrogel formed 121-122. Recently phase I trial of OncoGel were reported 121. Moreover, 
phase II/b clinical trials for treatment of brain, esophageal, and breast cancer are under 
way by Protherics.  
  There have been many reports on biodegradable thermo-gelling polymers consisting 
of PEG as a hydrophilic segment and aliphatic polyesters or polypeptide as a hydrophobic 
segment in the structure, such as, PLGA 123-124, poly(ε-caprolactone) (PCL) 125-126, poly(ε-
caprolactone-co-lactide) (PCLA) 127-128, poly(ε-caprolactone-co-glycolic acid) (PCGA) 
129-130, poly(ε-caprolactone-co-trimethylene carbonate) (PCTC) 131, poly(alanine) (PA) 132, 
poly(alanine-co-phenyl alanine) (PAF) 133 and so on. However, these thermo-gelling 
polymers have following several problems for clinical use 94. 
(1) Almost all of the biodegradable IPs are a sticky paste in dry state at r.t., and take a 
long time to be dissolved in an aqueous solution (usually more than 1 day).  
(2) Hydrogels consisting of such thermo-gelling polymers tend to revert to the sol state 
where a large amount of water or body fluid exists, such as in the intraperitoneal 
space and interior of blood vessels. 
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(3) The release rates of water-soluble hydrophilic low-molecular-weight drugs from 
biodegradable hydrogels are generally faster than hydrophobic and/or high-
molecular-weight drugs. 
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1.7 Overview of this work 
   In this work, we tried to create new class of thermo-gelling polymer systems solvig 
the problems described above as a minimally invasive implantable system. This thesis 
contains following another 6 chapters. Figure 1 shows overview of the works in this thesis. 
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Figure 1.  Overview of this thesis (chapter 2-7). 
 
   In chapter 2, a very quick preparative method at r.t. for aqueous IP solution is 
described. The effects of various water-soluble additives on the dispersion time of freeze-
dried PCGA-b-PEG-b-PCGA (tri-PCG) and sol-to-gel transition behavior of the 
copolymers were investigated. We found that some of the best formulations composed of 
tri-PCG and PEG as additives could be distributed in PBS to give suspension within 20 
sec at r.t. The obtained suspension could be sucked by syringe and exhibited temperature-
responsive sol-to-gel transition between r.t. and body temperature. This system should be 
convenient for instant preparation at clinical scene. 
 
   In chapter 3, new biodegradable injectable polymer systems forming chemically 
cross-linked hydrogel in response to temperature change to elongate duration time of gel 
state are described. Tri-PCG and tri-PCG attaching succinimide ester groups at both 
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termini (tri-PCG-SA-OSu) were synthesized. The micelle solution of mixture of tri-PCG 
and tri-PCG-SA-OSu was further mixed with a solution of water-soluble polyamine, such 
as poly-L-Lysine (PLys), which can form covalent bonds with the succinimide ester 
groups on the triblock copolymer termini. The obtained formulation showed temperature-
responsive irreversible gelation and longer duration of gel state in vitro and in vivo. 
 
   In chapter 4, temperature-responsive biodegradable injectable polymer systems 
forming covalently cross-linked hydrogel by Michael-addition type thiol-ene reaction is 
described. Tri-PCG attaching acryloyl groups at both termini (tri-PCG-Acryl) was 
synthesized. Tri-PCG-Acryl micelle solution was mixed with tri-PCG micelle entrapping 
a hydrophobic 6-functional oligothiol (DPMP). The mixture micelle solution (Molar 
ratio of tri-PCG and tri-PCG-Acryl = 1 : 1, code: 50%-S) exhibited sol-to-gel transition 
as increasing temperature, and then did not become a sol state after cooling at 4°C. This 
is due to that chemically cross-linking points were produced by Michael-addition type 
thiol-ene reaction. Moreover, we prepared freeze-dried-sample of PEG, tri-PCG/DPMP 
micelles, and tri-PCG-Acryl micelles. The obtained powdery sample could be dispersed 
within 30 sec in PBS at r.t. The obtained macroscopically homogeneous suspension 
(50%-D) also showed irreversible sol-to-gel transition in response to temperature similar 
with 50%-S. Furthermore, the obtained hydrogel with various contents of tri-PCG-Acryl 
showed longer duration time of the gel state in vitro and in vivo, and the duration time 
can be controlled by changing mixing ratio of tri-PCG-Acryl (16-50%). 
 
   In chapter 5, conventional control method of gel-forming pH region of biodegradable 
temperature-responsive injectable polymers is described. Carboxylic acid-terminated tri-
PCG (tri-PCG-COOH) and amine-terminated tri-PCG (tri-PCG-NH2) were synthesized.  
We investigated sol-to-gel transition behavior of tri-PCG-COOH, tri-PCG-NH2 and their 
mixture solution as functions of pH and temperature. Tri-PCG-COOH solution did not 
exhibit sol-gel transition behavior under the whole pH and temperature region 
investigated. Tri-PCG-NH2 solution exhibited sol-gel transition behavior under pH = 7-9. 
Sol-to-gel transition of the mixture solution of tri-PCG-COOH and tri-PCG-NH2 with 
various anion and cation ratio (A/C = 0.2-1.0) were investigated. The mixture solution 
(A/C = 1) exhibited sol-gel transition behavior under pH = 2-5 upon increasing 
temperature. The pH region showing sol-gel transition could be changed by A/C ratio.  
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   In chapter 6, the effects of length of PEG graft chains and PEG contents on the 
temperature-responsive sol-to-gel transition behavior of the previously reported graft-
copolymer type thermos-gelling polymers are described. A poly[(glycolic acid-alt-L-
aspartic acid)-co-DL-lactide]-grafted PEG, P(GD-DL-LA)-g-PEG were synthesized by 
the coupling reaction of carboxy acid groups of P(GD-DL-LA) with monomethoxy-PEG 
(MeO-PEG).P(GD-DL-LA)-g-PEG copolymers having similar total weight, different 
length of PEG, and different PEG contents were synthesized. Sol-gel transition 
temperature of P(GD-DL-LA)-g-PEG with higher molecular weight of PEG increased 
compared with the copolymers with lower molecular weight of PEG. The length of the 
PEG graft chain did not have negative effects on physical properties of hydrogels with 
elevating temperatures. 
 
   In chapter 7, a macromolecular prodrug-type biodegradable injectable polymer 
system of sustained release for low-molecular water-soluble drug is described. Then, 
unreacted residual carboxy acid groups were used for immobilization of water-soluble 
low-molecular weight drugs (levofloxacin [LEV]). P(GD-DL-LA)-g-PEG and P(GD-DL-
LA)-g-PEG/LEV solutions exhibited sol-to-gel transition between r.t. and body 
temperature. The immobilization of LEV onto P(GD-DL-LA)-g-PEG had no negative 
effect on the sol-to-gel transition behavior, mechanical strengths and degradation 
behavior of the hydrogel. The LEV release from obtained hydrogel were observed 
continued and sustained release of LEV for 11 weeks in vitro.  
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2.1 Introduction  
   Thermo-gelling polymers exhibiting a sol–gel transition between room temperature 
(r.t.) and body temperature can be used as injectable polymers (IPs). An aqueous solution 
of such polymers is in the sol state at r.t. and becomes a hydrogel in situ simply after 
injection into the body by a syringe. Biodegradable thermos-gelling polymers are of 
particular interest because of their potential for use in minimally invasive clinical 
therapies. Such hydrogels can easily entrap water-soluble bioactive reagents (for example, 
drugs, proteins, nucleic acids and so on) or living cells simply by mixing them into the 
polymer solution before administration. Thus, IP systems have been widely investigated 
for use as sustained drug delivery depots and as scaffolds for tissue regeneration 1-4. 
Normally, IPs exhibiting a temperature- responsive sol–gel transition possess amphiphilic 
structures with a delicate balance of hydrophilic and hydrophobic segments. Poly 
(ethylene glycol) (PEG) is a water-soluble polymer with excellent biocompatibility that 
has frequently been used as the hydrophilic segment in IP systems. Diblock and triblock 
copolymers of PEG and water-insoluble biodegradable aliphatic polyesters, such as 
poly(L-lactide), poly(D,L-lactide), poly(D,L-lactide-co-glycolide) and poly(ε-
caprolactone), have been investigated and applied as biodegradable IPs 5-9. We have 
reported several biodegradable IP systems exhibiting a temperature-responsive sol–gel 
transition and relatively high mechanical strength in the gel state using block or graft 
copolymers of polylactide and PEG having branched strcutures 10-11. However, almost all 
of the IPs reported previously are a sticky paste in the dry state at r.t., and require a 
considerable amount of time (usually more than 1 day) to be dissolved in an aqueous 
solution. These properties are inconvenient for the preparation of IP formulations in the 
laboratory and in the clinic, and they represent a significant barrier to the clinical 
application of IPs. To address this issue, Jeong 12, Ding 13 and Deng 14 reported a method 
for the solidification of amphiphilic block copolymer-type thermos-gelling polymers 
containing PEG and poly(ε-caprolactone) or their copolymers to achieve a powder form 
in the dry state. However, solubilization in an aqueous solution remained a problem in 
these systems, and it was necessary to heat the mixture of the polymer and solvent above 
the melting temperature of the copolymers to achieve dissolution. An additional problem 
is that aqueous solutions of the copolymer are likely to spontaneously transform into a 
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hydrogel after a certain period at r.t. because of the relatively high crystal-forming 
tendency of the hydrophobic segments.  
   Herein, we developed a quick and convenient preparative method for IP formulations. 
We used a triblock polymer composed of poly(ε-caprolactone-co-glycolic acid) (PCGA) 
and PEG, PCGA-b-PEG-b-PCGA, and investigated the effects of various additives on the 
dispersion time (DT) and gelation behavior of the copolymers in phosphate buffer 
solution (PBS; pH = 7.4, I = 0.14). The results indicated an appropriate combination of 
copolymer and additive for the quick preparation of an IP formulation exhibiting a 
temperature-responsive sol–gel transition between r.t. and body temperature. The method 
developed here should be convenient for use at the clinical scene.  
 
2.2 Experimental section 
2.2.1 Materials  
   PEG (Mn= 1000 and 1500; PEG1000 and PEG1500, polyacrylic acid (Mn = 5000), ε-
caprolactone (CL), tin-2-ethylhexanoate, maltose monohydrate, sucrose and lactose 
monohydrate were purchased from Wako Pure Chemical Ind. (Osaka, Japan). PEG (Mn 
= 2000, 4600 and 10000; PEG2000, PEG4600 and PEG10000) and monomethoxy-PEG (Mn 
= 5000; MeO-PEG5000) were purchased from Sigma-Aldrich (St Louis, MO, USA). 
Glycolide (GL) was obtained from Polysciences Inc. (Warrington, PA, USA). Polyvinyl 
alcohol (Mn = 2000) was purchased from Kanto Chemical Inc. (Tokyo, Japan). Sodium 
hyaluronate (Mn = 90000) was supplied by Kibun Food Chemifa Co., Ltd. (Tokyo, Japan). 
PCGA-b-PEG-b-PCGA triblock copolymers were synthesized by the ring-opening 
copolymerization of CL and GL in the presence of PEG1500 as a macroinitiator and tin-2-
ethylhexanoate as a catalyst at 160 ºC for 12 h, according to the method reported 
previously (Scheme 1) 13-15. Details of the characterization of the products are provided 
in Figure 1 and Table 1.  
 
2.2.2 Sample preparation and sol–gel transition  
   The temperature-responsive sol–gel transition behavior of the copolymer solution or 
suspension was investigated by the test-tube inversion method 10. Uniformly dissolved 
sample solution (named as S-sample) was prepared by mixing a predetermined amount 
of copolymer (solid) with PBS (pH = 7.4, I = 0.14) in a 5 ml vial. The mixture was shaken 
by a vortex mixer, and then heated at 60 ºC, which was above the Tm of the copolymer, 
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for 1 min. During this process, the sample became an opaque hydrogel. The hydrogel 
obtained in the vial was immersed in ice-cold water for 10 min to recover the sol state. 
This process was repeated several times. The resulting solution was then incubated at 4 
ºC for 12h to remove air bubbles. To determine the sol–gel transition temperature, Tgel, 
the vial of uniformly dissolved sample was immersed in a water bath at the desired 
temperature for 15 min, removed from the water bath and then inverted repetitively. The 
temperature was increased in 1 ºC increments, and Tgel was determined based on the 
criteria of ‘flow’ (= sol) and ‘no flow’ (= gel) over 30s. Measurements were repeated 
three times for each temperature to determine the transition temperature for a phase 
diagram. Powdery formulations of the copolymer with or without additives were prepared 
by solvent evaporation and freeze-drying. PCGA-b-PEG-b-PCGA (100 mg) with or 
without predetermined amount of additive (5–20 wt% to the copolymer) was put in a 
sample tube. Acetone or pure water (1 ml) was added to the sample tube, and the mixture 
was sonicated in a bath-type sonicator for a few minutes to give a clear solution. The 
obtained solution was added dropwise into 10 ml of pure water and further stirred for 20 
min. After removal of acetone by evaporation, the clear aqueous solution of PCGA-b-
PEG-b-PCGA with/without additives was freeze-dried to give a white, powdery mixture.  
   The apparent minimum DT of the powdery formulation was determined by a nylon 
mesh permeation test. The powdery polymer sample containing 100 mg of copolymer 
and a predetermined amount of additive was placed in a vial, and then PBS was added to 
the vial to achieve a copolymer concentration of 30 wt%. After vigorous mixing using a 
vortex mixer for a specified period of time at r.t., a sample was taken from the turbid 
suspension and dropped onto a nylon mesh (mesh size = 150mm) that was placed on a 
vacuum filtration apparatus. The DT was defined as the mixing time after which insoluble 
material was not observed on the nylon mesh. The suspension obtained by this dispersion 
procedure was named as D-sample.  
   Rheological measurements were performed on a dynamic rheometer (Thermo 
HAAKE RS600, Thermo Fisher Scientific, Waltham, MA, USA). A solvent trap was used 
to prevent evaporation of the solvent. Each sample was injected between parallel plates 
(diameter: 25 mm, gap of 1 mm) using a syringe. The data were collected at a controlled 
stress (4.0 dyn cm-2) and a frequency of 1.0 rad s-1 while heating at 0.5 ºC per min from 
20 to 50 ºC. The gelation temperature (Tgel) was defined as the temperature where the 
storage modulus (G’) overtook the loss modulus (G”).  
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2.3 Results and Discussion 
2.3.1 Synthesis of PCGA-b-PEG-b-PCGA triblock copolymer  
   The synthesis of the PCGA-b-PEG-b-PCGA triblock copolymer was performed twice, 
and each run gave slightly different samples (code: tri-PCG1 and tri-PCG2). The results 
from the characterization and the proton nuclear magnetic resonance (1H-NMR) spectra 
of the PCGA-b-PEG-b-PCGA triblock copolymers are shown in Table 1 and Figure 1, 
respectively. The molecular weight of each PCGA segment was ~ 1800 Da, and the total 
molecular weight of the triblock copolymers was 5000 or 5100 Da. The average degrees 
of polymerization (DP) for the CL and GA (glycolic acid, not GL) units were calculated 
from integrations of the CO-linked methylene (-CO-CH2-) peaks of the CL unit at 2.2–
2.5 p.p.m. and the methylene (-O-CH2-CO) peaks of the GA unit at 4.6–4.8 p.p.m. in the 
1H-NMR spectra. The DP of the CL and GA units for tri-PCG1 were calculated to be 14 
and 3.4, respectively, and for tri-PCG2 they were 14 and 1.5, respectively. The CL/GL in 
the feed was 7.0. If the reactivity of CL and GL was equal, CL/GA should be 3.5 because 
the GL unit contains two GA units. The CL/GA found in tri-PCG1 and tri-PCG2 was 4.1 
and 4.7, respectively. Because these values are 43.5, these results indicate a relatively 
higher reactivity of CL compared with GL. The average lengths of the caproyl-repeating 
units and the glycolyl-repeating units, Lc and Lg, were calculated from the 
1H-NMR 
spectra 16, 17 to be 4.3 and 1.1 for tri-PCG1, respectively. For tri-PCG2, these values were 
4.9 and 1.1, respectively. The melting point (Tm) of tri-PCG1 was observed to be 33 ºC, 
but the Tm of tri-PCG2 was slightly higher at 37 ºC. This difference in Tm reflects the 
slightly higher crystallinity of tri-PCG2 because of its larger Lc. These copolymers both 
had a powder morphology at r.t. in the dry state. A photograph of tri-PCG1 after drying 
is shown in Figure 2.  
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Scheme 1. Synthesis of PCGA-b-PEG-b-PCGA triblock copolymer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. NMR spectrum of PCGA-b-PEG-b-PCGA (tri-PCG1) (CL/GA = 4.1) triblock 
copolymer. 
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Table 1. Characterization of PCGA-b-PEG-b-PCGA triblock copolymers 
Code 
DP of 
CLa) 
DP of 
GA b) 
CL/GA c) LC d) LG d) Tm (°C) e) Mn (Da)f) Mw/Mng) 
tri-PCG1 14 3.4 4.1 4.3 1.1 33 5,100 1.6 
tri-PCG2 14 3.0 4.7 4.9 1.1 37 5,000 1.6 
a) Degree of polymerization of ε-caprolactone unit in a PCGA segment calculated 
from the methylene peaks in 1H-NMR (Figure 1, 2.2-2.5 ppm (f+f’)). 
b) Degree of polymerization of glycolic acid unit in a PCGA segment calculated by 1H-
NMR (Figure 1, 4.6-4.8 ppm (b+b’+b’’+b’’’)). 
c) Molar ratio of caprolactone/glycolic acid in a PCGA segment estimated by 1H-NMR 
(solvent: CDCl3). 
d) Average continuous sequence lengths of caproyl units and glycolyl units, Lc and Lg, 
were calculated by the following equations using data in 1H-NMR (Figure 1). 
LC = (f+f’)/f’  
LG = (b+b’+b’’+b’’’)/f’ 
e) Estimated by a differential scanning calorimeter. 
f) Estimated by 1H-NMR (solvent: CDCl3). 
g) Estimated by size-exclusion chromatography. 
 
 
 
 
 
 
 
Figure 2. Photograph of PCGA1.8k-b-PEG1.5k-b-PCGA1.8k (tri-PCG1) (CL/GA = 
4.1) triblock copolymer after dried under vacuum.  
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2.3.2 Sol–gel transition behavior of uniformly dissolved samples  
   The temperature-responsive sol–gel transition behavior for S-samples (tri-PCG1-S or 
tri-PCG2-S) in PBS as a function of polymer concentration was investigated by the test-
tube inversion method. The results for tri-PCG1-S are shown in Figure 1 as a phase 
diagram. The photographs in Figure 3 show the sol and gel states of tri-PCG1-S in PBS 
(30 wt%). tri-PCG1-S exhibited a sol–gel transition in the concentration range of 15–30 
wt%. The Tgel values of tri-PCG1-S at 20, 25 and 30 wt% were 36, 35 and 32 ºC, 
respectively. The Tgel values of tri-PCG2-S at 20, 25 and 30 wt% were slightly higher at 
38, 36 and 34 ºC, respectively. These results, which can be attributed to the slightly 
shorter hydrophobic segments in tri-PCG2 compared with tri-PCG1, suggest that the 
length of hydrophobic segment had greater influence on Tgel than the crystallinity. 
However, the differences were within 2 ºC and were not significant. The results from the 
rheological study of tri-PCG1-S (30 wt%) are shown in Figure 4 and Table 2. tri-PCG1-
S (30 wt%) showed an increase in storage modulus (G’) as temperature increased, and 
Tgel was observed to be 28.3 ºC. At 37 ºC, G’ was 233 Pa. The maximum value of G’ was 
found to be 279 Pa at 40.4 ºC.  
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Figure 3. Phase diagram of tri-PCG1 aqueous solution (tri-PCG1-S) at various 
concentrations by the test-tube inverting method and photographs of tri-PCG1 aqueous 
solution or hydrogel.  
 
 
Figure 4. Storage modulus (G’) (closed symbol) and loss modulus (G’’) (open symbols) 
as a function of temperature for tri-PCG1-S (▲, △), tri-PCG1-D (■, □)，and tri-PCG1-
D-10 (●, ○) in PBS (pH = 7.4，I = 0.14). The concentration of tri-PCG1 were 30 wt%.  
 
Table 2. Results of rheological studies of the copolymer samples with or without 
PEG2000 
Sample Content of PEG2000 (wt%) 
Tgel 
(ºC ) G’ at 37ºC (Pa) 
G’ max (Pa) 
(TG’max)(ºC)c) 
 Tri-PCG1-Sa) 0 28.3 233 279 (40.4) 
 Tri-PCG1-Db) 0 34.4 225 308 (38.9) 
 Tri-PCG1-D-P10b) 10 31.9 268 304 (39.4) 
a) S-sample, prepared by dissolving in PBS with heating process. 
b) D-sample, prepared by dispersion of freeze-dried polymer in PBS at r.t. 
c) Temperature when the G’ is maximum. 
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2.3.3 Effects of additives on DT  
   The effects of additives on the DT of freeze-dried samples were investigated by a 
nylon mesh test. The effects of additives on the nanoparticle suspension were also 
reported previously. 18 Disaccharides and water-soluble polymers were chosen as the 
additives based on the following expectations: (1) these additives can penetrate into the 
solid-state PCGA segment in the freeze-dried sample to reduce the size of crystals, and 
(2) these additives will not disturb the solidification of the polymers. Importantly, none 
of the additives disturbed solidification, as all of the freeze-dried samples showed a 
cotton-like morphology in air at r.t. (Figure 5a). With the exception of polyvinyl alcohol 
and sodium hyaluronate, all of the mixture samples passed the nylon mesh test, meaning 
that no residual solids were observed on the nylon mesh, and showed a turbid but 
macroscopically homogeneous distribution after several minutes of vortex mixing (Figure 
5b). These samples showed sol–gel transition behavior between 25 and 37 ºC (Figure 5c).  
 
 
 
Figure 5. Photographs of tri-PCG1 containing PEG2000 (10 wt% of polymer) as an 
additive. (a) After freeze-dry, (b) after the addition of PBS and stirring for 20 sec by 
vortex mixer, and (c) after further incubation at 37 ºC. The concentration of tri-PCG1 = 
30 wt%.  
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   The effects of the additives on the DT and sol–gel transition are summarized in Table 
3. It should be noted that because of limitations in the amount of available sample, tri-
PCG2 was used for these experiments rather than tri-PCG1. However, as described above, 
tri-PCG2 had Tgel values that were comparable to tri-PCG1 in the test-tube inverting test, 
and the differences were within 2 ºC. Thus, tri-PCG1 and tri-PCG2 were almost identical 
and would be expected to give similar results here. It took 5 min to obtain a homogeneous 
suspension of additive-free tri-PCG2. As a first step, the effects of additives (included at 
10wt% to tri-PCG2) on shortening DT were investigated. Sucrose, maltose and lactose 
were used as low-molecular-weight additives. Among these, lactose and maltose showed 
slight improvements in DT, but the effects were not significant. We then investigated the 
effects of several water-soluble polymers as additives for shortening DT. Among these, 
PEG2000, PEG4600and MeO-PEG5000 showed a significant shortening effect and reduced 
DT to o1 min (0.3, 0.5 and 0.5 min, respectively). However, the effect of polyacrylic acid 
was not significant, and sodium hyaluronate and polyvinyl alcohol did not give a 
homogeneous suspension. Next, we investigated the effects of mole- cular weight and 
concentration of PEG on the DT of the freeze-dried samples using PEG (Mn = 1000–10 
000). PEGs with molecular weights below 1000 Da were not used as additives because 
they are a waxy paste or liquid at r.t. and may have negative effects for obtaining a powder 
in the dry state. The DTs for PEG1000, PEG1500 and PEG10000 as additives were 4 min at 
all concentrations tested. The 10 wt% of PEG2000 was found to be the best for shortening 
the DT (0.3 min) of tri-PCG2. The obtained macroscopically homogeneous suspension 
exhibited a sol–gel transition between r.t. and body temperature (Figure 5). Finally, we 
investigated the effects of the addition of PEG2000 on the sol–gel transition temperature 
and physical properties of the hydrogel.  
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Table 3. Effects of additives on dispersion time and sol-gel transition of tri-PCG2 
Additive 
Concentration of 
additivea) 
(wt% to polymer) 
Dispersion by 
nylon mesh 
testb) 
Dispersion 
timec)  
(min) 
Sol-gel 
transition 
at 25 – 37ºCd) 
none - + 5.0 + 
PEG1000 
5 + 2.0 + 
10 + 3.0 + 
15 + 2.0 + 
20 + 2.0 + 
PEG1500 
5 + 1.0 + 
10 + 2.5 + 
15 + 2.0 + 
20 + 2.0 + 
PEG2000 
5 + 3.5 + 
10 + 0.3 + 
15 + 1.0 + 
20 + 4.0 + 
PEG4600 
5 + 1.5 + 
10 + 0.5 + 
15 + 2.0 + 
20 + 2.0 + 
PEG10000 
5 + 1.5 + 
10 + 1.0 + 
15 + 2.0 + 
20 + 4.0 + 
MeO-PEG5000 10 + 0.5 + 
PAA 10 + 3.5 + 
PVA 10 - N.D.e) N.D.e) 
HANa 10 - N.D.e) N.D. e) 
Sucrose 10 + 4.0 + 
Lactose 10 + 2.0 + 
Maltose 10 + 2.0 + 
a) Amount of additives in wt% to the copolymer. 
b) Dispersion state determined by the nylon mesh test. +: macroscopically 
homogeneous distribution (no residue was observed by the nylon mesh test),  
-: heterogeneous distribution (residue was observed by the nylon mesh test). 
c) Time to obtain homogeneous distribution state to pass the nylon mesh test. 
d) Determined by test-tube inverting method, +: gelation was observed, -: no gelation 
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was observed. 
e) Not determined. 
 
 
   In addition to the results for tri-PCG1-S, the results of the D-sample with PEG2000 (10 
wt% to tri-PCG1) (tri-PCG1-D-P10) and without additives (tri-PCG1-D) are shown in 
Figure 4 and Table 2. The Tgel of tri-PCG1-D was 34.4 ºC that was higher than that of tri-
PCG1-S (28.3 ºC). This value was slightly higher than the Tm of tri-PCG1 (33 ºC). This 
result suggests that the sol–gel transition can occur after melting of the solid-state cores 
of the micelles for the D-samples. On the other hand, the Tgel of tri-PCG1-D-P10 was 31.9 
ºC, and this was higher than the Tgel of tri-PCG1-S but lower than that of tri-PCG1-D. 
These results indicate that the addition of PEG2000 had a reducing effect on the Tgel of 
the D-sample by penetrating into the solid-state cores of the micelles of the D-sample. tri-
PCG1-D-P10 showed a slightly higher G’ than tri-PCG1-S and tri-PCG1-D. However, 
the maximum G’ (G’MAX) and the temperature when G’ is max maximized (TG’MAX) were 
similar for these three samples. We also investigated the effects of the concentration of 
PEG2000 on the Tgel and physical properties of tri-PCG1-D (Table 4). The Tgel values for 
tri-PCG1-D-P5 (5%), tri-PCG1-D-P10 (10%) and tri-PCG1-D-P20 (20%) were within 
29.9–31.9 ºC and were not considerably different. The concentration of the PEG did not 
have a large effect on Tgel. The G’MAX value of tri-PCG1-D-P20 (151 Pa) was lower than 
those of tri-PCG1-D-P5 and tri-PCG1-D-P10 (231 and 304 Pa, respectively). This result 
suggests that a large amount of PEG may have a negative effect on the physical strength 
of the hydrogel. Moreover, we investigated the evolution of G’ and G” over time for tri-
PCG1-D, tri-PCG1-D-P10 and tri-PCG1-S after heating to 37 ºC (Figure 6 and Table 5). 
The gelation times of these samples were within 1min. These results indicate that the 
addition of PEG2000 does not have a negative effect on the phase transition behavior of 
the samples. For the cases of D-samples containing disaccharides as additives, G’MAX 
values of the hydrogels were significantly lower (80–110 Pa) than those of tri-PCG1-D 
and tri-PCG1-D-P10 (Table 6). Interestingly, the addition of an appropriate amount of 
PEG (10%) slightly improved the physical strength of the hydrogel compared with the 
low- molecular-weight additives. This result may be explained by the appropriate amount 
of PEG having a bridging effect during micelle aggregation. 19 These results are consistent 
with previous reports showing that the aggregation of micelles in block copolymer IP 
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systems was accelerated in the presence of PEG 20. Overall, the mixture of tri-PCG1 and 
10 wt% PEG2000 was the best formulation for achieving rapid dispersion and maximizing 
the physical properties of the hydrogel.  
 
Table 4. Results of rheological studies of the copolymer samples with or without 
PEG2000 
Sample Content of PEG2000 (wt%) 
Tgel 
(ºC ) G’ at 37ºC (Pa) 
G’ max (Pa) 
(TG’max)(ºC)c) 
 tri-PCG1-Sa) 0 28.3 233 279 (40.4) 
 tri-PCG1-Db) 0 34.4 225 308 (38.9) 
 tri-PCG1-D-P5b) 5 29.9 227 231 (37.3) 
 tri-PCG1-D-P10b) 10 31.9 268 304 (39.4) 
 tri-PCG1-D-P20b) 20 31.1 139 151(35.8) 
a) S-sample, prepared by dissolving in PBS with heating process. 
b) D-sample, prepared by dispersion of freeze-dried polymer in PBS at r.t. 
c) Temperature when the G’ is maximum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Storage modulus (G’) (closed symbol) and loss modulus (G’’) (open symbols) 
as a function of temperature for tri-PCG1-S (▲, △), tri-PCG1-D (■, □)，and tri-PCG1-
D-10 (●, ○) in PBS (pH = 7.4，I = 0.14). The tri-PCG1 concentrations were 30 wt%. 
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Table 5. Results of rheological studies of the copolymer samples with or without 
PEG2000 
Sample 
Content of 
PEG2000 (wt%) 
Gelation time 
（min） 
G’ max (Pa) 
(TG’max)(min)c) 
tri-PCG1-S a) 0 0.5 408 (>58) 
tri-PCG1-D b) 0 0.5 420 (>58) 
tri-PCG1-D-P10 b) 10 1 272 (25) 
a) S-sample, prepared by dissolving in PBS with heating process. 
b) D-sample, prepared by dispersion of freeze-dried polymer in PBS at r.t. 
c) Temperature when the G’ is maximum. 
 
Table 6. Results of rheological studies of tri-PCG1-D with disaccharides  
Additive Content of additives added (wt%) Tgel (ºC ) 
G’ (Pa) at 
37ºC 
G’ max (Pa) 
and TG’ max (ºC) 
 Sucrose 10 35.4 28.6 84.9 (40.9) 
 Maltose 10 34.9 26.0 107.3 (40.9) 
 Lactose 10 33.3 32.1 84.2 (39.9) 
 
2.4 CONCLUSIONS  
   We synthesized PCGA-b-PEG-b-PCGA triblock copolymers that exhibited a sol–gel 
transition between r.t. and body temperature and had a powder morphology in the dry 
state at r.t. To prepare a uniformly dissolved solution (S-sample) of the copolymer, a 
heating process (above the Tm) was needed. It took 5 min to obtain a macroscopically 
homogeneous suspension of the copolymer (D-sample) by dispersion of freeze-dried 
samples in PBS with vortex mixing. However, the DT to prepare D-sample could be 
significantly shortened by the addition of PEG before the freeze-drying process. The 
shortest DT (0.3min) was obtained when 10wt% of PEG2000 was used as an additive. The 
obtained suspension of tri-PCG1 and 10 wt% of PEG2000 in PBS (tri-PCG1-D-P10) 
exhibited a temperature-responsive sol–gel transition at 31.9 ºC as well as a slightly 
higher physical strength compared with additive-free samples. The formulation 
developed in this work, which requires a short preparation time from freeze-dried samples 
(< 1 min), should be very convenient for use in clinical applications, as a medical doctor 
could easily prepare an IP formulation in the clinic.  
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Chapter 3 
 
Biodegradable Injectable Polymer Systems 
Exhibiting Temperature-Responsive 
Irreversible Sol-to-Gel Transition by 
Covalent Bond Formation 
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3.1 Introduction 
   In the past several decades, polymer hydrogels have been extensively investigated as 
implantable biomedical materials 1-5, because hydrogels contain a large amount of water 
and have a three-dimensional network possessing some similarities with soft tissues and 
the extracellular matrix. Specifically, in situ gelation systems have received much 
attention as injectable polymer (IP) systems. Such IP solutions are in the sol state before 
injection, and can be mixed with bioactive reagents or living cells. The obtained solution 
or suspension can easily be injected into the body by a simple syringe injection, and 
becomes a hydrogel at the injected site. Biodegradable IP systems are expected to be 
applied as drug releasing depots in drug delivery systems (DDS) 6-8, scaffolds for tissue 
engineering 9-11, materials for adhesion prevention after surgical operations 12-14, 
embolization treatments of blood vessels 15-17, and endoscopic submucosal dissection 
(ESD) materials 18.  
   Several methods of in situ formation of hydrogels in IP systems have been reported. 
Stimuli-responsive IP systems usually can form physically cross-linked hydrogels in 
response to external stimuli such as temperature 19-21, pH, and ionic length 22-24. The 
driving forces of these physically cross-linked gelation systems are mainly hydrophobic 
interactions 25-27, electrostatic interactions 28-30, or stereo-complex formation 31-33. Several 
block copolymers of hydrophilic poly(ethylene glycol) (PEG) and biodegradable 
hydrophobic aliphatic polyesters or polypeptides are known to show temperature-
responsive sol-to-gel transitions between room temperature (r.t.) and body temperature 
by hydrophobic interactions. Typical examples of such aliphatic polyesters are 
poly(lactide-co-glycolide) (PLGA) 34,35, poly(ε-caprolactone) (PCL) 36,37, poly(ε-
caprolactone-co-lactide) (PCLA) 38,39, poly(ε-caprolactone-co-glycolic acid) (PCGA) 
40,41, and poly(ε-caprolactone-co-trimethylene carbonate) (PCTC) 42. Polypeptide 
examples include poly(alanine) 43 and poly(alanine-co-phenyl alanine) 44. These 
temperature-responsive gelation systems, so-called thermo-gelling polymers, that exhibit 
sol-to-gel transitions have an advantage in rapid gelation in response to temperature 
changes. However, hydrogels consisting of such thermo-gelling polymers tend to revert 
to the sol state where a large amount of water or body fluid exists, such as in the 
intraperitoneal space and interior of blood vessels, because the main driving force of 
gelation in these systems is a non-covalent hydrophobic interaction and gel formation is 
an equilibrium process. This property provides an obstacle to the application of IP 
 55 
systems for DDS, scaffolds for tissue regeneration, post-operative anti-adhesives in 
intraperitoneal space and embolization in blood vessels. Therefore, thermo-gelling 
polymer systems with longer and controllable duration time of the gel state in the body 
are needed. On this issue, block copolymers of PEG and PCL (PCL-PEG-PCL, PEG-
PCL-PEG) 36-39 and SC 31-33 forming block copolymer combinations were reported to 
show somewhat irreversible gelation in response to temperature by crystallization of PCL 
block and SC formation of PLLA and PDLA. However, PCL block copolymer systems 
need to be heated above their melting temperature (around 40 °C) to be dissolved in 
aqueous solution, and SC systems must be two-solution-mixing systems.  
   Alternatively, in situ gelation systems by chemical (covalent) cross-linking such as 
polymerization systems and coupling reaction systems have been reported. These 
covalent gelation systems have advantages in longer gel state duration times and 
relatively high mechanical strength of the obtained hydrogels. In a polymerization system, 
a chemically cross-linked hydrogel can be obtained by radical polymerization of vinyl 
(acryl or methacryl) groups attached to a biodegradable backbone polymer 47,48. A 
photoinitiator is typically added to the solution of the polymer carrying polymerizable 
groups, and in situ gelation is achieved upon initiation such as with UV irradiation. 
However, UV irradiation and the photoinitiators are potentially toxic 49, and the polymer 
chains produced by polymerization are not biodegradable. Coupling reaction gelation 
systems are typically mixing systems of two polymers carrying multivalent reactive 
groups, where the polymers can react with each other to form a chemically cross-linked 
hydrogel without UV irradiation. Coupling reaction gelation systems using Michael 
addition 50, alkyne-azide click chemistry 51, Diels-Alder reaction 52, 53, amine/succinimide 
coupling 54,55, and enzymatic 56 reactions have been reported. However, it is generally 
difficult to control the gelation time of these coupling reaction systems, which is a very 
important factor. If the gelation is too slow, the polymer solution may flow from the 
injected site and cause an initial burst of the drugs. If the gelation is too fast, clotting in a 
syringe may occur during the injection process. In addition, in these systems, the injection 
must be carried out immediately after the two solutions are mixed. For this reason, a 
special syringe for mixing two solutions is also needed. Based on the situation above, IP 
systems having the advantages of both systems, temperature-responsive physical gelation 
and covalent bond formation, are desired to achieve favorable gelation time, longer 
duration time of the gel state and biodegradability.  
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   In this study, we prepared novel and simple biodegradable injectable polymer systems 
exhibiting temperature-responsive irreversible gelation through covalent bond formation 
to achieve elongation of the gel state duration time by simply mixing a thermo-gelling 
polymer having reactive groups with a polyamine in solution. Activated ester 
(succinimide ester, OSu) groups were introduced on both termini of a thermo-gelling 
triblock copolymer of PCGA and PEG (PCGA-b-PEG-b-PCGA, tri-PCG) through a 
succinate linker to give a triblock copolymer with attached OSu groups (tri-PCG-SA-
OSu). The micelle solution prepared from the mixture of tri-PCG and tri-PCG-SA-OSu 
was mixed with a polyamine solution. We found that the obtained solution was in the sol 
state after mixing at r.t., and exhibited an irreversible sol-to-gel transition in response to 
a temperature increase by covalent bond formation. We carried out fundamental studies 
on the temperature-responsive sol-to-gel transition behavior, duration time of the gel state 
under physiological conditions, and in vivo and in vitro biocompatibility of the hydrogels 
to apply this system in injectable biomedical materials. 
 
3.2 Experimental section 
3.2.1 Materials  
   Poly(ethylene glycol) (PEG) (molecular weight (MW) = 1,540 and 2,000 Da) 
(PEG1500, PEG2000), ε-caprolactone (CL), tin 2-ethylhexanoate [Sn(Oct)2], N,N’-
dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP) and N-
hydroxysuccinimide (NHS) were purchased from Wako Pure Chemical Ind. (Osaka, 
Japan). Glycolide (GL) was obtained from Musashino Chemical Laboratory, Ltd. (Tokyo, 
Japan). 4-Armed branched polyethylene glycol having terminal amine groups (4-arm 
PEG-NH2, MW = 5,000) was prepared from 4-arm PEG-OH (see Supporting 
Information) supplied from NOF Co. (Tokyo, Japan) and dried under vacuum at 120 °C 
prior to use. Hydrochloride salts of L-Lysine (Lys), Lys-Lys, and Lys-Lys-Lys, poly-L-
Lysine hydrobromide (MW = 5,000 or 15,000 Da) (PLys5k or PLys15k), PEI 
(polyethyleneimine, MW = 10,000 Da) and BSA (bovine serum albumine) were 
purchased from Sigma-Aldrich (St. Louis, USA). Fetal calf serum (FCS) was obtained 
from Thermo Fisher Scientific (Waltham, USA). Eagle’s minimum essential medium (E-
MEM) was purchased from Nissui Pharmaceutical Co. (Tokyo, Japan). Sprague–Dawley 
(SD) rats (7 weeks old, average body weights 150 g) were purchased from Japan SLC, 
Inc. (Hamamatsu, Japan). The other reagents were commercial grade and used without 
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further purification.  
 
3.2.2 Measurements 
   1H nuclear magnetic resonance (1H-NMR) spectra were recorded on a nuclear 
magnetic resonance spectrometer (400 MHz, JNM-GSX-400, JEOL) using deuterated 
solvent (CDCl3 or D2O). The chemical shifts were calibrated against tetramethylsilane 
(TMS) and/or solvent signal. The number-average molecular weights (Mn) were 
calculated from 1H-NMR spectra. The weight-average molecular weights (Mw) and 
polydispersity indexes (Mw/Mn) of the polymers were determined by size exclusion 
chromatography (SEC) (column: TSKgel Multipore HXL-M × 2, detector: RI). The 
measurements were performed using DMF as an eluent at a flow rate of 1.0 mL min-1 at 
40 °C using a series of PEG as standards.  
 
3.2.3 Synthesis 
   We synthesized PCGA-b-PEG-b-PCGA triblock copolymer (tri-PCG) as a thermo-
gelling polymer by ring-opening copolymerization of CL and GL in the presence of 
PEG1500 or PEG2000 as a macroinitiator and Sn(Oct)2 as a catalyst at 160 °C for 12 h 
according to the method reported previously41 (Scheme 1). Typical procedures are as 
follows. PEG1500 (15.1 g, 9.82 mmol) in a 100-mL flask with a stopcock was dried under 
vacuum at 140 ºC for 3 h. After cooling to r.t., CL (31.7 g, 278 mmol), GL (5.37 g, 46.3 
mmol) [molar ratio of CL to GL (CL/GL) was 6.0] and Sn(Oct)2 (131 mg, 32.2 µmol) 
were added to the flask and dried under vacuum at r.t. for 12 h. Polymerization was then 
carried out at 160 ºC for 12 h by soaking the flask in an oil bath. The product was purified 
by reprecipitation using chloroform (100 mL) as a good solvent and diethylether (1000 
mL) as a poor solvent to give a white solid of tri-PCG (tri-PCG-1). Similar procedures 
were carried out using PEG2000 to give tri-PCG-2 having different PEG and PCGA lengths. 
Mn and the average degrees of polymerization for CL and glycolic acid (GA) units in a 
PCGA segment were estimated by 1H-NMR (solvent: CDCl3). Average continuous 
sequence lengths of caproyl units and glycolyl units (Lc and Lg) in a PCGA segment were 
also estimated from 1H-NMR spectra according to the literature41.  
   PCGA-b-PEG-b-PCGA with OSu groups attached on both termini (tri-PCG-SA-OSu) 
was synthesized using tri-PCG-1 according to the method described in Scheme 2. 
Hydroxy-termini of tri-PCG-1 were converted to COOH groups by the reaction with 
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succinic anhydride as follows. tri-PCG-1 (19.9 g, 3.85 mmol) was dried under vacuum at 
130 ºC. The mixture of tri-PCG-1 and succinic anhydride (3.87 g, 38.6 mmol) was 
dispersed in anhydrous toluene (30 mL) and refluxed at 140 ºC for 24 h. The reaction 
mixture was cooled to r.t. and filtered by suction filtration to remove unreacted succinic 
anhydride. The obtained tri-PCG-SA-OH was dried under vacuum at r.t. for 24 h. DCC 
(1.77 g, 8.47 mmol) dissolved in dichloromethane (5 mL) was added dropwise into the 
tri-PCG-SA-OH (20.6 g, 3.85 mmol) in dichloromethane (70 mL) and then stirred at 0 ºC 
for 2 h. DMAP (364 mg, 3.08 mmol) and NHS (1.43 g, 12.3 mmol) dissolved in 
dichloromethane (5 mL) were added to the reaction mixture, which was further stirred at 
r.t. for 24 h. The reaction mixture was filtered by suction filtration to remove the 
dicyclohexylurea formed. The filtrate was evaporated and reprecipitated using 
chloroform (50 mL) as a good solvent and a mixture of diethylether and methanol (10/1, 
v/v) (1000 mL) as a poor solvent. The obtained white solid was dried under vacuum for 
72 h to give tri-PCG-SA-OSu. 
 
3.2.4 Preparation and Sol-to-Gel Transition Behavior of IP Formulation  
   The sample polymer solutions (IP formulations) were prepared as follows. 
Predetermined amounts of copolymers, tri-PCG-1 and tri-PCG-SA-OSu, were mixed 
(molar ratio = 1:1) in the solid (powder) state, and placed in a sample tube with phosphate 
buffered saline (PBS) (10 mM, pH = 7.4). After shaking with a vortex mixer for 1 min at 
r.t., the obtained dispersion was heated at 60 ºC above the melting temperature (Tm) of 
the copolymers for 5 sec, and further stirred by a vortex mixer for 1 min at r.t. The tube 
was immersed in ice-cold water for 10 min. These procedures were repeated until the 
mixture was in the sol state without an insoluble part. The obtained solution was then 
sonicated in a bath-type sonicator for a few minutes to give a clear solution. The pH of 
the solution was adjusted to 7.4 by adding a small amount of 1 M NaOH aq. or HCl aq. 
A predetermined amount of PLys5k (or other polyamines) was dissolved in PBS. The 
PLys5k solution and the polymer (mixture of tri-PCG-1/tri-PCG-SA-OSu) solution 
prepared above were then mixed together in a vial at r.t. (OSu : NH2 = 1 : 1, final polymer 
concentration: 25 wt%). The obtained IP formulation is expressed as F(P1/S+PLys5k), 
where P1/S is the mixture of tri-PCG-1 (P1) and tri-PCG-SA-OSu (S). The other IP 
formulations, tri-PCG-1 alone, mixture of tri-PCG-1 and tri-PCG-SA-OSu without 
PLys5k, and mixture of tri-PCG-1 and PLys5k, were expressed as F(P1), F(P1/S), and 
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F(P1+PLys), respectively, and used as controls. 
   The sol-to-gel transition behavior of the IP formulations was investigated by a test-
tube inverting method10. A vial containing sample solution was immersed in a water bath 
at the desired temperature for 15 min, removed from the water bath, then inverted 
repeatedly to determine Tgel based on the criteria of ‘‘flow’’ (= sol) and ‘‘no flow’’ (= gel) 
in 30 sec, with a temperature increment of 1 °C per step. Measurements were repeated 
three times for each temperature to determine the transition temperature in the phase 
diagram.  
 
3.2.5 Rheological Studies  
   Temperature dependent and time course rheological measurements on the 
temperature-induced sol-to-gel transition of the IP formulations were carried out by using 
a dynamic rheometer (Thermo HAAKE RS600, Thermo Fisher Scientific, Waltham, MA, 
USA). A solvent trap was used for preventing vaporization of the solvent. Each sample 
was placed between parallel plates (25 mm diameter and 1.0 mm gap) using a syringe. 
The data was collected under controlled stress (4.0 dyn/cm2) and a frequency of 1.0 rad/s. 
For temperature dependent measurements, the heating rate was 0.5 °C/min. The storage 
modulus (G’) and loss modulus (G”) of the formulations in the range of 20-50 °C were 
monitored and the gelation temperature (Tgel) was defined as the cross-over point of G’ 
and G”. To determine the reversibility (irreversibility) of the sol-to-gel transition of the 
samples, G’ and G” values were monitored upon temperature changes as follows. The 
sample was placed in the dynamic rheometer at 25 °C, and kept for 5 min. The 
temperature was then raised to 37 °C. After another 5 min, the temperature was decreased 
to 25 °C and the G’ and G” values were monitored for 60 min. For investigation of 
mechanical properties after gelation for a longer time course, the temperature was 
increased from r.t. to 37 °C, and kept at 37 °C, while G’ and G” values were monitored 
for 400 min.  
 
3.2.6 Determination of Covalent Gel Fraction  
   To confirm and evaluate the covalent cross-linking formation in the hydrogel upon 
the temperature-responsive sol-to-gel transition, the amount of insoluble fraction against 
DMSO for the F(P1/S+PLys5k) hydrogel was measured. The formulation 
F(P1/S+PLys5k) (300 µL) in a vial was heated up to 37 °C and kept at 37 °C. After a 
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given period, DMSO (1 mL) was added to dissolve the soluble polymers, which were not 
covalently bonded, and then the supernatant was removed. This process was repeated 4 
times. The obtained precipitate was washed with water (1 mL, 2 times) and acetone (1 
mL, 2 times), and dried in vacuo before weighing. 
 
3.2.7 Duration Time of Gel State  
   To determine the duration time of the gel state and to investigate the swelling and 
hydrolytic degradation behavior in PBS, hydrogels soaking in PBS were observed for 
predetermined periods. Each sample (300 µL) in a small glass tube (2.5 mL; diameter: 10 
mm; height: 35 mm) was incubated at 37 °C for 1 min to produce the hydrogel. Each 
hydrogel obtained in the small glass tube without a cap was placed at the bottom of a 
larger (30 mL) sample tube (diameter: 30 mm; height: 63 mm) filled with PBS (25 mL) 
at 37 °C to immerse the small glass tube entirely. After picking up the small glass tube 
from the larger sample tube and removing the supernatant carefully, the sol or gel state of 
each sample was determined by the test-tube inverting method, and the weight of the 
remaining swelled hydrogel was measured. The weight change of the gel fraction (%) 
was calculated by the following equation: 
Weight of gel fraction (%) = (Wt / W0) ´ 100  
where Wt is weight of the gel fraction at each sampling time, and W0 is initial weight of 
the gel fraction.  
 
3.2.8 Cytotoxicity  
   To evaluate the cytocompatibility of the IP formulations, the cytotoxicity of the 
diluted solution of IP formulations was investigated against L929 mouse fibroblast cells 
by the WST-8 assay. L929 mouse fibroblast cells (100 µL, 1.0 × 104 cells/mL) in E-MEM 
containing 10% FCS were seeded into a 96-well microplate and cultured in a humidified 
atmosphere containing 5% CO2 at 37 °C. After preincubation for 24 h, aliquots of a 
sample solution were added to the wells, which were then further incubated for 24 h. 
Thereafter, 10 µL of WST-8 reagent (Dojindo, Tokyo, Japan) was added to the cell culture 
medium and incubation continued for another 3 h. The absorbance of each well at 450 
nm was measured by a microplate reader. Data are expressed as mean + SD (n = 12). The 
cell viability was calculated using the following equation:  
cell viability (%) = Nt / Nc × 100 
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where Nt and Nc are the number of cells with and without samples after 24 h of incubation, 
respectively. Moreover, the cytotoxicity of hydrolysates of the IP hydrogels was also 
investigated.  
 
3.2.9 In Vivo Gel Formation and Duration of Gel State  
   In vivo gel formation after injection and duration of the gel state for the IP 
formulations were investigated using female SD rats. The IP formulations (25 wt%, 200 
µL) were injected subcutaneously into rats using a syringe with a 25-gauge needle after 
anesthetizing the rats with isoflurane. The rats were sacrificed on days 1 or 8 after 
injection, and the state of the hydrogel and tissue around the hydrogel were observed by 
naked eyes. Histological section samples were prepared by hematoxylin-eosin (HE) 
staining (Applied Medical Research Laboratory Co.). Moreover, a part of the residual 
hydrogel was removed from the injection sites for evaluation by rheological 
measurements. These animal experiments were approved by the guidelines of animal 
experiments given at Kansai University. 
 
3.3 Results and discussion 
3.3.1 Synthesis of tri-PCG and tri-PCG-SA-OSu 
   An ABA-triblock copolymer of PCGA and PEG, tri-PCG-1, was synthesized 
according to Scheme 1 by ring-opening copolymerization of CL and GL in the presence 
of PEG1500 as a macroinitiator. Table 1 summarizes the characterization results of the 
obtained tri-PCG-1. The Mn of the hydrophobic PCGA segment was about 1,800 Da and 
the total Mn was 5,200 Da for tri-PCG-1, where MW of the PEG segment was 1,540 Da. 
Degrees of polymerization of CL and GA units in the PCGA segment were 14 and 3.8, 
respectively, and the molar ratio of CL/GA was 3.6 estimated from 1H-NMR spectra41. 
Average continuous sequence lengths of caproyl units and glycolyl units, Lc and Lg, were 
3.7 and 1.0, respectively41. Tri-PCG-SA-OSu was synthesized using tri-PCG-1 (Scheme 
2). The characterization results of tri-PCG-SA-OSu are also shown in Table 1. The degree 
of substitution of OSu group/OH groups was calculated to be 98% based on the 1H-NMR 
spectra (Figure 1). A slight increase in molecular weight was observed in the SEC profiles 
upon the introduction of SA-OSu groups (Figure 2). IR spectra of tri-PCG-1 and tri-PCG-
SA-OSu were also differential IR spectrum of tri-PCG-1 and tri-PCG-SA-OSu. IR spectra 
were recorded on a spectrometer FT/IR-4200 Type A (JASCO) for tri-PCG-1 and tri-
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PCG- SA-OSu by KBr methods. The results are shown in Figure 3. The difference was 
not clear in the original spectra of tri-PCG-1 and tri-PCG-SA-OSu. But in the differential 
spectra (Figure 3(b)) the absorbance of succinimide ester group was clearly observed at 
1740, 1780, and 1820 cm-1.  
The obtained tri-PCG-1 and tri-PCG-SA-OSu were powders in the dry state at r.t. 
(Figure 4).  
 
Scheme 1. Synthesis of PCGA-b-PEG-b-PCGA triblock copolymer (tri-PCG). 
 
 
Scheme 2. Synthesis route for tri-PCG-SA-OSu. 
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Table 1. Characterization of triblock copolymers (tri-PCG) and tri-PCG-SA-OSu  
Code Mn (Da) b) Mw (Da) c) Mw/Mn c) Degree of substitution (%) d) 
Tri-PCG 5,200 6,500 1.4 - 
Tri-PCG-SA-OSu 5,100 7,600 1.4 98 
a) Molar ratio of CL/GA in a PCGA segment estimated from 1H-NMR spectra. 
b) Number-average molecular weight estimated from 1H-NMR spectra. 
c) Estimated by size-exclusion chromatography (eluent: DMF, standard: PEG). 
d) Degree of substitution of OSu group calculated by 1H-NMR. 
 
 
Figure 1. 1H-NMR spectra for (a) tri-PCG, (b) tri-PCG-SA-OH and (c) tri-PCG-SA-OSu 
in CDCl3. Left: 0-8.0 ppm, right: 2.5-3.2 ppm  
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Figure 2. SEC elution curves for tri-PCG-2 (dotted line) and tri-PCG-SA-OSu (solid line) 
(eluent: DMF, standard: PEG).  
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Figure 3. Top: IR spectra for (a) tri-PCG and (b) tri-PCG-SA-OSu. Bottom: Differential 
IR spectra of tri-PCG-SA-OSu and tri-PCG in 1700-1850 cm-1.  
 
 
 
Figure 4. Photographs of (a) tri-PCG-1 and (b) tri-PCG-SA-OSu in dry state at r.t. 
 
 
 
 
 
 
 
 
 
Wavenumbers (cm-1)
Tr
an
sm
itt
an
ce
170017201740176017801800182018401860
 66 
3.3.2 Sol-to-gel Transition Behavior  
   We investigated the temperature-responsive sol-to-gel transition behavior of the tri-
PCG-1 solution and a mixture of tri-PCG-1 and tri-PCG-SA-OSu solution [tri-PCG/tri-
PCG-SA-OSu = 1/1 (mol/mol)] by the test-tube inversion method. The phase diagram of 
the tri-PCG-1 solution is shown in Figure 5a. The tri-PCG-1 solution exhibited a 
temperature-responsive sol-to-gel transition at concentrations over 15%. Tgel of tri-PCG-
1 at 25 wt% was 33 °C. The pure tri-PCG-SA-OSu was difficult to dissolve in PBS, and 
only a 25 wt% solution exhibited the sol-to-gel transition at 42 °C (Figure 5b). The tri-
PCG-SA-OSu solutions (15-20 wt%) showed a sol-to-precipitate transition with 
increasing temperature. It is known that the sol-to-gel transition behavior of amphiphilic 
block copolymers is strongly dependent on the hydrophobic-hydrophilic balance of the 
block copolymers: increasing hydrophobicity leads to a decrease in Tgel. These results 
suggest that substitution of OH groups with SA-OSu groups on the copolymer termini 
affected the hydrophilic-hydrophobic balance of the copolymer by increasing the 
hydrophobicity. Therefore, we employed a mixing strategy to prepare chemically reactive 
micelles exhibiting temperature-responsive sol-to-gel transitions between r.t. and body 
temperature. The phase diagram of the 1:1 mixture of tri-PCG-1 and tri-PCG-SA-OSu 
was similar to that of tri-PCG-1 (Figure 5c). The mixture solution exhibited the 
temperature-responsive sol-to-gel transition at concentrations over 15%. The Tgel value 
of the mixture solution was 34 °C at 25 wt%, quite similar to tri-PCG-1 (33 °C, 25 wt%). 
These results indicate that mixing with tri-PCG-SA-OSu (less than 50 mol%) did not have 
a great influence on the sol-to-gel transition behavior of the tri-PCG-1 solution. We also 
investigated the temperature-responsive sol-to-gel transition behavior of tri-PCG/tri-
PCG-SA-OSu in the presence of PLys5k [F(P1/S+PLys5k)]. The Tgel for the IP 
formulation F(P1/S+PLys5k) [total block copolymer concentration = 25 wt%, tri-
PCG/tri-PCG-SA-OSu = 1/1 (mol/mol), [OSu] = [NH2] = 62 mM, [PLys5k] = 1.2 wt%] 
was 34 °C, the same as the tri-PCG/tri-PCG-SA-OSu mixture solution. The addition of 
PLys5k had no significant influence on the sol-to gel transition phenomenon of the tri-
PCG/tri-PCG-SA-OSu mixture at the first temperature increase. 
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Figure 5. Phase diagrams of (a) tri-PCG-1, (b) tri-PCG-SA-OSu and (c) mixture of tri-
PCG-1 and tri-PCG-SA-OSu (1/1) (mol/mol) in PBS. ●: Sol, ✖: Gel, ▲: Precipitate. 
Insets are photographs of the polymer solutions (25wt%) at 25°C and 37°C.  
 
 
   The sol-to-gel transition behavior of these IP formulations was also investigated by 
rheological measurements. The results of temperature-dependent measurements on G’ 
and G” for the IP formulations (total polymer concentration = 25 wt%) are shown in 
Figure 6. In these measurements, Tgel is defined as the temperature at which G’ exceeds 
G”. Tgel for F(P1/S+PLys5k) was 35.2 °C and the maximum G’ (G’max) value was 
observed to be 105 Pa at 41.3 °C. The Tgel values for F(P1/S), F(P1+PLys5k) and F(P1) 
were 33.4, 35.2 and 33.4 °C, respectively (Table 2). These results suggested that the 
addition of PLys5k slightly increased the Tgel value of the solution.  
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Figure 6. Storage (G’, closed symbol) and loss modulus (G”, open symbol) of 
F(P1/S+PLys5k) (■,□), F(P1/S) (◆, ◇), F(P1+PLys5k) (▲, △) and F(P1) (●,○) 
aqueous solutions (25wt%, pH = 7.4) as a function of temperature. Total polymer 
concentration = 25wt%. 
 
 
Table 2. Results of rheological studies  
Code Tgel (°C) G’ (Pa) (400 min) 
tri-PCG-1/tri-PCG-SA-OSu + PLys5k 35.2 389 
tri-PCG-1/tri-PCG-SA-OSu 33.4 202 
tri-PCG-1 + PLys5k 35.2 194 
tri-PCG-1 33.4 373 
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   The reversibility (and irreversibility) of the sol-to-gel transition behavior of the IP 
formulations was investigated after heating (37 °C) and cooling (4 °C) by the test-tube 
inverting method (Figure 7). All of the IP formulations exhibited sol-to-gel transitions 
upon heating from r.t. to 37 °C within 30 sec. After cooling at 4 °C for 1 min, 
F(P1/S+PLys5k) was still in the gel state, although F(P1/S) without PLys5k, 
F(P1+PLys5k) and F(P1) reverted to the sol state at the same condition. These results 
show that the sol-to-gel transition of F(P1/S), F(P1+PLys5k) and F(P1) was reversible, 
but irreversible for F(P1/S+PLys5k). F(P1/S+PLys5k) did not show gelation after mixing 
with PLys5k solution at 25 °C, and remained in the sol state for more than 24 h incubation 
at 25 °C (Figure 8). However, after incubation at 25 °C for 24 h, F(P1/S+PLys5k) 
exhibited a sol-to-gel transition upon heating at 37 °C, indicating that the sol-to-gel 
transition ability was preserved during the incubation at 25 °C. These results suggest that 
covalent bond formation occurred between PLys5k and tri-PCG-SA-OSu only upon the 
temperature-induced sol-to-gel transition. To eliminate the possibility that just increasing 
the temperature to 37 °C caused the covalent bonds to form, we carried out a control 
experiment using a copolymer that did not show Tgel around 37 °C (tri-PCG-2). We 
synthesized tri-PCG-2 having longer PEG (2,000 Da) and shorter PCGA segments (1,050 
Da) compared with tri-PCG-1 according to a method similar to the one described above 
(Table 3). Tri-PCG-2 and the mixture of tri-PCG-2/tri-PCG-SA-OSu solution did not 
show a sol-to-gel transition below 65 °C (Figure 6a). The formulation F(P2/S+PLys5k) 
[total block copolymer concentration = 25 wt%, tri-PCG-2/tri-PCG-SA-OSu = 1/1 
(mol/mol), [OSu] = [NH2] = 62 mM] did not exhibit sol-to-gel transition behavior for 1 
day kept at 37 °C (Figure 6b). These results suggest that a temperature increase alone was 
not the trigger for covalent bond formation; covalent bond formation occurred only upon 
the sol-to-gel phase transition.  
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Figure 7. Photographs of (a) F(P1/S+PLys5k), (b) F(P1/S), (c) F(P1+PLys5k) and (d) 
F(P1) after heating at 37 °C for 1 min and subsequent cooling at 4 °C for 1 min. 
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Figure 8. (a) Photographs of F(P1/S+PLys5k) just after mixing with PLys5k and 1 day 
for at 25 °C, subsequent heating at 37°C and cooling 4°C.  
 
 
Table 3. Characterization of tri-PCG-2 
Code Mn(Da)a) Mw(Da)b) Mw/Mnb) DP of 
CLc) 
DP of 
GAc) 
CL/GA LC LG 
Tri-PCG-2 4,100 5,700 1.4 8.0 2.2 3.7 3.6 1.0 
a)  Estimated by 1H-NMR (solvent: CDCl3).   
b)  Estimated by SEC (eluent: DMF, standard: PEG).   
c)  Degree of polymerization (DP) of CL and GA unit in a PCGA segment estimated 
from 1H-NMR.   
d)  Molar ratio of CL/GA in a PCGA segment estimated by 1H-NMR.   
e)  Average continuous sequence lengths of CL and GA units (Lc and Lg) calculated 
from 1H-NMR.  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Figure 9. (a) Photographs for tri-PCG-2 solution in PBS (25wt%) at 25, 37, 65°C. (b) 
Photographs of F(P2/S+PLys5k) after heating at 37°C for 1 min and 1day.  
 
   The reversibility (or irreversibility) of the sol-to-gel transition of the IP formulation 
was also investigated by rheological measurements. G’ and G” values for the IP 
formulations upon heating and subsequent cooling are shown in Figure 10. The G’ values 
for all IP formulations surpassed the G” values immediately upon heating to 37 °C, 
indicating sol-to-gel transitions. After 5 min of incubation at 37 °C, the samples were 
cooled to 25 °C. The G’ values for F(P1/S), F(P1+PLys5k) and F(P1) decreased below 
the G” within 20 min after cooling to 25 °C, indicating gel-to-sol transitions. Therefore, 
the sol-to-gel transitions for these IP formulations were reversible. On the other hand, the 
G’ value for F(P1/S+PLys5k) remained higher than the G” value for at least 60 min, 
maintaining the gel state; the sol-to-gel transition for F(P1/S+PLys5k) was irreversible. 
These results suggest that covalent bond formation occurred in F(P1/S+PLys5k) upon the 
temperature-induced sol-to-gel transition and some amount of covalent cross-linking 
points were formed in the hydrogel network. 
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Figure 10. symbols) for (a) F(P1/S+PLys5k) (■,□), (b) F(P1/S) (◆, ◇), (c) 
F(P1+PLys5k) (▲, △) and (d) F(P1) (●,○) after heating to 37 °C and subsequent 
cooling to 25 °C. Total copolymer concentration = 25 wt%. Temperature change schedule 
is shown at the bottom of each figure.  
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   To confirm the formation of a covalently cross-linked hydrogel for the 
F(P1/S+PLys5k) system, we estimated the amount of covalently cross-linked (insoluble) 
fraction in the hydrogel. The hydrogel formed by heating to 37 °C was kept at 37 °C. 
After a certain period, DMSO as a good solvent for the copolymers and PLys5k was added 
to the hydrogel to dissolve the non-cross-linked polymers. The obtained insoluble part 
was washed with water and acetone, and dried. 300 µL of the original F(P1/S+PLys5k) 
consists of 36.1 mg of tri-PCG-1, 38.9 mg of tri-PCG-SA-OSu and 2.5 mg of PLys5k. 
The weight fractions of hydrogel insoluble against DMSO, acetone and water after 1 min, 
60 min, 3 hours and 24 hours were 9.8, 20.1, 22.3 and 22.5 mg, respectively. These results 
indicated that cross-linked tri-PCG-SA-OSu molecules were about 23% and 48% of total 
tri-PCG-SA-OSu after 1 and 60 min, respectively, and reached a plateau around 53% in 
3 hours (Figure 11). Thus, while covalent cross-linking was in fact occurring in this 
system, not all of the tri-PCG-SA-OSu in the system took part in the cross-linked network. 
 
 
Figure 11. The amount of insoluble fraction as a function of incubation time after 
temperature raising to 37°C. Insoluble fraction ratio (%) = (weight of insoluble fraction) 
/ (weight of tri-PCG- SA-OSu in the initial sample) × 100  
 
   Considering these results, a mechanism for the formation of covalent cross-links in 
F(P1/S+PLys5k) during the sol-to-gel transition can be proposed as illustrated in Figure 
12. Below Tgel, the tri-PCG-1/tri-PCG-SA-OSu mixture is dissolved in flower-like 
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micelle form. The OSu groups on the tri-PCG-SA-OSu termini exist inside of a 
hydrophobic micelle core, and do not have contact with PLys5k in the aqueous phase. 
Upon the temperature increase, dehydration of PEG segments and shrinking of the free 
volume of PEG occurs to allow perturbation of the micelles and exposes hydrophobic 
cores including OSu groups to the aqueous phase. This phenomenon causes micellar 
aggregations and allows attack of the NH2 groups of PLys5k on the OSu groups exposed 
on the micelle surfaces, forming covalent bonds. Finally, the micelle aggregations form a 
fibrous network of a physically cross-linked hydrogel and partial covalent cross-links in 
the fibers are formed. Because of the existence of covalent cross-linking, the gel-to-sol 
transition upon cooling does not occur. The exposure of hydrophobic PCGA segments 
and OSu groups of the copolymer was also suggested by 1H-NMR studies of a diluted 
aqueous solution of tri-PCG/tri-PCG-SA-OSu at 25 °C and 37 °C (Figure 13). To 
investigate environmental changes of PCGA segments and OSu groups of tri-PCG-1/tri-
PCG-SA-OSu mixture micelles upon increasing temperature, 1H-NMR spectra of tri-
PCG-1/tri-PCG-SA-OSu were measured. 1H-NMR spectra of the tri-PCG-1/tri-PCG-SA-
OSu (1:1) solution in D2O (10 wt%) at 25 and 37 °C are shown in Figure 13. In CDCl3, 
methylene protons of PEG (around 3.6 ppm) and PCGA (1.0-2.0 ppm) segments in CP-
OSu exhibited sharp peaks (Figure 13), because CDCl3 is a good solvent for both PEG 
and PCGA segments. On the other hand, in D2O, methylene protons of PEG were 
observed as sharp peaks, but the methylene protons of the PCGA segment and OSu group 
were broad peaks at 25 °C, because D2O is a good solvent for PEG, but a poor solvent for 
the PCGA segment and OSu group. These results suggest that tri-PCG-1/tri-PCG-SA-
OSu was dissolved in water as a core-shell type micelle, where PCGA segments 
containing OSu groups form hydrophobic cores and PEG segments form hydrophilic 
shells. The OSu groups on the termini of the PCGA segment existed in the micelle core 
and were covered by the PEG shell. Upon increasing temperature to 37 °C, peaks of PEG, 
PCGA segment and OSu groups were slightly shifted downfield, and the peak of the OSu 
group became sharp. Furthermore, the integral ratio of PCGA segments slightly increased, 
and the relative integral ratio (a)/(b) for PCGA (a) to PEG (b) increased from 1.08 to 1.19. 
These results suggest that the PCGA segment and OSu group were exposed to the aqueous 
environment upon increasing temperature, which induced micelle aggregation and 
consequent sol-to-gel transition. These phenomena must occur in the F(P1/S+PLys) 
system, which allows the OSu groups to make contact with the NH2 groups of PLys in 
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the aqueous phase to form covalent bonds. The aggregation phenomenon of the micelles 
upon increasing temperature was also confirmed by DLS measurements of the diluted 
solution (Figure 14 and Table 4). To confirm the occurrence of micelle aggregation, the 
hydrodynamic diameters (Dh) and size distributions of F(P1/S+PLys), F(P1/S) and F(P1) 
micelles in water under diluted condition (0.5 wt%) at 25 °C and 37 °C were investigated 
by dynamic light scattering (DLS) measurements. The Dh and polydispersity index (PDI) 
of the polymer aggregates or micelles in aqueous solution were measured by dynamic 
light scattering (DLS) (Malvern Instruments, Ltd., Zetasizer nano Z ZEN2600) at 25 or 
37 °C using a detection angle of 173° with a He-Ne laser as the incident beam. The 
copolymer was dissolved in a small amount of acetone and added dropwise to phosphate 
buffered saline (PBS, pH = 7.4). After stirring for 20 min, acetone was removed by 
evaporation. The final polymer concentration was 0.5 wt%. Before the DLS 
measurements, sample solutions were filtered with a filter (pore size: 0.2 µm). The results 
are summarized in Figure 14. As the temperature increased from 25 °C to 37 °C, an 
increase in Dh value was observed for all samples. These results support that the sol-to-
gel transition at high concentration was induced by temperature-induced micelle 
aggregation. The Dh values for F(P1/S+PLys), F(P1/S) and F(P1) at 25 °C were almost 
the same, but at 37 °C the Dh value of F(P1/S+PLys) was larger than those of F(P1/S) 
and F(P1), suggesting the aggregation of micelles by covalent bonds in addition to 
hydrophobic interactions. 
 
 
 
Figure 12. Schematic illustration for temperature-responsive irreversible sol-to-gel 
transition mechanism of F(P1/S+PLys5k) while increasing temperature from r.t. to body 
temperature.  
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Figure 13. 1H-NMR spectra of tri-PCG/tri-PCG-SA-OSu in D2O (10wt%) at 25 and 37°C. 
(a) CH2 of PEG and (b) CH2 of caployl unit and (c) OSu group of CP-OSu. Left: 0-6 ppm, 
right: 2.5-3.1 ppm.  
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Figure 14. Size distribution for (a) F(P1/S+PLys5k) (■), (b) F(P1/S) (◆) and (c) 
F(P1) (●) in PBS at 25 and 37°C.  
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Table 4. Z-average of diameter and size distributions for diluted F(P1/S+PLys5k), 
F(P1/S) and F(P1) in PBS at 25 and 37°C. Polymer concentration was 0.5wt%. 
Sample Temperature (°C) Dh (Z-average) (nm) PDI 
F(P1/S+PLys5k) 25 25.6 0.22 
 37 106 0.07 
F(P1/S) 25 26.6 0.29 
 37 96.4 0.14 
F(P1) 25 27.5 0.26 
 37 64.0 0.25 
 
 
   We also monitored the time course of G’ and G” values of the IP formulations for a 
longer time (0 - 400 min) while maintaining the temperature at 37 °C (Figure 15). G’ and 
G” values of the IP formulations increased gradually and reached plateaus in ca. 200-400 
min. The G’ values after 400 min are also summarized in Table 2. The F(P1+PLys5k) 
system showed a smaller G’ value (194 Pa) compared with F(P1). The addition of PLys5k 
to F(P1) had a negative effect on the mechanical strength of the hydrogel. Furthermore, 
the G’ value of the F(P1/S+PLys5k) system was 389 Pa, higher than those of F(P1/S) 
and F(P1+PLys5k). These results indicate that partial covalent cross-linking contributed 
to enhance the physical strength of the hydrogel. During the process, no obvious 
degradation of the polymer was observed (Table 5 and Figure 16). However, the storage 
modulus of F(P1/S+PLys5k) system was not very high (<400Pa) even after 400 min. The 
storage modulus of this system was larger than first  
34 generation thermo-gelling polymers such as PLGA-PEG-PLGA, but smaller than the 
recent thermo-gelling polymer systems exhibiting higher mechanical strength by crystal 
formation or branched structures 10,33,36-39. It may not be enough to keep gel shape after 
in vivo injection. However, such thermo-gelling polymer system have enough physical 
polymers having higher crystallinity (higher content of PCL) or polymers having strength 
to be utilized for anti-adhesive materials and temporal embolization of treatment of blood 
vessels. Moreover, the physical strength of the system can be improved by using branched 
structures. Enlargement of tri-PCG-SA-OSu content in the formulation may be 
F(P1+PLys5k) and F(P1) became sol states within 1 day during incubation at 37 °C 
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[Figure 6 (b)(c)(d)]. These results suggest that physical cross-linking of these systems is 
another and simple possibility. In this study, we employed mixing strategy because tri- 
PCG-SA-OSu prepared here did not show water-solubility and appropriate sol-gel 
transition temperature. But, it probably is possible to prepare tri-PCG-SA-OSu exhibiting 
water-solubility and sol-gel transition temperature between r.t. and body temperature by 
employing a shorter hydrophobic segment or a longer PEG segment. Subsequently, the 
content of tri-PCG-SA-OSu can be increased and the physical strength of the obtained 
gel would be improved by covalently cross-linked network all over the hydrogel.  
 
 
Figure 15. Time course of storage (G’, closed symbol) and loss (G”, open symbol) 
moduli for F(P1/S+PLys) (■, □), F(P1/S) (◆, ◇), F(P1+PLys) (▲, △) and F(P1) 
(●, ○) at 37°C.  
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Figure 16. SEC elution curves for (a) soluble part of F(P1/S+PLys5k) and (b) F(P1) after 
400 min incubation at 37 °C, and (c) tri-PCG-SA-OSu, and (d) tri-PCG-1 (eluent: DMF, 
standard: PEG).  
 
Table 5. Results of SEC after 400 min incubation at 37°C for F(P1/S+PLys) and F(P1) 
Code Mn Mw Mw/Mn 
Soluble part of F(P1/S+PLys) (after 400 min incubation at 
37 °C) 
5,500 10,000 1.8 
F(P1) (Tri-PCG-1) (after 400 min incubation at 37 °C) 4,300 6,000 1.4 
Tri-PCG-1 4,000 5,800 1.5 
 
 
 
 
 
 
m
V
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3.3.3 Duration of Gel State and Swelling  
   To evaluate the duration of the gel state for the IP formulation under highly wet 
conditions, states of the hydrogels after soaking in an excess amount of PBS at 37 °C 
were investigated by the test-tube inverting method. F(P1/S) F(P1+PLys5k) and F(P1) 
became sol states within 1 day during incubation at 37 °C [Figure 17 (b)(c)(d)]. These 
results suggest that physical cross-linking of these systems is an equilibrium process, and 
the copolymers in the hydrogel dissociated and dissolved in PBS under the critical 
gelation concentration within 24 hours. On the other hand, F(P1/S+PLys5k) maintained 
its gel state after 11 days, and finally reverted back to the sol state after 12 days [Figure 
17 (a)], which was much longer than those of the other systems. These results indicate 
that the formation of partial covalent cross-linking significantly elongated the duration 
time of the gel state in the IP formulation. The gel-to-sol change for the F(P1/S+PLys5k) 
system after 12 days is probably due to main-chain hydrolysis of tri-PCG-1 and tri-PCG-
SA-OSu. To confirm this, we also investigated the degradation behavior of the tri-PCG-
1 hydrogel soaked in PBS at 37 °C by monitoring the change in molecular weight using 
SEC (Figure 18). The MW reduction of tri-PCG-1 in 7 days was confirmed, which 
supported the above hypothesis.  
   We further investigated the possibility of polyamines other than PLys5k on the 
elongation of the gel state duration time. IP formulations F(P1/S+polyamine) were 
prepared using various polyamines including oligoamines in the same manner as for the 
case of PLys5k with a molar mixing ratio of OSu : NH2 = 1 : 1 (polymer concentration: 
25 wt%) in PBS. The reversibility of gelation and duration time of the gel state are 
summarized in Table 3. All of the IP formulations containing various polyamines showed 
no gelation just after mixing the polyamine and tri-PCG-1/tri-PCG-SA-OSu solutions, 
and showed sol-to-gel transitions upon heating to 37 °C. Thus, the oligo- and polyamines 
tested had no negative effects on the temperature-responsive sol-to-gel transition. In the 
presence of the monomer, dimer and trimer of Lys (Lys, Lys-Lys and Lys-Lys-Lys), 
irreversible gelation was not observed. Lys-Lys and Lys-Lys-Lys showed a slight 
elongation of the duration time, but it was not significant (2 days) (Figure 19). These 
results indicate that Lys-Lys and Lys-Lys-Lys could not form enough covalent cross-
linking points during 1 min heating at 37 °C, and could not maintain their gel state after 
cooling at 4 °C. All of the other polyamines tested, PLys15k, BSA, 4-arm PEG-NH2 and 
PEI10k, showed irreversible sol-to-gel transitions as did as PLys5k. Thus, the molecular 
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weight of oligo- and polyamines is important for irreversible gelation. Among these 
polyamines, PLys5k and PLys15k showed significantly longer duration times of the gel 
state (more than 10 days). BSA showed a slightly longer duration time (4 days), whereas 
the elongation of duration time by 4-arm PEG-NH2 and PEI was not very significant (2 
days). These results suggest that the existence of primary amine groups and the number 
of amine groups in a polymer molecule (> 4) are also important for significant elongation 
of duration time of the gel state. Swelling and degradation of F(P1/S+polyamine) 
exhibiting irreversible gelation were evaluated as weight changes of swelled gel fraction 
(Figure 20(a)). These IP formulations containing polyamines showed swelling after 
soaking in PBS. The maximum swelling ratios are in the range of 110-130%. The swelling 
ratio for PLys5k and PLys15k systems exhibiting longer gel state duration times increased 
gradually to 130% in 3-5 days suggesting the existence of cross-linking points throughout 
the hydrogel. However, the other systems (BSA, 4-arm PEG-NH2, PEI) showed rapid 
decreases in gel fraction after 1 day. In these systems, cross-linking only proceeded 
partially and rapid erosion of the hydrogels occurred. The swelling for F(P1/S+PLys15) 
was quicker than F(P1/S+PLys5k). This is probably because PLys15k with its larger MW 
had difficulty penetrating into the fibrous network of the hydrogel. It is interesting that 
F(P1/S+BSA) showed irreversible gelation and a certain level of elongation of the gel 
state duration time. This result suggests that human serum proteins in the blood (such as 
human serum albumin) can act as cross-link support agents and F(P1/S) without 
polyamine may show irreversible gelation after contact with whole blood. 
   Additionally, we investigated the effect of the mixing ratio of PLys5k to tri-PCG-SA-
OSu on the duration of the gel state (Figure 20(b)). We prepared F(P1/S+PLys5k)(1/n) 
with a mixing ratio of OSu : NH2 = n : 1, where n = 2, 3, 5, and these IP formulations 
showed an irreversible sol-to-gel transition after 10 min heating at 37 °C and cooling at 
4 °C for 1 min, too. The duration time of the gel state for F(P1/S+PLys5k) with NH2/OSu 
= 1/1 (the same date in Figure 20(a)), 1/2, 1/3, and 1/5 after soaking in PBS were 11, 8, 
5, 2 days, and these hydrogels reverted to the sol state after 12, 9, 6 and 3 days, 
respectively. These results suggest that the duration time of the gel state can easily be 
controlled by changing the mixing ratio of PLys5k to tri-PCG-SA-OSu. 
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Figure 17. Photographs of (a) F(P1/S+PLys5k), (b) F(P1/S), (c) F(P1+PLys5k) and (d) 
F(P1) after soaking in PBS for 0, 1, 12 days at 37 °C. 
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Figure 18. Degradation profiles of tri-PCG-1 in PBS at 37°C. 
 
 
  
Figure 19. Swelling and erosion profiles of F(P1/S+oligoamine) hydrogel using Lys 
(□), Lys-Lys (△) and Lys-Lys-Lys (○) soaked in PBS at 37°C.  
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Figure 20. (a) Swelling and erosion profiles of F(P1/S+polyamine) hydrogels using 
various polyamines soaked in PBS at 37 °C. PLys5k (●), PLys15k (■), BSA (✖), 4- 
arm PEG-NH (▲), PEI (◆). (b) Swelling and erosion profiles of F(P1/S+PLys5k) 
hydrogels with different molar ratio of NH2/OSu. NH2/OSu = 1/1 (●), 1/2(◆), 1/3(■) 
and 1/5 (▲).  
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3.3.4 Biocompatibility  
   To evaluate the biocompatibility of the IP formulations, in vitro cytotoxicity against 
L929 fibroblast cells was investigated. Cell viability in the presence of diluted IP 
formulations or PLys5k as a function of concentration is shown in Figure 21. Although 
PLys5k, which is known to be toxic as a polycation, showed cytotoxicity at a high 
concentration (> 0.01wt%), the IP formulations, F(P1/S+PLys5k), F(P1/S) and F(P1), 
did not show significant cytotoxicity against L929 fibroblast cells in the concentration 
range tested (< 1 wt%). The cytotoxicity of IP formulation F(P1/S+PLys5k) was lower 
than PLys5k with the same PLys5k concentration [Figure 22(a)]. The hydrolysate of the 
IP hydrogel also did not show significant cytotoxicity [Figure 22(b)].  
 
 
  
Figure 21. Cell viability of L929 fibroblast cells incubated in the presence of 
F(P1/S+PLys5k) (■), F(P1/S) (◆), F(P1) (●) and PLys5k (✖) in E-MEM containing 
10% FCS at 37 °C for 24 h. 
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Figure 22. Cell viability of L929 fibroblast cells incubtated in E-MEM containing 10% 
FCS for 24 h in the presence of (a) F(P1/S+PLys5k) (■) and PLys (✖) as a function of 
concentration of PLys, (b) and in the presence of hydrolysate of F(P1/S+PLys5k) (■), 
F(P1/S) (◆) and F(P1) (●) as a function of polymer concentration. 
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   In vivo gel formation, duration of gel state, and biocompatibility were investigated for 
F(P1/S+PLys5k) after subcutaneous injection into SD rats. Figure 23 shows photographs 
of the hydrogels of F(P1/S+PLys5k) and F(P1) on days 1 and 8 after subcutaneous 
injection. These IP hydrogels remained close to the injected sites, and significant 
inflammation and angiogenesis were not observed. The F(P1/S+PLys5k) samples were 
recognized to be in the gel state on days 1 and 8, although F(P1) samples showed lower 
viscosity and were recognized to be in the sol state on days 1 and 8. The sol or gel state 
of these samples removed from the injected site was confirmed by rheological 
measurements (Table 6 and Figure 24). On both days 1 and 8, the G’ values for 
F(P1/S+PLys5k) were higher than their G’’ values, indicating the gel state. The G’ value 
for F(P1) was almost the same as the G’’ value on day 1 but lower than the G’’ value on 
day 8, meaning the hydrogel reverted to the sol state about 1 day after injection. These 
results suggested that covalent cross-linking in the F(P1/S+PLys5k) system occurred in 
vivo, too, and was significantly effective in prolonging the duration time of the gel state. 
   The results of histological analysis after HE staining are shown in Figure 25. No 
immunological response was observed in any samples. Although slight nonspecific 
granulation and fibrosis were observed on day 8 for both F(P1/S+PLys5k) and F(P1), the 
histocompatibilities of the formulations were mostly good. 
 
  
Figure 23. Photographs of (a) F(P1/S+PLys5k) and (b) F(P1) hydrogels in rats on day 1 
and day 8 after subcutaneous injection. 
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Figure 24. Storage (closed symbols) and loss (open symbols) moduli of F(P1/S+PLys5k) 
(■,□) and F(P1) (●,○) hydrogels removed from rats on day 1, day 8 after 
subcutaneous injection.  
 
Table 6. Storage and loss moduli of the IP formulation after in vivo injection 
Sample Time after injection (day) G’ (Pa) G” (Pa) 
F(P1/S+PLys5k) 
1 87.4 35.7 
8 43.7 23.4 
F(P1) 
1 10.4 11.0 
8 0.002 0.01 
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Figure 25. Results of histological analysis for the samples after subcutaneous injection 
into rats on days 1 and 8 after injection. (a) F(P1/S+PLys5k), (b) F(P1) and (c) PBS. 
 
3.4 Conclusions 
   A novel injectable polymer system exhibiting temperature-responsive irreversible 
gelation was successfully prepared by the simple mixing of solutions of tri-PCG/tri-PCG-
SA-OSu and PLys5k. The formulation obtained, F(P1/S+PLys5k), was still in the sol 
state after 1 day, and showed rapid sol-to-gel transition (within 30 sec) in response to a 
temperature increase. The Tgel was between r.t. and body temperature. The obtained 
hydrogel did not revert to the sol state after cooling to 4 °C indicating that the sol-to-gel 
transition of this system was irreversible. The irreversible sol-to-gel transition was due to 
covalent bond formation between OSu groups on the termini of tri-PCG-SA-OSu and 
NH2 groups of the polyamine (typically PLys5k) that came in contact with each other 
after micelle perturbation during the sol-to-gel transition. There was only partial 
formation of a covalently cross-linked hydrogel, but enough to exhibit a longer duration 
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time of the gel state after soaking in PBS compared with control systems (in the absence 
of OSu groups or polyamines). The duration time of the gel state of the F(P1/S+PLys5k) 
system was 11 days, and the hydrogel reverted to the sol state after 12 days due to 
degradation of the main chains. The duration time of the gel state can be tuned by 
changing the molar ratio of OSu and NH2. This system showed good biocompatibility 
and long (> 8 days) duration time of the gel state after in vivo subcutaneous injection into 
rats. It is very important that the formulation remain in the sol state for a long time (> 1 
day) after mixing, which is in contrast to simply mixing two solutions, for ease of 
injection by a medical professional in a clinical setting. Problems with the gel-to-sol 
change and erosion in the early stages after injection for previous injectable hydrogel 
systems are solved using this injectable polymer system exhibiting tunable duration time 
of the gel state. The utility of the biodegradable IP systems was significantly improved 
by this IP system exhibiting temperature-responsive irreversible gelation. Therefore, this 
developed IP system can be applied in clinical biomedical devices, such as drug releasing 
depots, scaffolds for regenerative medicine, adhesion prevention materials, and 
embolization agents. 
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4.1 Introduction 
   Some kinds of polymer aqueous solutions exhibit sol-to-gel transition in response to 
temperature increase. Such thermo-gelling polymer systems have attracted great attention 
in the past two decades as implantable biomedical materials. In particular, biodegradable 
thermo-gelling polymer aqueous solutions with a sol-to-gel transition point (Tgel) between 
room temperature (r.t.) and body temperature are expected to be useful for injectable 
polymer (IP) systems 1-5. Sol state IP solution at r.t. can easily entrap living cells or drugs 
and the solution can be easily injected into the body by a syringe to become a hydrogel at 
the injected site. Based on their favorable properties, such as biodegradability, 
biocompatibility, physical softness, highly swelling with water etc., biodegradable IP 
systems are expected for applied as scaffold for tissue engineering 6-8, drug delivery 
system (DDS) 9-11, adhesion prevention material 12-14, embolization material 15-17 and 
endoscopic submucosal dissection (ESD) 18. Several kinds of amphiphilic block 
copolymers consisting of hydrophobic biodegradable aliphatic polyesters and hydrophilic 
poly(ethylene glycol) (PEG) with relatively small molecular weight (MW), which can be 
excreted from kidney, were reported as typical examples of biodegradable IPs for 
biomedical application 3-5, 18-25.  
Such temperature-responsive IP systems exhibit rapid sol-to-gel transition to form 
hydrogel by physical (non-covalent) cross-linking (aggregation) of polymers. However, 
one of the practical problems for these temperature-responsive gelation systems is short 
duration time of gel state in the body. The hydrogel formed tends to revert to the sol state 
within a short period (typically less than 24 h) where a large amount of water or body 
fluid exists, such as in the intraperitoneal space and interior of blood vessels, because the 
main driving force of gelation in these systems is a non-covalent hydrophobic interaction 
and gel formation is an equilibrium process. This property provides an obstacle to the 
application of IP systems as implant biomedical materials.  
Alternatively, in situ gelation systems by chemical (covalent) cross-linking such as 
polymerization systems and coupling reaction systems have been reported 26-30. The 
covalent gelation systems have advantages in longer duration time of gel state and 
relatively high mechanical strength of the obtained hydrogels, but also have problems. In 
polymerization system, how and when the polymerization starts is the issue. UV 
irradiation and the photoinitiators are potential toxic, and polymer chains produced by 
polymerization are not biodegradable. In coupling reaction system, it is generally difficult 
 101 
to control the gelation time, and a special syringe for two solution mixing is needed. 
Therefore, biodegradable IP systems having the advantages of both systems, temperature-
responsive physical gelation and covalent bond formation, are desired to achieve 
favorable gelation time, longer duration time of the gel state and biodegradability. Block 
copolymers of PEG and polycaprolactone (PCL) 20-22, 31 and SC formation of polylactide 
(PLA) blocks 32-34 were reported to show irreversible gelation and gave somewhat 
solutions on this issue by crystallization of PCL block and SC formation of PLLA and 
PDLA.  
   Very recently, we have reported a temperature-triggered covalent gelation system by 
a “mixing strategy” using IP having reactive succinimide ester (OSu) groups at the termini 
and water-soluble polyamines 35. We synthesized linear triblock copolymer consisting of 
PEG and copolymer of ε-caprolactone (CL) and glycolic acid (GA) (PCGA), PCGA-b-
PEG-b-PCGA (tri-PCG) as temperature-responsive IP, and attached OSu groups at the 
both termini. The obtained tri-PCG micelle solution was mixed with solution of water-
soluble polyamine, such as polylysine (PLys). The mixed solution was still sol state after 
mixing at r.t., but underwent gelation in response to temperature increase. Once formed, 
the hydrogel was gel state even after cooling: the sol-to-gel transition was irreversible. 
OSu groups and amino groups of polyamines existed in the micelle core and aqueous 
phase, respectively, and the covalent bonds formation between them occurred only on the 
sol-to-gel transition, where the micelle core was exposed to aqueous phase providing OSu 
attacking to amino groups of polyamine. The hydrogel formed showed longer duration 
time of gel state and the period was controllable from 1 day to 12 days 35. However, this 
system used amide bond formation reaction between OSu groups and amino groups. 
Amino groups exist in many biomolecules, and OSu groups can react with these 
biomolecules located in blood, body fluid and cell surface. 
   We focused on Michael addition type (non-radical) thiol-ene reaction as bio-
orthogonal reaction 36-39. Bio-orthogonal reaction means chemical reaction that can occur 
inside of living systems without interfering with native biochemical processes. In this 
study, we designed temperature-triggered covalent gelation systems exhibiting longer and 
controllable duration time of gel state by a “mixing strategy” utilizing thiol-ene reaction. 
Acryloyl groups were introduced on both termini of tri-PCG to give tri-PCG-Acryl. We 
chose dipentaerythritolhexakis(3-mercaptopropionate) (DPMP) as a commercially 
available hexa-functional polythiol to form chemical cross-linking with acryloyl groups 
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by thiol-ene reaction. This molecule is insoluble in aqueous solution because of 
hydrophobicity and was incorporated into the core of tri-PCG micelles. Then, the 
obtained tri-PCG-Acry micelle solution were mixed with the solution of DPMP-loaded 
tri-PCG micelles. We then found that the mixed solution exhibited temperature-
responsible irreversible sol-to-gel transition. In this paper, we report on the temperature-
responsive sol-to-gel transition behavior and its irreversibility of the mixed system of 
DPMP-loaded tri-PCG micelles + tri-PCG micelle. Especially, the differences compared 
with previous OSu/amine system 35 would be discussed, where the polyamine in previous 
system existed in aqueous phase. Moreover, physical properties of the hydrogel, duration 
time of the gel state under physiological conditions, and in vivo and in vitro 
biocompatibility of the hydrogels would be also investigated. 
   On the other hand, another problem for previous biodegradable IP systems was on the 
preparation process of IP formulations. Most of biodegradable IPs reported previously 
required a long time (usually more than 24 hours) to be dissolved in an aqueous solution. 
This property is very inconvenient at clinical scene and has been one of the obstacles for 
clinical application of the IPs. We recently developed a very quick preparative method 
for IP formulation using PEG as additives. We could obtain macroscopically 
homogeneous milky suspension in only 20 sec of vortex mixing after the addition of 
phosphate buffered saline (PBS) to the freeze-dried tri-PCG containing 10% of PEG (MW 
= 2,000 Da). The obtained suspension can be sucked and injected by a syringe. The sol-
to-gel transition behavior and the properties of the hydrogel were basically the same as 
tri-PCG solution obtained by usual heating dissolution method. In this study, we applied 
this freeze-dry/PEG addition method on the preparation of the injection formulation of 
temperature-responsible covalent gelation system to establish rapid and instant 
preparation method, too. Especially, during the study, we accidentally found that the 
freeze-dry/PEG addition method had another merit in this system. We found that the 
mixed formulation of DPMP-loaded tri-PCG micelles + tri-PCG-Acry micelle system 
prepared by freeze-dry/PEG addition method showed higher stability during incubation 
at r.t. compared with the sample prepared by usual heating dissolution method. 
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4.2 Experimental section 
4.2.1 Materials    
   PEG (MW = 1,540 and 2,000 Da) (PEG1500, PEG2000), CL, tin 2-ethylhexanoate 
[Sn(Oct)2], N,N’-dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP) 
were purchased from Wako Pure Chemical Ind. (Osaka, Japan). Glycolide (GL) and 
acrylic acid were obtained from Musashino Chemical Laboratory, Ltd. (Tokyo, Japan). 
and Sigma-Aldrich, respectively. DPMP was a gift from SC Organic Chemical Co., Ltd. 
(Osaka, Japan). Eagle’s minimum essential medium (E-MEM) was purchased from 
Nissui Pharmaceutical Co. (Tokyo, Japan). Sprague–Dawley (SD) rats (7 weeks old, 
average body weights 150 g) were purchased from Japan SLC, Inc. (Hamamatsu, Japan). 
Water was purified by a Mili-Q (Milipore). The other reagents were commercial grades 
and used without further purification. 
 
4.2.2 Measurements  
   1H nuclear magnetic resonance (1H-NMR) spectra were recorded on a nuclear 
magnetic resonance spectrometer (400 MHz, JNM-GSX-400, JEOL) using deuterated 
solvent (CDCl3). The chemical shifts were calibrated against tetramethylsilane (TMS) 
and/or solvent signal. The number-average molecular weights (Mn) were calculated from 
1H-NMR spectra. The weight-average molecular weights (Mw) and polydispersity indexes 
(Mw/Mn) of the polymers were determined by size exclusion chromatography (SEC) 
(column: TSKgel Multipore HXL-M × 2, detector: RI). The measurements were performed 
using DMF as an eluent at a flow rate of 1.0 mL min-1 at 40 °C using a series of PEG as 
standards. 
 
4.2.3 Synthesis of tri-PCG and tri-PCG-Acryl 
   PCGA-b-PEG-b-PCGA triblock copolymer (tri-PCG) was synthesized by ring-
opening copolymerization of CL and GL in the presence of PEG1500 as a macroinitiator 
and Sn(Oct)2 as a catalyst at 160°C for 12 h according to the method reported previously 
25. The synthesis was carried out by changing monomer feeds to give tri-PCG-1 and tri-
PCG-2 having different PCGA lengths and CL/GA ratios. tri-PCG-1 was used for 
preparation of IP formulation and tri-PCG-2 was used as materials for synthesis of tri-
PCG-Acryl. 
   tri-PCG-Acryl was synthesized according to the method described in Scheme 1. DCC 
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(6.24 g, 30.2 mmol) dissolved in dichloromethane (25 mL) was added dropwise into 
acrylic acid (2.17 g, 30.1 mmol) in dichloromethane (3 mL), and stirred at 0 ºC for 2 h. 
tri-PCG-2 (20.3 g, 5.08 mmol) and DMAP (616 mg, 5.04 mmol) dissolved in 
dichloromethane (40 mL) were added to the reaction mixture, and further stirred at r.t. for 
24 h. The reaction mixture was filtered by suction filtration to remove dicyclohexylurea 
as biproduct. The filtrate was evaporated, and the obtained solid was reprecipitated using 
chloroform (40 mL) as a good solvent and a mixture of n-hexane and ethanol (8/2, v/v) 
(1000 mL) as a poor solvent. The obtained white solid was dried under vacuum for 72 h 
to give tri-PCG-Acryl. 
 
4.2.4 Preparation of IP Formulations 
The IP formulation samples were prepared by two different methods, heating 
dissolution method (named as S-sample) and freeze-dry dispersion method (named as D-
sample) (Scheme 2).  
The S-samples (expressed as S(xxx)) was prepared as follows. Aqueous solution of 
DPMP-loaded tri-PCG-1 micelle were prepared by a solvent evaporation method. Given 
amounts of the tri-PCG-1 and DPMP was dissolved in acetone (copolymer concentration: 
100 mg/mL) in a glass vial at r.t. The mixture solution was added dropwise into pure 
water (copolymer concentration: 10 mg/ml). The mixture solution was stirred at r.t. for 5 
min, and then sonicated in a bath-type sonicator at 0 ºC for 30 min to give a clear solution. 
After removal of acetone by evaporation, the clear micelle solution was lyophilized to 
give powdery DPMP-loaded micelle. The given amount of powdery DPMP-loaded 
micelle was placed in a vial, and phosphate buffered saline (PBS) (10 mM, pH = 7.4) was 
added to the sample tube. After shaking with a vortex mixer for 1 min at r.t., the obtained 
dispersion was heated at 60 ºC above the melting temperature (Tm) of the copolymers for 
5 sec, and further stirred by a vortex mixer for 1 min at r.t. The tube was immersed in ice-
cold water for 10 min. These procedures were repeated until an insoluble part was not 
observed. The obtained solution was further sonicated in a bath-type sonicator for a few 
minutes to give a clear solution. The pH of the solution was adjusted to 7.4 by adding a 
small amount of 1 M NaOH aq. or HCl aq. to give DPMP-loaded tri-PCG-1 micelle in 
PBS (Solution-A, 25 wt%). The tri-PCG-Acryl micelle in PBS was also prepared by same 
method described above (Solution-B, 25wt%). DPMP-loaded tri-PCG-1 micelle in PBS 
(Solution-A, 25 wt%) and tri-PCG-Acryl micelle in PBS (Solution-B, 25wt%) were then 
 105 
mixed together in various mixing ratios at r.t. to give S-samples (total polymer 
concentration = 25wt%). Mixing ratios of Solution-A/Solution-B were 1/1, 1.5/1, 1.8/1 , 
2/1, and 5 /1, giving weight contents of tri-PCG-Acryl in total polymer was 50, 40, 36, 
33, 16 wt%, respectively. The amounts of DPMP in the samples were adjusted to fulfill 
SH/acryl = 1/1. The obtained S-sample IP formulations are expressed as S(P1/D+PAX), 
where P1 /D and PA mean tri-PCG-1 (P1) containing DPMP (/D) and tri-PCG-Acryl (PA) 
and x mean wt% of tri-PCG-Acry in the total polymer. So, the S-samples with 50, 40, 36, 
33, 16 wt% of tri-PCG-Acry in total polymer are expressed as S(P1/D+PA50), 
S(P1/D+PA40), S(P1/D+PA36), S(P1/D+PA33), S(P1/D+PA16), respectively. The control 
S-sample IP solutions, tri-PCG-1 alone, tri-PCG-Acryl alone, mixture of tri-PCG-1 and 
tri-PCG-Acryl without DPMP, and tri-PCG-1 containing DPMP, are expressed as S(P1), 
S(PA), S(P1+PA) and S(P1/D), respectively.  
   D-samples (expressed as D(xxx)) were prepared as follows. Aqueous solution of 
DPMP-loaded tri-PCG-1 micelle with PEG2000 as an additive were prepared by a solvent 
evaporation method. The micelle solution containing PEG2000 (10 wt% of tri-PCG-1) was 
prepared by same method described above. The solution was lyophilized to give powdery 
DPMP-loaded tri-PCG-1 micelle containing 10 wt% of PEG2000 (Powder-A). The freeze-
dried tri-PCG-Acryl micelle was prepared by the same method above (Powder-B). The 
obtained Powder-A and Powder-B were mixed in various mixing ratios, and then PBS 
was added to the vial to fulfill total copolymer (tri-PCG-1 + tri-PCG-Acry) concentration 
= 25 wt%. The sample were mixed vigorously using a vortex mixer for 30 sec at r.t. to 
give milky dispersions (D-samples). The obtained D-sample IP formulations are 
expressed as D(P1/D+PAX), according to same manner as S-samples. D-samples with 50 
and 40 wt% of tri-PCG-Acry in total copolymer were prepared, and expressed as 
D(P1/D+PA50), D(P1/D+PA40), respectively. The control D-sample IP solutions, tri-
PCG-1 alone, tri-PCG-Acryl alone, mixture of tri-PCG-1 and tri-PCG-Acry without 
DPMP, and tri-PCG-1 containing DPMP, are expressed as D(P1), D(PA), D(P1+PA) and 
D(P1/D), respectively.  
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Scheme 2. Preparation of IP formulation (S-samples and D-samples). 
 
4.2.5 Sol-to-gel transition and rheological measurements 
   The sol-to-gel transition behaviors of the IP formulations were investigated by a test-
tube inverting method 7 and rheological measurements. Test-tube inverting method was 
carried out to make phase diagrams as follows. A vial containing IP formulation was 
immersed in a water bath at the desired temperature for 15 min, removed from the water 
bath, then inverted repeatedly to determine sol state or gel state based on the criteria of 
‘‘flow’’ (= sol) and ‘‘no flow’’ (= gel) in 30 sec, with a temperature increment of 1°C per 
step. Measurements were repeated three times for each temperature.  
   Sol-to-gel transition behavior of the IP formulations was also investigated by 
rheological measurements (temperature dependence and time course) using a dynamic 
rheometer (Thermo HAAKE RS600, Thermo Fisher Scientific, Waltham, MA, USA). A 
solvent trap was used for preventing vaporization of the solvent. The diameter of parallel 
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plate was 35 mm and gap of 0.3 mm. The controlled stress and a frequency were 4.0 
dyn/cm2 and 1.0 rad/s, respectively. The heating rate was set at 0.5 °C/min for temperature 
dependence measurements. The storage modulus (G’) and loss modulus (G”) of the 
formulations at 20-50℃ were observed and the gelation temperature (Tgel) can be defined 
cross-over point of G’ and G”. For investigation of mechanical properties after gelation 
for a longer time, the temperature was increased immediately from r.t. to 37 °C, and kept 
at 37 °C, while G’ and G” values were monitored for 15 h. To evaluate the reversibility 
(irreversibility) of the sol-to-gel transition of the samples, G’ and G” values were 
monitored upon temperature changes as follows. The sample was placed in the dynamic 
rheometer at 25 °C, and kept for 5 min. The temperature was then raised to 37 °C. After 
another 5 min, the temperature was decreased to 25 °C and the G’ and G” values were 
monitored for 60 min.  
 
4.2.6 Determination of covalent gel fraction 
   To evaluate the covalent cross-linking formation in the hydrogel upon the 
temperature-responsive sol-to-gel transition, the amount of insoluble fraction against 
acetone (good solvent of copolymers) were investigated for the S(P1/D+PA40), and 
D(P1/D+PA40) hydrogel. The IP formulation (300 m L) in a vial was heated up to 37 °C 
and kept at 37 °C for 24 h. After that, acetone was added to dissolve the soluble polymers, 
which were not covalently bonded, and then the supernatant was removed. This process 
was repeated 4 times. The obtained hydrogels was washed with pure water and acetone, 
and dried in vacuo before weighing. The gel fraction (%) was expressed as (weight of 
insoluble part) / (total weight of tri-PCG-Acryl + DPMP) ´ 100 (%) 
 
4.2.7 Duration time of gel state 
Duration time of the hydrogel in PBS were investigated. The IP formulation (300 µl) 
was placed in a small vial (2.5 mL; diameter: 10 mm; height: 35 mm) and incubated at 
37 °C for 1 min to prepare the hydrogel. The obtained hydrogel in the small vials without 
a cap was placed at the bottom of a lager (30 mL) sample tube with flat bottom (diameter: 
30 mm, height: 63 mm). Then, PBS at 37 °C was added gently to the sample tube and 
incubated at 37 °C. After removal of supernatant from the sample tube, sol or gel state of 
the sample was determined by a test-tube inverting method. Then, the weight of the 
remaining swelled hydrogel was measured. The weight change of the gel fraction (%) 
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was calculated by the following equation:  
	 	 	 	 	 	 	 Weight of gel fraction (%) = (Wt / W0) × 100  
where Wt is weight of the gel fraction at each sampling time, and W0 is initial weight of 
the gel.  
 
4.2.8 Cytotoxicity 
   The viability of L929 mouse fibroblast cells after incubation with the diluted IP 
formulations for 24 h was investigated by WST-8 assay (Dojindo, Tokyo, Japan). L929 
mouse fibroblast cells (1.0 × 104 cells/mL, 100 µL,) in E-MEM containing 10% fetal 
bovine serum (FBS) was seeded into a 96-well microplate and cultured in a humidified 
atmosphere containing 5% CO2 at 37 °C. After preincubation for 24 h, aliquots of a 
diluted IP formulation were added to the cells, which were then further incubated for 24 
h. Thereafter, 10 µL of WST-8 reagent was added to all cell culture medium and further 
incubated for another 3 h (total 27 h). At the end of the incubation period, the microplates 
were read at 450 nm in a microplate reader. The average background absorbance from 
control wells was subtracted from the sample data. It was confirmed that each sample 
value was in the linear region of the standard curve of the WST-8 assay. Data are 
expressed as the means and SE (n = 12). The cell viability was calculated using the 
following equation:  
cell viability (%) = Nt / Nc × 100 
where Nt and Nc are the number of cells with or without samples after 24 h of incubation, 
respectively.  
 
4.2.9 In vivo gelation, duration of gel state, and compatibility 
   In vivo gelation and duration of the gel state of the IP formulations were investigated 
using female SD rats. The IP formulation (25 wt%, 200 µL) were injected subcutaneously 
into rats using a syringe with 25-gauge needle after anesthetizing the rats with isoflurane. 
The rats were sacrificed on certain days after injection, and the state of the hydrogel and 
tissue around the hydrogel were observed by naked eyes. Histological section samples 
were developed by hematoxylin-eosin (HE) staining (Applied Medical Research 
Laboratory Co.). Moreover, a part of the residual hydrogel was taken out from the 
injection sites for evaluation by rheological measurements. These animal experiments for 
in vivo gel formation and duration of the gel state were accepted by the guidelines of 
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animal experiments given at Kansai University. 
 
4.3 Results and discussion  
4.3.1 Synthesis of tri-PCG and tri-PCG-Acryl      
   tri-PCGs were synthesized by ring-opening polymerization of CL and GL in the 
presence of PEG1500 as a macro-initiator using Sn(Oct)2 as a catalyst. The MW of the 
PCGA segment and total MW of tri-PCG-1 were1,900 and 5,300 Da, respectively. Those 
of tri-PCG-2 were1,200 and 4,000 Da, respectively. tri-PCG-2 was used for the synthesis 
of tri-PCG-Acry, and tri-PCG-1 was used for all of the following measurements. Detailed 
methods and characterizations of the tri-PCGs were described in the Table 1 and 2. 
   tri-PCG-Acryl was synthesized using tri-PCG-2 according to Scheme 1. The 1H-NMR 
spectra of tri-PCG-2 and tri-PCG-Acryl were shown in Supporting Information (Figure 
1). The degree of substitution of acryloyl groups per OH groups was calculated to be 92% 
based on the 1H-NMR spectra. The results of SEC analysis before and after introduction 
of acryloyl groups were also shown in Figure 2. Unimodal distributions were observed 
for tri-PCG-2 and tri-PCG-Acryl, and a slight increase in MW was observed in the SEC 
profiles upon the introduction of acryloyl groups. The obtained tri-PCG-1 and tri-PCG-
Acryl were powders in the dry state at r.t. (Figure 3). 
 
 
Scheme 1. Synthesis route for tri-PCG-Acryl. 
 
 
 
 
 
OH
O
HO
O
O
O
O
O
O
O
O
O
H
y Z Z yx
tri-PCG Acrylic acid
O
O
O
O
O
O
O
O
O
O
y Z Z yx
O
O
O
Acryl-capped PCGA-b-PEG-b-PCGA (tri-PCG-Acryl)
DCM, 12 h
DCC, DMAP
 110 
Table 1. Characterization of PCGA-b-PEG-b-PCGA triblock copolymers 
Code 
DP of 
CL a) 
DP of 
GA b) 
CL/GA c) LC d) LG d) Mn (Da) f) Mw/Mn g) 
Tri-PCG-1 14 4.2 3.4 3.6 1.1 5,300 1.4 
Tri-PCG-2 9.4 2.6 3.7 3.8 1.0 4,000 1.4 
a) Degree of polymerization of ε-caprolactone unit in a PCGA segment calculated 
from the methylene peaks in 1H-NMR (2.2-2.5 ppm (f+f’)). 
b) Degree of polymerization of glycolic acid unit in a PCGA segment calculated by 
1H-NMR (4.6-4.8 ppm (b+b’+b’’+b’’’)). 
c) Molar ratio of caprolactone/glycolic acid in a PCGA segment estimated by 1H-NMR 
(solvent: CDCl3). 
d) Average continuous sequence lengths of caproyl units and glycolyl units, Lc and Lg, 
were calculated by the following equations using data in 1H-NMR. 
LC = (f+f’)/f’  
LG = (b+b’+b’’+b’’’)/f’ 
e) Estimated by a differential scanning calorimeter. 
f) Estimated by 1H-NMR (solvent: CDCl3). 
g) Estimated by size-exclusion chromatography (eluent: DMF, standard: PEG). 
 
Table 2. Characterization of triblock copolymers (tri-PCG-2) and tri-PCG-Acryl 
Code Mn (Da) b) Mw (Da) c) Mw/Mn c) Degree of substitution (%) d) 
Tri-PCG-2 4,000 4,100 1.4 - 
Tri-PCG-Acryl 4,100 4,200 1.3 92 
a) Number-average molecular weight estimated from 1H-NMR spectra. 
b) Estimated by size-exclusion chromatography (eluent: DMF, standard: PEG). 
c) Degree of substitution of Acryloyl group calculated  
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Figure 1. 1H-NMR spectra for (a) tri-PCG and (b) tri-PCG-Acryl in CDCl3. 
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Figure 2. SEC elution curves for tri-PCG-2 (dotted line) and tri-PCG-Acryl (solid line) 
(eluent: DMF, standard: PEG). 
 
 
 
Figure 3. Photographs of (a) tri-PCG-2 and (b) tri-PCG-Acryl in dry state at r.t. 
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4.3.2. Sol-to-gel transition behavior of the IP formulations 
   Before investigating covalent gelation, the temperature-responsive sol-to-gel 
transition behavior of the copolymers, tri-PCG-1 and tri-PCG-Acryl , and their mixtures 
(tri-PCG/tri-PCG-Acryl = 1/1, 2/1 and 5/1 (w/w)) in PBS at concentration range from 15-
25 wt% by a test-tube inversion method. These all samples were prepared by heating 
dissolution. The phase diagrams of these copolymers and mixtures are shown in Figure 
4. Pure tri-PCG-1 solution, and the 2/1 and 5/1 mixture solution of tri-PCG/tri-PCG-Acryl 
exhibited temperature-responsive sol-to-gel transitions at 15-25 wt%. The 1/1 mixtures 
of tri-PCG/tri-PCG-Acryl and pure tri-PCG-Acryl solution showed gelation at 20-25 wt% 
and only 25 wt%, respectively. All of these samples showed sol-to-gel transition at 25 
wt%, and the sol-to-gel transition temperature was 32-33 °C. These results indicate that 
mixing with tri-PCG-Acryl (less than 50 wt%) did not have a great influence on the sol-
to-gel transition behavior of the tri-PCG-1 solution. The following experiments were 
carried out at the total copolymer concentration at 25 wt%, unless otherwise noted. To 
confirm the influence of the addition of DPMP, sol-to-gel transition of DPMP-loaded tri-
PCG-1 solution, S(P1/D) [loading ratio: DPMP/(DPMP+tri-PCG-1) × 100 (w/w)=4.2 
wt%] (copolymer concentration 25wt%), was investigated. This sample showed sol-to-
gel transition at 34 °C, which was similar with tri-PCG-1 without DPMP.  
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Figure 4. Phase diagrams of (a) tri-PCG-1, (b) tri-PCG-Acryl, (c) mixture of tri-PCG-1 
and tri-PCG-Acryl (1/1), (d) (2/1) and (5/1) (mol/mol) in PBS. ●: Sol, ✖: Gel, ▲: 
Precipitate. Insets are photographs of the polymer solutions (25wt%) at 25°C and 37°C.  
 
   Then, we investigated of the temperature-responsive sol-to-gel transition behavior of 
the IP formulations and their reversibility (irreversibility). Scheme 2 shows the 
preparation methods for S-samples (by heating dissolution) and D-samples (freeze dry 
dispersion). Photographs of sol-to-gel transition for S(P1+PA50), S(P1/D+PA50) and 
D(P1/D+PA50) are shown in Figure 5 as typical examples. S(P1+PA50) (1:1 mixture of 
tri-PCG-1 micelle solution and tri-PCG-Acryl micelle solution, without DPMP) showed 
gelation on heating to 37 °C, and revert to the sol state on cooling to 4 °C: the sol-to-gel 
transition of S(P1+PA50) was reversible (Figure 5(a)). S(P1/D+PA50) prepared by mixing 
DPMP-loaded tri-PCG-1 micelle solution and tri-PCG-Acryl micelle solution was sol 
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state just after mixing at r.t., and showed gelation on heating to 37 °C, too. This sample 
was still gel state after cooling to 4 °C: the sol-gel-transition of S(P1/D+PA50) was 
irreversible (Figure 5(b)). These results suggest that DPMP molecules in tri-PCG micelles 
did not react with tri-PCG-Acryl in the other micelles on the solution mixing, and the 
possibility of occurrence of covalent cross-linking between DPMP molecules and 
acryloyl groups of tri-PCG-Acryl molecules only upon the temperature-responsive sol-
to-gel transition in the presence of DPMP. D(P1/D+PA50), D-sample with similar polymer 
content with S(P1/D+PA50), was a turbid milky suspension, and showed similar 
irreversible sol-to-gel transition behavior with S(P1/D+PA50). These results mean the 
preparation method had no significant influence on the sol-to-gel transition of the 
formulation as reported previously 25, and subsequent irreversible gelation, too. The 
photographs for controls and other formulations having different tri-PCG-Acryl contents 
in similar procedures were shown in Figure 6. It was confirmed that the irreversible 
gelation were observed only in the presence of both of DPMP and tri-PCG-Acryl. 
 
 
Figure 5.  Photographs of (a) S(P1+PA50), (b) S(P1/D+PA50) and (c) D(P1D+PA50) 
after preparation at 25 ºC, subsequent heating at 37ºC for 1 min, and further cooling at 
4ºC for 1 min. Total copolymer concentration = 25 wt%. 
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Figure 6.  Photographs of (a) S(P1/D+PA40), (b) S(P1/D+PA36), (c) S(P1/D+PA33), (d) 
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S(P1/D+PA16), (e) D(P1/D+PA40), (f) S(P1), (g) S(P1/D)-S and (h) S(PA) after heating 
at 37 °C for 1 min and subsequent cooling at 4 °C for 1 min. Total copolymer 
concentration = 25 wt%. 
As described above, S(P1/D+PA50) was sol state just after mixing at r.t., but the 
viscosity of the solution gradually increased during the incubation at r.t. The solution 
become a gel after 3 h incubation at 25 ºC, and the gelation was irreversible (Figure 7(a)). 
So, we investigated the effects of longer time incubation at 4 ºC after preparation. The 
results were shown in Figure 7(b). S(P1/D+PA50) did not show gelation during 24 h 
incubation at 4 ºC, and the formulation showed irreversible sol-to-gel transition 
subsequent heating and cooling. Thiol-ene reactions between DPMP and acryloyl groups 
did not proceed just on mixing because these molecules existed separately in the different 
micelles and did not encounter. However, the results mean that polymer exchange 
between these polymeric micelles could proceed gradually at 25 ºC (sol state) to form 
anchoring between micelles, and the exchange could be suppressed by keeping at 4 ºC. 
The sol-to-gel transition ability was kept during incubation at 4 ºC for at least 24 h. This 
means that the formulation can be stored in a refrigerator at least one day after preparation 
(mixing) to refrain from spontaneous gelation. Interestingly, on the other hand, 
D(P1/D+PA50) did not show spontaneous gelation after 24 h incubation at 25 ºC, and 
subsequently showed irreversible sol-to-gel transition on heating and cooling. The 
spontaneous gelation at 25 ºC can be avoided by freeze-dry dispersion preparation method.  
 
Figure 7.  Photographs of (a) S(P1/D+PA50) incubated at 25 ºC for 3 h after preparation 
and subsequent cooling to 4 ºC, (b) S(P1/D+PA50) incubated at 4 ºC for 24 h after 
preparation, subsequent heating to 37 ºC and cooling to 4 ºC, (c) D(P1/D+PA50) incubated 
at 25 ºC for 24 h after preparation, subsequent heating to 37 ºC and cooling to 4 ºC. 
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We had previously obtained the information that the micelle cores of the D-samples were 
solid and crystalline states, but the S-samples were not, and the gelation temperature of 
tri-PCG micelle solution was depend on the melting temperature (Tm) of the copolymer 
(unpublished data, see Figure 8). The results of dynamic scanning calorimetry (DSC) 
analysis of the formulations were shown in Figure 9 and Table 3. The melting peaks, 
which can be assigned to tri-PCG-1, were clearly observed in D-samples, but not in S-
samples. This must be the main reason that D-samples did not show spontaneous gelation 
at 25 ºC by suppression of polymer exchange reaction. So, D-samples has an advantages 
not only for convenient instant preparation of formulation at clinical scene, but also for 
one solution formulation: no need of two solution mixing at clinical scene. 
 
 
Figure 8. Gelation temperature (Tgel) and melting temperature (Tm) (▲) of S- (●) or D- 
(■) sample as a function of CL/GA. 
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Figure 9.  DSC thermoglams of (a) F(P/D/P1)-D, (b) F(PA)-D, (c) F(P/D/P1+PA-50)-
D suspension, and (d) F(D/P1)-S, (e) F(PA)-S, (f) F(D/P1+PA-50)-S solution in PBS 
(total polymer concentration: 25wt%). (g) Tri-PCG-Acryl, (h) Tri-PCG-1, (i) PEG1500 and 
(j) PEG2000 in dry state. 
 
Table 3. Thermal properties of the F(P/D/P1)-D, F(PA)-D, F(P/D/P1+PA-50)-D, 
F(D/P1)-S, F(PA)-S, F(D/P1+PA-50)-S suspension or solution in PBS, and Tri-PCG-1, 
Tri-PCG-Acryl, PEG1500, PEG2000 in dry state. 
Sample Tm (°C) 
F(P/D/P1)-D 31.7 
F(PA)-D 32.2 
F(P/D/P1+PA-50)-D 32.2 
F(D/P1)-S N.D. a) 
F(PA)-S N.D. a) 
F(D/P1+PA-50)-S N.D. a) 
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Tri-PCG-1 33.7 
Tri-PCG-Acryl 31.2 
PEG1500 49.7 
PEG2000 53.9 
a) Not detected. 
 
   The sol-to-gel transition behavior of the IP formulations was also investigated by 
rheological measurements. The typical results of temperature-dependence of G’ and G” 
for the IP formulations (total block copolymer concentration = 25wt%) are shown in 
Figure 10. Using these results, sol-to-gel transition temperature, Tgel, can be estimated as 
the temperature at which G’ overtook G”. The Tgel values estimated from these 
measurements were summarized in Table 4, and the results for control samples were 
shown in Figure 11. In Figure 10(a), G’ and G” values for S(P1/D+PA50), D(P1/D+PA50) 
and S(P1+PA50) were shown to compare the effect of DPMP and preparation methods. 
Tgel values for S(P1/D+PA50), D(P1/D+PA50) and S(P1+PA50) were 27.8 °C, 31.3 °C and 
33.8 °C, respectively. These results mean that the addition of DPMP (/D) decreased Tgel 
value, and the Tgel values for D-samples were higher than that of S-samples. As described 
above, we confirmed previously that Tgel values of D-samples of tri-PCGs were higher 
than those for S-samples and almost equal to the Tm values of the copolymers (Figure 9). 
The results shown in Figure 10(a) showed good agreements with our previous results. In 
Figure 10(b) G’ and G” values for S-samples having different content of tri-PCG-Acryl 
without DPMP, S(P1+PA50), S(P1+PA33) and S(P1+PA16), were shown. These samples 
showed almost the same Tgel value as S(P1). These results indicate the presence of tri-
PCG-Acryl micelles in the formulation has almost no influence on the Tgel value in the 
range of less than 50%. The G' values at 37 °C and maximum value of G' (G’MAX) at 
which temperature (TG’MAX) of these formulations were also shown in Table 4. These G' 
values were relatively small ( < 510Pa) but had no importance, because the G' values for 
covalent bonds forming samples increased gradually after heating to 37 °C as discussed 
later. The reversibility (or irreversibility) of the sol-to-gel transition of the IP formulation 
was also investigated by rheological studies. G’ and G” values for the IP formulations 
upon heating to 37 °C and subsequent cooling to 25 °C were recorded. The results for 
S(P1/D+PA50), D(P1/D+PA50) and S(P1+PA50) were shown in Figure 12 as typical 
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examples, and the results other formulation were shown in Figure 12. The G’ values for 
all IP formulations surpassed the G” values immediately upon heating to 37 °C, indicating 
sol-to-gel transitions. After 5 min incubation at 37 °C for, the samples were cooled to 
25 °C. The G’ values for S(P1+PA50) without DPMP decreased below the G” within 50 
min after cooling to 25 °C, indicating gel-to-sol transitions. Therefore, the sol-to-gel 
transitions for the IP formulations without DPMP indicated reversible. On the other hand, 
the G’ value for S(P1/D+PA50) and D(P1/D+PA50) remained higher than the G” value for 
at least 90 min, maintaining the gel state; the sol-to-gel transition for S(P1/D+PA50) and 
D(P1/D+PA50) were irreversible. Other samples having different PCG-Acryl contents 
also showed irreversible sol-to-gel transition. These results indicated that covalent bond 
formation occurred in these samples upon the temperature-induced sol-to-gel transition 
and some amount of covalent cross-linking points were generated in the hydrogel network.  
 
 
 
Figure 10. Storage (G’, closed symbols) and loss moduli (G”, open symbols) of (a) 
S(P1/D+PA50) (■ , □ ), D(P1/D+PA50) (● , ○ ), S(P1+PA50) (▲ , △ ) and (b) 
S(P1+PA50)-S (●, ○), S(P1+PA33) (■, □), and S(P1+PA16) (▲, △) as a function of 
temperature. Total copolymer concentration = 25wt%. 
 
 
Table 4.  Results of rheological studies. 
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Code Tgel (°C) G’ (Pa) at 37°C G’MAX (Pa) and TG’MAX (°C) 
S(P1/D+PA50) a) 27.8 233 510 (41.8) 
D(P1/D+PA50) a) 31.3 161 383 (43.8) 
S(P1+PA50) 33.8 39.1 136 (42.8) 
S(P1+PA33) 34.3 46.1 143 (41.4) 
S(P1+PA16) 34.3 36.0 108 (40.7) 
a) content of DPMP = 5.5 wt% for tri-PCG-1, mole of DPMP = mole of tri-PCG-Acryl. 
b) content of DPMP = 4.3 wt% for total copolymer. 
 
 
Figure 11. Storage (G’, closed symbols) and loss moduli (G”, open symbols) of (a) S(P1) 
(●,○), S(P1/D) (■, □), S(PA) (▲, △) as a function of temperature. Total copolymer 
concentration = 25wt%. 
Table 5.  Results of rheological studies. 
Code Tgel (°C) G’ (Pa) at 37°C G’MAX (Pa) and TG’MAX (°C) 
S(P1) 34.3 32.4 74.2 (39.7) 
S(P1/D)b) 32.8 29.0 38.3 (40.2) 
S(PA) 32.9 114 138 (37.7) 
a) content of DPMP = 5.5 wt% for tri-PCG-1, mole of DPMP = mole of tri-PCG-Acryl. 
b) content of DPMP = 4.3 wt% for total copolymer. 
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Figure 12. Time course of storage (G’, closed symbols) and loss moduli (G”, open 
symbols) for (a) S(P1/D+PA50), (b) D(P1/D+PA50), (c) S(P1+PA50) after heating to 37°C 
and subsequent cooling to 25°C. Total copolymer concentration = 25 wt%. Temperature 
change schedule was shown in the bottom of each Figure. 
 
   To confirm the formation of a covalently cross-linked hydrogel for S(P1/D+PA40) and 
D(P1/D+PA40) system, we estimated the amount of covalently cross-linked (insoluble) 
fraction in the hydrogel. The weight fractions of S(P1/D+PA40) and D(P1/D+PA40) 
insoluble against acetone and water after incubating at 37 °C for 24 hours were 84.8 ± 
7.0 wt%. and 72.6 ± 3.4 wt%, respectively, in total weights of tri-PCG-Acryl + DPMP. 
These results indicated that chemically cross-linked hydrogel was actually formed for 
S(P1/D+PA40) and D(P1/D+PA40) after physical gelation on sol-gel-transiton and further 
incubation at 37 °C, and there was no significant difference between S-sample and D-
sample. But after just 1 min heating at 37 °C, S(P1/D+PA40) and D(P1/D+PA40) could be 
dissolved in acetone. So, the cross-linking reaction proceed gradually. 
   We also investigated the time course of G’ values of the IP formulations for a longer 
time (0 - 15 h) after heating to 37 °C and further maintaining at 37 °C. In Figure 13, 
results for S(P1/D+PA50), S(P1/D+PA36), S(P1+PA50) and D(P1/D+PA50) were shown 
as typical examples. The G’ values after 15 h were summarized in Table 6. G’ values for 
S(P1/D+PA50) was the highest, 4,235 Pa, among the samples tested. The G’ value (after 
15 h) decreased with decrease in tri-PCG-Acryl content. The S(P1/D+PA16) showed 
smaller G’ value, which are almost the same as S(P1+PA50) without DPMP. 
D(P1/D+PA50) and D(P1/D+PA40) showed quite similar G’ values (after 15 h), 4,122 and 
3,908 Pa, with those of D(P1/D+PA50) and D(P1/D+PA40) having the same tri-PCG-
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Acryl contents, respectively. The G’ values observed in this covalent bond formation 
system was much higher than those of our previous results on NH2/OSu coupling system 
35, which showed only 389 Pa after 400 min incubation at 37 °C. These results mean the 
physical strength of the hydrogel in this system can easily be controlled by changing 
mixing ratio of tri-PCG-Acryl in the system. Moreover, to provide physically strong 
hydrogels, this hydrophobic DPMP entrapping system was more effective than our 
previous system using tri-PCG-OSu having reactive OSu groups at the termini and 
addition of water-soluble polyamine in aqueous phase. 
 
 
Figure 13. Time course of storage moduli (G’) of S(P1/D+PA50) (■), S(P1/D+PA40)  
(◆), D(P1/D+PA50) (●) and S(P1D+PA33) (▲) at 37 °C. Total copolymer concentration 
= 25wt%.  
 
Table 2. G’ of each samples after heating at 37 °C for 15 h 
Code of formulation G’ (Pa) after 15h 
S(P1/D+PA50) 4,235 
S(P1/D+PA40) 4,013 
S(P1/D+PA36) 3,477 
S(P1/D+PA33) 2,014 
S(P1/D+PA16) 591 
S(P1+PA50) 530 
D(P1/D+PA50) 4,122 
D(P1/D+PA40) 3,908 
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   Considering these results, we proposed a mechanism for the formation of covalent 
cross-links in S(D/P1+PAx) and D(D/P1+PAx) during the sol-to-gel transition as 
illustrated in Figure 14. Below Tgel, the mixture of DPMP-loaded tri-PCG-1 solution and 
tri-PCG-Acryl solution is dissolved in flower-like micelle forms. The acryloyl groups on 
the tri-PCG-Acryl termini exist inside of a hydrophobic micelle core, and do not have 
contact with thiol groups of DPMP in the tri-PCG-1 micelle core. As the temperature 
increase, dehydration of PEG segments and shrinking of the free volume of PEG occurs 
to allow perturbation of the micelles. This phenomenon causes micellar aggregations and 
which form a fibrous network of a physically cross-linked hydrogel. Finally, thiol groups 
of DPMP in the tri-PCG-1 micelle core and acryloyl groups react by Michael-addition 
type thiol-ene reaction in the fiber-like micelle aggregates and form covalent cross-
linking. D-sample, D(D/P1+PAx), the mechanism is basically the same as S-sample, 
S(D/P1+PAx). Only the differences are that the existence of PEG between the freeze-
dried micelle help to dispersion in PBS to provide rapid preparation, and the solid state 
micelle core suppress the polymer exchange between micelle below transition 
temperature.  
 
Figure 14. Schematic illustration for temperature-responsive irreversible sol-to-gel 
transition mechanism of S(D/P1+PAx) and D(D/P1+PAx) with increasing temperature 
from r.t. and body temperature.  
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4.3.3 Duration of Gel State and Swelling  
   We investigated the duration of the gel state for the IP formulation under highly wet 
conditions, states of the hydrogels after soaking in PBS (25 mL) at 37 °C by the test-tube 
inverting method. S(P1+PA50), S(P1/D) and S(P1) became sol states within 1 day during 
incubation at 37 °C (Figure 15). These results indicated that physical cross-linking of 
these systems is an equilibrium process, and the copolymers in the hydrogel dissociated 
and dissolved in PBS under the critical gelation concentration within 24 hours. On the 
other hand, S(P1/D+PA50) maintained its gel state after 93 days, and finally disappearance 
after 94 days (Figure 15a), which was much longer than those of the other systems. The 
degradation of the S(P1/D+PAx) hydrogel is probably due to main-chain hydrolysis of 
tri-PCG-1 and tri-PCG-Acryl. To confirm this, we also investigated the degradation 
behavior of the tri-PCG-1 hydrogel soaked in PBS at 37 °C by monitoring the change in 
molecular weight using SEC (Figure 16). The MW reduction of tri-PCG-1 in 30 days was 
confirmed, which supported the above hypothesis. Furthermore, we investigated the 
effect of the mixing ratio of tri-PCG-Acryl and tri-PCG on the duration of the gel state. 
Duration time of the gel state for S(P1/D+PA40), S(P1/D+PA36), S(P1/D+PA33) and 
S(P1/D+PA16) were 64, 37, 12, 5 days, respectively (Figure 17(a)). These results 
indicated that duration time of gel state can be easily controlled by changing mixing ratio 
of tri-PCG-Acryl (16-50%). Additionally, we investigated duration of the gel state for 
S(P1/D+PAx) systems. Duration of the gel state of D(P1/D+PA50) D(P1/D+PA40) 
systems showed 94, 63days, respectively (Figure 17(b)). These results were similar with 
S(P1/D+PAx) systems. These IP formulations showed swelling after soaking in PBS. The 
maximum swelling ratios of are in the range of 110-150%. The swelling ratio for 
S(P1/D+PA50) and D(P1/D+PA50) systems exhibiting longer gel state duration times 
increased gradually to 130% in 30-60 days suggesting the existence of cross-linking 
points throughout the hydrogel. S(P1/D+PA33) hydrogel composed of the existence of 
partial covalent cross-links by gel dissolving test. These results indicated that the duration 
time of the gel state can easily be controlled by changing the mixing ratio of tri-PCG-
Acryl to tri-PCG. 
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Figure 15. Photographs of (a) S(P1/D+PA50) (b) D(P1/D+PA50) and S(P1+PA50) after 
soaking in PBS for 0, 1, 30, 60, 88 days at 37 °C.  
 
 
Figure 16. Degradation profiles of tri-PCG-1 in PBS at 37°C. 
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Figure 17. Swelling and erosion profiles of (a) S(P1/D+PA50) (●), S(P1/D+PA40) (■), 
S(P1/D+PA36) (◆), S(P1/D+PA33), (▲), S(P1/D+PA16), (b) D(P1/D+PA50) (○), and 
D(P1/D+PA40) (□) hydrogel soaked in PBS at 37°C.  
 
4.3.4 Biocompatibility 
   We investigated the biocompatibility of the IP formulations, in vitro cytotoxicity 
against L929 fibroblast cells. In vitro viability against L929 fibroblast cells of diluted IP 
formulations as a function of concentration is shown in Figure 20. Although the IP 
formulations, S(P1/D+PA), S(P1/D), S(PA) and S(P1), did not show significant 
cytotoxicity against L929 fibroblast cells in the concentration range tested (< 1wt%) 
(Figure 18).  
   In vivo gel formation, duration of gel state, and biocompatibility were investigated for 
S(P1/D+PA40), S(P1/D+PA36), S(P1/D+PA33), S(P1/D+PA16), D(P1/D+PA40) and S(P1) 
after subcutaneous injection into SD rats. Figure 19, 20 shows photographs of the 
hydrogels of S(P1/D+PA40) and S(P1) on each day after subcutaneous injection. These 
IP hydrogels remained close to the injected sites, and significant inflammation and 
angiogenesis were not observed. The S(P1/D+PA40), S(P1/D+PA36), S(P1/D+PA33), 
S(P1/D+PA16) and D(P1/D+PA40) samples were recognized to be in the gel state on each 
day although F(P1) samples showed lower viscosity and were recognized to be in the sol 
state on days 1 and 8. To evaluate the sol or gel state of these samples removed from the 
injected site, which was investigated by rheological measurements. On each day, the G’ 
values for S(P1/D+PA40), S(P1/D+PA36), S(P1/D+PA33), S(P1/D+PA16) and 
D(P1/D+PA40) were higher than their G’’ values, indicating the gel state. The G’ value 
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for F(P1) was almost the same as the G’’ value on day 1 but lower than the G’’ value on 
day 8, meaning the hydrogel reverted to the sol state about 1 day after injection. 
Furthermore, the G’ values for S(P1/D+PA40) decreased with the passage of time (Figure 
21). These results suggested that covalent cross-linking in the S(P1/D+PA) and 
D(P1/D+PA) systems occurred in vivo, too, and exhibited a significantly longer duration 
time of the gel state and controlled the time by changing mixing ratio of tri-PCG-Acryl. 
   We investigated histological analysis after HE staining around the injected tissue. 
Figure 22 showed the images of the HE stained tissue. No immunological response was 
observed in any samples. Although slight nonspecific granulation and fibrosis were 
observed on day 8 for both S(P1/D+PA40) and S(P1), the histocompatibilities of the 
formulations were mostly good 
 
 
 
 
Figure 18.  cell viability of L929 fibroblast cells induced in the presence of S(P1/D) 
(▲), S(PA) (◆), S(P1) (●) and S(P1/D+PA50) (■) in E-MEM containing 10% FBS at 
37 °C for 24 h. 
 
 130 
 
Figure 19. Photographs of (a) F(D/P1+PA-40)-S hydrogels in rats on day 1, 8, 30 and 68 
after subcutaneous injection.  
 
Figure 20. Photographs of (a) F(D/P1+PA-36)-S, (b) F(D/P1+PA-33)-S, (c) 
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F(D/P1+PA-16)-S and (d) F(P/D/P1+PA-40)-D hydrogels in rats on day 1, 8, 30 and 68 
after subcutaneous injection.  
 
 
Figure 21. Storage (G’, closed symbols) and loss moduli (G”, open symbols) of 
F(D/P1+PA-40)-S (■, □) hydrogels in rats on day 1, 8, 30 and 68 after subcutaneous 
injection. 
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Figure 22. Results of histological analysis for the samples after subcutaneous injection 
into rats on day 1 and 8 after injection. (a) F(D/P1+PA-40)-S, (b) F(P1)-S and (c) PBS 
 
 
 
 
 
 
 
 
 
 
(b)
(c)
(a)
Day 1 Day 8
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4.4 Conclusion 
   A novel biodegradable IP system exhibiting temperature-responsive irreversible sol-
to-gel transition by covalent bond formation via Michael addition reaction and a very 
quick preparation method at r.t. for aqueous IP solution was successfully prepared by the 
mixing of solutions of DPMP/tri-PCG and tri-PCG-Acryl. The S(P1/D+PA) solution was 
still in the sol state after 1 day at 4 °C, and showed rapid sol-to-gel transition (within 30 
sec) between r.t. and body temperature. The Tgel was about 33 °C. The obtained hydrogel 
did not revert to the sol state after cooling to 4 °C. These phenomenon indicating that the 
sol-to-gel transition of this system was irreversible, this is due to that covalent bond 
formation between Acryloyl groups on the termini of tri-PCG-Acryl and SH groups of 
the DPMP that came in contact with each other after micelle perturbation during the sol-
to-gel transition. The hydrogel formed partial covalent cross-links in the hydrogel, but 
enough to exhibit a longer duration time of the gel state after soaking in PBS compared 
with control systems (in the absence of tri-PCG-Acryl). The duration time of the gel state 
for the S(P1/D+PA) and D(P1/D+PA) with various content of tri-PCG-Acryl were 4-93 
days. The duration time of the gel state can be tuned by changing the molar ratio of tri-
PCG and tri-PCG-Acryl. The formulation showed good biocompatibility and exhibited a 
significantly longer duration time of the gel state after in vivo subcutaneous injection into 
rats. It is very important that the formulation remain in the sol state for a long time (> 1 
day) after mixing at 4 °C, which is in contrast to simply mixing two solutions, for ease of 
injection by a medical professional in a clinical setting. Problems with revert to the sol 
state under highly wet conditions for previous biodegradable IP hydrogel systems are 
solved using this developed IP system exhibiting tunable duration time of the gel state. 
Furthermore, this system should be convenient for instant preparation at clinical scene. 
Therefore, this developed IP system is an excellent candidate for drug releasing depots, 
scaffolds for regenerative medicine, adhesion prevention materials, and embolization 
agents. 
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Chapter 5 
 
Injectable and biodegradable temperature-
responsive mixed polymer systems providing 
variable gel-forming pH regions 
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5.1 Introduction 
   In the past several decades, aqueous solutions of biodegradable polymers exhibiting 
sol-to-gel transitions have received much attention as injectable polymer (IP) systems for 
use in minimally invasive therapies, regenerative medicines and other biomedical 
applications. IP systems exhibiting sol-to-gel transitions in response to external stimuli, 
such as temperature and pH, have been reported 1-9. Among them, biodegradable 
temperature-responsive sol-to-gel transition polymers, also called thermo-gelling 
polymers, having transition points between r.t. and body temperature have been 
extensively investigated because of the following advantages. Aqueous solutions of such 
polymers are in the sol state at r.t. and undergo immediate gelation at body temperature 
after injection into the body to form hydrogels at the injected sites. They are degraded 
under physiological conditions and subsequently eliminated from the body by 
metabolism or renal clearance after completion of their expected roles. At r.t., these 
polymer solutions can be easily mixed with bioactive molecules (such as drugs, proteins, 
peptides and nucleic acids) or living cells (patients’ cells or various stem cells), and can 
easily be injected through a syringe or a microcatheter to form a hydrogel containing the 
cells at the injected sites. Therefore, thermo-gelling polymer systems are expected to be 
applied for drug delivery depots exhibiting sustained release of drugs 10-12, cellular 
scaffolds for regenerative medicine 13-15, barriers of post-operative adhesion 16-18, vascular 
embolization agents 19-21 and endoscopic submucosal dissection (ESD) 22. 
   Amphiphilic block copolymers of hydrophilic poly(ethylene glycol) (PEG) and a 
hydrophobic aliphatic polyester are known as typical biodegradable thermo-gelling 
polymers. For example, IP systems using poly(lactide-co-glycolide) (PLGA) 5, 23 and 
poly(ε-caprolactone) (PCL) 24 as hydrophobic aliphatic polyester segments have been 
reported. We recently reported thermo-gelling polymer systems using triblock 
copolymers of poly(ε-caprolactone-co-glycolic acid) (PCGA) and PEG, PCGA-b-PEG-
b-PCGA (tri-PCG), which were in dry powder form at r.t. as convenient IP systems 25-28. 
However, sometimes an aqueous solution of such a thermo-gelling polymer exhibits 
gelation during the injection process when using a long microcatheter. The temperature 
in a small diameter microcatheter inserted deeply into the body can easily reach the 
gelation temperature. On this issue, Lee et al. reported dual stimuli responsive IP systems 
exhibiting pH- and temperature-responsive sol-to-gel transitions 2, 29, 30. Such pH- and 
temperature-responsive systems do not show sol-to-gel transitions in microcatheters, but 
 141 
become gels after injection into the body under physiological conditions (temperature and 
pH) at the injected site, and have great advantages compared with conventional 
temperature-responsive IPs from the fail-safe standpoint in clinical treatments. Several 
pH- and temperature-responsive block copolymer systems containing positively or 
negatively charged groups such as sulfamethazine oligomer 31, poly(β-amino ester) 32, 
and a sulfonamide derivative 33 have been reported. These copolymer solutions can be 
injected by small-diameter devices such as syringes or microcatheters and exhibit sol-to-
gel transitions triggered by temperature and pH of the injected site. In these systems, the 
ionization and deionization conditions of the functional groups of the copolymers have a 
great influence on their sol-to-gel transition behavior. 
   It is well known that organs, tissues and blood in different sites in the body have 
different pHs, for example, tumors (pH = 5–7), stomach (1–2), small intestine (8.4), large 
intestine (7.0), liver (8.3) and normal blood (7.4) 34. Therefore, it is an important challenge 
to provide pH- and temperature-responsive IP systems exhibiting gelation at various and 
specific pH regions. Previously reported temperature and pH-responsive IP systems 
having only positively (or negatively) charged groups showed gelation windows at 
neutral-to-basic or neutral-to-acidic pH regions (larger pH than neutral or smaller pH than 
neutral), where the charged groups are deprotonated or protonated to be nonionic, 
respectively. The gel-forming pH region may be controlled by employing charged groups 
having various pKa values. To achieve this, however, IP systems having different charged 
groups must be synthesized for each case. IP systems having both positively and 
negatively charged groups may also be prepared. However, once synthesized, the gel-
forming pH region of the obtained IP cannot be easily changed. Thus, a simple IP system 
providing a variable gel-forming pH region is desired. 
   In this study, we succeeded in creating an IP system with a variable and controllable 
gel-forming pH region by a mixing strategy. Carboxylic acid-terminated PCGA-b-PEG-
b-PCGA (tri-PCG-COOH) and primary amine-terminated PCGA-b-PEG-b-PCGA (tri-
PCG-NH2) were synthesized. We investigated the sol-to-gel transition of the mixed 
solution of tri-PCG-COOH and tri-PCG-NH2, and found that the gel-forming pH region 
of the mixed system can easily be controlled by changing the mixing ratio. 
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5.2 Experimental section 
5.2.1 Materials 
   Poly(ethylene glycol) (PEG) (molecular weight (MW) = 1,540 Da) (PEG1500), ε-
caprolactone (CL), tin 2-ethylhexanoate (Sn(Oct)2), N,N’-dicyclohexylcarbodiimide 
(DCC), 4-N,N-dimethylaminopyridine (DMAP), N-(tert-butoxycarbonyl)glycine (Boc-
Gly), succinic anhydride (SA), and trifluoroacetic acid (TFA) were purchased from Wako 
Pure Chemical Ind. (Osaka, Japan). Glycolide (GL) was obtained from Musashino 
Chemical Laboratory, Ltd. (Tokyo, Japan). The other reagents were commercial grade 
and used without further purification. 
 
5.2.2 Measurements 
   1H nuclear magnetic resonance (1H-NMR) spectra were recorded on a nuclear 
magnetic resonance spectrometer (400 MHz, JNM-GSX-400, JEOL) using deuterated 
solvent (CDCl3 or D2O). The chemical shifts were calibrated against tetramethylsilane 
(TMS) and/or solvent signal. The number-average molecular weights (Mn) were 
calculated from 1H-NMR spectra. The weight-average molecular weights (Mw) and 
polydispersity indexes (Mw/Mn) of the polymers were determined by size-exclusion 
chromatography (SEC) (column: TSKgel Multipore HXL-M × 2; detector: RI). The 
measurements were performed using DMF as an eluent at a flow rate of 1.0 mL min-1 at 
40 °C using a series of PEG as standards. 
 
5.2.3 Synthesis of tri-PCG, tri-PCG-COOH and tri-PCG-NH2 
   PCGA-b-PEG-b-PCGA triblock copolymers (tri-PCGs) having hydroxyl termini 
were synthesized by ring-opening copolymerization of CL and GL in the presence of 
PEG1500 as a macroinitiator and Sn(Oct)2 as a catalyst at 160 °C for 12 h according to the 
method reported previously27, 28 (see Supporting Information, Scheme S1). As shown in 
Table 1, tri-PCGs having different degrees of polymerization, tri-PCG(2.0k) and tri-
PCG(2.3k), were prepared. The average degrees of polymerization for CL and glycolic 
acid (GA) units in the PCGA segments were estimated by 1H-NMR (solvent: CDCl3). 
Average continuous sequence lengths of caproyl units and glycolyl units (Lc and Lg) in 
the PCGA segments were also estimated from 1H-NMR spectra according to the literature 
34. 
   Tri-PCG having carboxylic acid groups on both termini (tri-PCG-COOH) was 
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synthesized by the reaction of succinic anhydride with tri-PCG(2.0k) according to the 
same method reported previously28 (Scheme 1). A mixture of tri-PCG(2.0k) (3.84 g, 0.69 
mmol) and SA (1.38 g, 13.7 mmol) was dispersed in anhydrous toluene (10 mL) and 
refluxed at 130 ºC for 6 h. After cooling at r.t., unreacted SA was removed by suction 
filtration. The obtained filtrate was poured into a mixture of diethylether/ethanol (9/1, 
v/v) (800 mL) to give tri-PCG-COOH as a precipitate. The obtained precipitate was dried 
under vacuum for 24 h. 
   Tri-PCG with primary amine groups on both termini (tri-PCG-NH2) was synthesized 
by the coupling reaction of tri-PCG(2.3k) with Boc-Gly and subsequent removal of the 
Boc groups according to Scheme 2. Boc-Gly (3.02 g, 24.8 mmol) and DCC (5.13 g, 24.9 
mmol) were dissolved separately in dichloromethane (10 mL). The DCC solution was 
added dropwise to the Boc-Gly solution and the obtained mixed solution was stirred at 0 
ºC for 2 h. tri-PCG(2.3k) (15.1 g, 2.47 mmol) and DMAP (159 mg, 1.30 mmol) were 
dissolved in dichloromethane (15 mL). The solution of DCC and Boc-Gly was added 
dropwise into the solution of tri-PCG(2.3k) and DMAP, and then stirred at 0 ºC for 1 h 
and at r.t. for 12 h. The product was purified by reprecipitation using chloroform (30 mL) 
as the good solvent and a mixture of diethylether/ethanol (6/4, v/v) (600 mL) as the poor 
solvent to give tri-PCG(Boc-Gly)2. The precipitate was dried in vacuo for 24 h. Removal 
of the Boc group was carried out by acid treatment. TFA (50 mL, 653 mmol) was added 
to the tri-PCG(Boc-Gly)2 (14.0 g) dissolved in dichloromethane (10 mL) at 0 ºC, and the 
solution was stirred for 1 h. The deprotected copolymer was purified by a reprecipitation 
method using chloroform as good solvent and n-hexane as poor solvent. The obtained 
precipitate was dissolved in chloroform (80 mL), and TEA (3 mL, 21.5 mmol) was added 
to the solution. After 1 min stirring at 0 ºC, the copolymer solution was reprecipitated 
using diethylether (900 mL), and then dried in vacuo for 15 h to give tri-PCG-NH2. 
   
5.2.4 Temperature-responsive sol-to-gel transition 
   The temperature-responsive sol-to-gel transition behavior of the aqueous solutions of 
the samples (tri-PCG-NH2, tri-PCG-COOH and their mixtures) was investigated by the 
test-tube inverting method14. Each copolymer solution with a given concentration was 
prepared by dissolving the copolymer in phosphate buffer (PB) (50mM, pH = 7.4). 
Copolymers (solid) were added to PB and shaken with a vortex mixer for 1 min. The 
obtained dispersion was heated at 60 ºC (above the melting temperature (Tm) of the 
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copolymer) for 10 sec, and further stirred by vortex mixing for 1 min. The obtained 
mixture in a vial was then immersed in ice-cooled water for 10 min to become the sol 
state. The pH of the solution was adjusted to the desired values by the addition of 1 M 
NaOHaq or 1 M HClaq. The mixed sample solutions containing both tri-PCG-NH2 and 
tri-PCG-COOH at various mixing ratios (A/C = 0.2, 0.5 or 1.0), where A is the amount 
of tri-PCG-COOH (anion) and C is the amount of tri-PCG-NH2 (cation), were prepared 
as follows. Each copolymer solution was prepared as described above. The obtained two 
solutions were mixed at various mixing ratios at r.t. and stirred by vortex mixing for 1 
min. After cooling at 0 ºC for 10 min, the pH of the solution was adjusted to the desired 
values by the addition of 1 M NaOHaq or 1 M HClaq. A vial containing the sample 
solution was immersed in a water bath at the desired temperature for 15 min, removed 
from the water bath, then inverted repeatedly to determine Tgel based on the criteria of 
‘‘flow’’ (= sol) and ‘‘no flow’’ (= gel) in 30 s, with a temperature increment of 1 °C per 
step. Measurements were repeated three times for each temperature to determine the 
transition temperature in the phase diagram. 
 
5.2.5 DLS and ζ-potential measurements 
   The hydrodynamic diameter (Dh) and ζ-potential of the micelles in the aqueous 
copolymer solution and the mixed solution were measured by dynamic light scattering 
(DLS) using a Zetasizer nano Z ZEN2600 instrument (Malvern Instruments, Ltd.) under 
diluted conditions (0.5 wt%). The Dh and ζ-potential of the micelles in aqueous solution 
were recorded at 25 °C and a detection angle of 173° with a He-Ne laser as the incident 
beam. Micelle solutions of the copolymers were prepared by the solvent evaporation 
method. The copolymer dissolved in acetone was added dropwise to PB. After stirring 
for 20 min, acetone was removed by evaporation. The pH value of the obtained micelle 
solution was adjusted to the desired pH using 1 M HClaq or 1 M NaOHaq. The final 
polymer concentration was adjusted to 0.5 wt%. Before DLS measurements, the sample 
solution was filtered with a filter (pore size = 0.2 µm). 
 
5.2.6 Agarose gel electrophoresis 
   Agarose gel electrophoresis for the copolymers and their micelle mixtures containing 
pyrene as a probe was carried out by using 0.6 wt% agarose gel in PB (pH = 7.4) (200 V, 
210 min, 25 ºC). The results were visualized by UV light (312 nm) illumination using an 
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Image Quant LAS 4000. The copolymer micelle containing pyrene was prepared by the 
solvent evaporation method. Each copolymer (5.0 mg) was dissolved in acetone 
containing pyrene (50 µL, 10 mg/mL). The solution was added dropwise into PB (1.0 mL, 
pH = 7.4) and stirred for 20 min. After removal of acetone under reduced pressure, the 
obtained solution was filtered through a 0.2 µm filter to remove unloaded pyrene to give 
a pyrene-loaded micelle solution. The micelle solutions of tri-PCG-COOH and tri-PCG-
NH2 at various ratios (A/C = 0.2–2.0) were prepared by mixing predetermined amounts 
of tri-PCG-COOH solution (0.5 wt%, pH = 7.4) and tri-PCG-NH2 solution (0.5 wt%, pH 
= 7.4). The obtained samples were used as is, or after incubation at 37 ºC for 30 min and 
subsequent cooling at 25 ºC for 30 min. 
 
5.3 Results and discussion 
5.3.1 Synthesis of copolymers 
   The introduction of ionizable carboxylic acid or primary amino groups onto both 
termini of tri-PCGs was successfully carried out according to Schemes 1 and 2. The 
characterizations of the obtained tri-PCGs, tri-PCG-COOH and tri-PCG-NH2 are shown 
in Table 1. Two types of tri-PCGs, tri-PCG(2.0k) and tri-PCG(2.3k), were synthesized 
with MWs of their hydrophobic PCGA segments of 2,000 and 2,300 Da, respectively. 
The average degrees of polymerization for CL and glycolic acid (GA) units in the PCGA 
segments were estimated by 1H-NMR. Average continuous sequence lengths of caproyl 
units and glycolyl units (Lc and Lg) in the PCGA segments were also estimated from the 
1H-NMR spectra according to the literature34. The obtained tri-PCG(2.0k) and tri-
PCG(2.3k) were used for the syntheses of tri-PCG-COOH and tri-PCG-NH2, respectively. 
The 1H-NMR spectra of tri-PCG(2.0k) and tri-PCG-COOH are shown in Figure 1. The 
degree of substitution (DS) of the succinyl group in tri-PCG-COOH was calculated to be 
92% from the integral ratio of the methylene protons (-CH2-CH2-) of the succinyl group 
at 2.6–2.8 ppm (Figure 1). The 1H-NMR spectra of tri-PCG(2.3k), tri-PCG(Boc-Gly)2 
and tri-PCG-NH2 are shown in Figure 2. The DS of Boc-Gly on tri-PCG(Boc-Gly)2 was 
calculated from the peaks at 1.2–1.5 ppm for the methyl proton of the Boc group to be 
over 99%. The disappearance of the Boc groups after deprotection was also confirmed by 
1H-NMR, indicating quantitative removal of the Boc groups (introduction of primary 
amine groups) on the termini of tri-PCG-NH2. All copolymers obtained, tri-PCGs, tri-
PCG-COOH and tri-PCG-NH2, were in powder form in the dry state at r.t. (Figure 3). 
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Scheme 1. Synthesis of tri-PCG-COOH. 
 
 
Scheme 2. Synthesis of tri-PCG-NH2. 
 
Table 1. Characterization of the copolymers 
Code Mn (Da) a) 
Mw/
Mn b) 
DP of 
CL c) 
DP of 
GA d) 
CL/G
A e) 
LC f) LG f) 
DS of COOH or 
NH2 groups (%)a) 
tri-PCG(2.0k) 5,600 1.5 15 4.2 3.7 3.8 1.1 - 
tri-PCG-COOH 5,600       92 
tri-PCG(2.3k) 6,100 1.6 18 5.0 3.5 3.8 1.1 - 
tri-PCG-NH2 6,500       99 
a) Estimated by 1H-NMR (solvent: CDCl3). 
b) Estimated by size-exclusion chromatography (eluent: DMF; standard: PEG). 
c) Degree of polymerization of ε-caprolactone unit in a PCGA segment estimated from 
1H-NMR. 
d) Degree of polymerization of glycolic acid unit in the PCGA segment estimated from 
1H-NMR. 
e) Molar ratio of caprolactone/glycolic acid in the PCGA segment estimated by 1H-
NMR. 
f) Average continuous sequence lengths of caproyl units (Lc) and and glycolyl units 
(Lg) were calculated from 1H-NMR by the method in the literature34 
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Figure 1.  1H-NMR spectra for (a) tri-PCG(2.0k) and (b) tri-PCG-COOH in CDCl3. 
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Figure 2.  1H-NMR spectra for (a) tri-PCG(2.3k), (b) tri-PCG(Boc-Gly)2, and (c) tri-
PCG-NH2 in CDCl3. 
 
 
Figure 3. Photographs of (a) tri-PCG(2.0k), (b) tri-PCG-COOH and (c) tri-PCG-NH2 in 
dry state at r.t. 
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5.3.2 Sol-to-gel transition behavior at various pH 
   The temperature-responsive sol-to-gel transition behavior of the aqueous solutions of 
the copolymers and the mixtures of the copolymers at various mixing ratios under various 
pH conditions was investigated. The phase diagrams of the tri-PCG(2.0k) solution as a 
function of concentration (15–30 wt%, at pH = 7.4) and pH (pH = 2–10, 15 wt%) are 
shown in Figures 4a and 4b. The tri-PCG(2.3k) was insoluble in PB. The tri-PCG(2.0k) 
aqueous solutions showed temperature-responsive sol-to-gel transitions when the 
concentration was over 15 wt% and the gelation temperature (Tgel) was between r.t. and 
body temperature (37 ºC) (Figure 4a). The tri-PCG(2.0k) aqueous solutions (15 wt%) 
showed temperature-responsive sol-to-gel transitions over a wide pH range (pH = 2–10), 
and Tgel values in the same pH range were between r.t. and body temperature. Tgel values 
in the acidic pH range (pH = 2–4) were slightly higher than those in the neutral pH range 
(pH = 6–10). This phenomenon should be due to the stronger hydrogen bonding of the 
hydronium ion (H3O+) to the oxygen atom of PEG at pHs lower than 7, as reported 
previously 35. 
 
 
 
 
 
 
 
 
 
Figure 4. Temperature-dependent phase diagrams of tri-PCG(2.0k) as a function of (a) 
concentration (15–30 wt%) (pH = 7.4) and (b) pH (2–10) (polymer concentration = 15 
wt%) in PB. ●: Sol; ✖: Gel; ▲: Precipitate. 
 
   The phase diagrams of tri-PCG-COOH and tri-PCG-NH2 solutions under various pHs 
are shown in Figures 5a and 5b, respectively. The tri-PCG-COOH solution (15 wt%) did 
not undergo a sol-to-gel transition under the tested pH and temperature ranges of 2–9 and 
10–60 ºC, respectively, and exhibited only a sol-to-precipitate transition with increasing 
 150 
temperature at low pH (pH = 2–4). On the other hand, the tri-PCG-NH2 solution exhibited 
a sol-to-gel transition at neutral and basic pH (7.4–9.0). These results indicated that either 
a large amount of anionic carboxylate groups or nonionic carboxylic acid groups had 
negative effects on the temperature-responsive sol-to-gel transition behavior. Although 
cationic ammonium groups had negative effects on the temperature-responsive sol-to-gel 
transition, non-ionic amine groups did not have much effect. 
 
 
Figure 5. Temperature-dependent phase diagrams of (a) tri-PCG-COOH, and (b) tri-
PCG-NH2 at various pHs (polymer concentration = 15 wt%) in PB. ●: Sol; ✖: Gel; ▲: 
Precipitate. 
 
   We investigated the sol-to-gel transition behavior of the mixed solutions of tri-PCG-
COOH and tri-PCG-NH2 at various mixing ratios. Figure 6 shows photographs of the tri-
PCG-COOH solution, tri-PCG-NH2 solution and their mixtures. As can be seen in Figure 
6, the transparency of the solution did not change very much after mixing. The viscosity 
of the solution did not increase either. This means that ion complex formation between 
tri-PCG-COO- and tri-PCG-NH3+ did not occur or at least did not cause large-scale 
aggregation of the micelles in the solution. 
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Figure 6. Photographs of aqueous solutions of tri-PCG-COOH, tri-PCG-NH2 and their 
1:1 mixture (A/C = 1) at 25 °C (total polymer concentration = 15 wt%, pH = 7.4). 
 
   Interestingly, several mixed solutions of tri-PCG-COOH and tri-PCG-NH2 showed 
temperature-responsive sol-to-gel transition behavior at different pH regions depending 
on the mixing ratio. In Figure 7, photographs of the 1:1 mixture of tri-PCG-COOH and 
tri-PCG-NH2 before and after temperature-responsive sol-to-gel and gel-to-sol transitions 
of the solution at pH = 4.0 are shown as typical examples. At pH = 4.0, the mixture 
underwent gelation upon heating to 37 ºC, and Tgel was 35 ºC. During subsequent cooling 
to 4 ºC over 1 min, the hydrogel turned into the sol state, showing that the sol-to-gel 
transition of this system was reversible against temperature change.  
 
 
Figure 7. Photographs for the 1:1 mixture of tri-PCG-COOH and tri-PCG-NH2 (A/C = 
1) at pH = 4.0 at 25 °C, after 1 min at 37 °C, and after subsequent 1 min cooling at 4 °C. 
Total polymer concentration = 15 wt%. 
 
   Figures 8a, 8b and 8c show phase diagrams of the mixtures of tri-PCG-COOH and 
tri-PCG-NH2 at various mixing ratios (A/C = 0.2, 0.5 or 1.0). The 1:1 mixture (A/C = 
1.0) exhibited sol-to-gel transition behavior between r.t. and body temperature at pH = 
2.0–4.0 (Figure 5a), although neither tri-PCG-COOH nor tri-PCG-NH2 showed sol-to-
gel transitions in the pH = 2.0–4.0 region (Figure 5). The gel-forming pH regions for the 
mixed samples with 0.5 and 0.2 A/C ratios were pH = 2.0–5.0 and 4.0–7.4, respectively 
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(Figures 8b and 8c). The mixture having a larger A/C value (>1.0) did not exhibit a sol-
to-gel transition in the pH (2.0–9.0), concentration (15–30 wt%) and temperature (10–60 
ºC) ranges tested. Figure 9 shows representative photographs of the mixed solutions of 
tri-PCG-COOH and tri-PCG-NH2 at various A/C ratios under various pHs at 37 °C. The 
gel-forming pH region of the mixed solution shifted to basic pH with decreasing A/C 
ratio.  
 
 
Figure 8. Temperature-dependent phase diagrams of mixtures of tri-PCG-COOH and tri-
PCG-NH2 at A/C ratios at various pHs in PB. (a) A/C = 1.0, (b) A/C = 0.5, and (c) A/C = 
0.2. Total polymer concentration = 15 wt%. ●: Sol; ✖: Gel; ▲: Precipitate. 
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Figure 9. Photographs for examples of the mixed solutions of tri-PCG-COOH and tri-
PCG-NH2 at various A/C ratios under various pHs at 37 °C. Total polymer concentration 
= 15 wt%. 
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   Additional photographs under various conditions (pH and temperature) are shown in 
Figure 10. The sol-to-gel transition phenomena of the mixed solutions were also 
confirmed by rheological measurements (Figure 11, Table 2). 
 
 
 
 
Figure 10. Photographs for the mixture of tri-PCG-COOH and tri-PCG-NH2 with various 
A/C ratio at various temperature. (a) A/C = 1.0, (b) 0.5, (c) 0.2 as a function of 
temperature. total polymer concentration: 15wt%. 
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Figure 11.  Storage (G’, closed symbol) and loss moduli (G”, open symbol) for the 
mixture of tri-PCG-COOH and tri-PCG-NH2 with various A/C ratio as a function of 
temperature at various pH. (a) A/C = 1.0, (b) 0.5 and (c) 0.2. ●,	◯, pH = 2.0, ▲, △, 
pH = 5.0, ■,□, pH = 7.4. Total polymer concentration = 15 wt% 
Table 2 Tgel values estimated from rheological studies   
Sample pH Tgel (°C) 
A/C = 1.0 
2.0 36.2 
5.0 40.2 
7.4 N.D.a) 
A/C = 0.5 
2.0 37.8 
5.0 39.7 
7.4 N.D. 
A/C = 0.2 
2.0 38.8 
5.0 39.8 
7.4 39.7 
a) Not detected. 
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   In order to obtain micro-environmental information for the pH- and temperature-
responsive sol-to-gel transition behavior, hydrodynamic diameters (Dh) and ζ-potential 
values of the micelles in diluted solutions of the copolymer mixtures were investigated 
by DLS at various pHs. Figure 12 shows Dh and ζ-potential values of each copolymer 
micelle solution at various pHs. The average micelle size of tri-PCG-COOH at pH 7.4–
9.0 was about 30 nm, but increased with decreasing pH due to hydration of the ionized 
carboxylate groups at basic pH and hydrophobic interactions at acidic pH. Such pH-
dependent phenomena agreed well with previous reports35. The size of the tri-PCG-NH2 
micelles was about 100 nm at pH 7.4–9.0 and decreased slightly with decreasing pH. The 
average micelle sizes of nonionic tri-PCG were 80–90 nm, and remained almost constant 
with pH changes. The ζ-potential values for these polymer micelles were as expected 
from the functional groups attached. tri-PCG was almost zero over the entire pH range 
tested; tri-PCG-COOH and tri-PCG-NH2 showed negative and positive values in 
response to pH. The ζ-potential values of tri-PCG-COOH and tri-PCG-NH2 became zero 
at pH = 2.0 and pH = 9.0, respectively. tri-PCG-NH2 and tri-PCG showed larger micelle 
sizes compared with tri-PCG-COOH. The sizes were larger than expected from the 
molecular size and their flower-like micelle aggregation state, suggesting the occurrence 
of inter-micellar aggregation. This may be due to their stronger hydrophobic interactions 
and weaker electrostatic repulsion. This was also supported by their larger polydispersity 
indexes and bimodal size distributions (Figure 13 and Table 3). 
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Figure 13. (a) Size distributions and (b) ζ-potentials of tri-PCG(2.0k) (▲), tri-PCGC-
COOH (●), and tri-PCG-NH2 (■) micelles in PB at 25 ºC as a function of pH. 
 
 
Figure 14. Size distribution of (a) tri-PCG-COOH, (b) tri-PCG-NH2 and (c) mixture of 
tri-PCG-COOH and tri-PCG-NH2 (A/C = 1.0) micelle in PB (pH = 7.4) at 25 °C. Polymer 
concentration = 0.5 wt%. 
 
Table 3 Z-average of diameters and size distributions for diluted CP2.0k-COOH, CP2.3k-
NH2 and their mixture (A/C = 1.0) in PB (pH = 7.4). Polymer concentrations was 0.5wt% 
Sample Dh (Z-average) (nm) PDI 
tri-PCG-COOH 24.8 0.09 
tri-PCG-NH2 97.2 0.26 
Mixture (A/C = 1.0) 94.1 0.32 
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   Dh and ζ-potential values for the mixtures of tri-PCG-COOH and tri-PCG-NH2 are 
also shown in Figure 15. The average size of micelles for the mixtures (A/C = 1.0, 0.5, 
0.2) were in the range of 80–110 nm at pH 2.0–9.0, and not very different from the size 
of tri-PCG-NH2 micelles. These results suggested that mixing of tri-PCG-COOH and tri-
PCG-NH2 micelles did not induce further inter-micellar aggregation by electrostatic 
interaction between these micelles. The ζ-potential values for these mixed solutions (A/C 
= 0.2–1.0) changed from positive to negative values with increasing pH depending on 
their mixing ratios. The pH values where the ζ-potential became zero for the mixed 
micelles with A/C = 1.0, 0.5 and 0.2 were about 4.9, 5.5 and 6.8, respectively. From the 
results shown in Figure 5, gel-forming pH regions for the mixtures A/C = 1.0, 0.5 and 0.2 
were 2.0–4.0, 2.0–5.0 and 4.0–7.4, respectively, and slightly different from the pH at 
which the ζ-potential became zero. Considering these results, the micelles possessed 
slightly negative charges in the gel-forming pH region. These results suggested that a 
small excess of negatively charged carboxylate groups did not interfere with the sol-to-
gel transition but accelerated the gelation. 
 
Figure 15. (a) Size distributions and (b) ζ-potentials of mixture of tri-PCGC-COOH and 
tri-PCG-NH2 micelles at various mixing ratios in PB at 25 ºC as a function of pH. A/C = 
1.0 (▲), 0.5 (◆), 0.2 (●). 
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     The ζ-potential measurements give averaged values of the particles. It is still 
unclear whether there were the same amounts of positively charged micelles and 
negatively charged micelles, or if each micelle had the same amount of negative and 
positive charges, when the ζ-potential value of the solution was zero. Therefore, we 
carried out agarose gel electrophoresis for the copolymers and their mixtures (A/C = 0.2–
2.0) before and after heating. The results are shown in Figure 16. Before heating, each 
copolymer (tri-PCG(2.0k), tri-PCG-COOH, tri-PCG-NH2) showed almost clear single 
bands (Lanes 1, 3 and 5). Positively charged tri-PCG-NH2 micelles moved in the upper 
direction. The mobility of the mixtures (A/C = 0.2–2.0) decreased with decreasing A/C 
ratios by neutralization of negative charges (Lanes 7, 9, 11 and 13). The bands for pure 
tri-PCG-COOH micelles and pure tri-PCG-NH2 micelles observed in Lanes 3 and 5 were 
not observed before or after heating in Lanes 7–14. Even numbered lanes show the results 
after heating at 37 °C for 30 min and subsequent cooling at 25 °C. Significant differences 
were not observed before and after heating for any of the samples. As described above, 
we prepared mixed solutions by the solution mixing method from each polymer solution. 
We also prepared mixed micelle solutions by the direct mixing method in the solid state 
(two copolymers were dissolved in organic solvent, dried to a solid, and then dissolved 
in PB). However, the obtained mixed samples showed essentially the same properties as 
samples prepared by the solution mixing method (data not shown). All these results 
indicate that enough exchange of polymer molecules between positively charged micelles 
and negatively charged micelles occurred at an early stage after mixing at r.t., and this 
provided mixed polymer micelles exhibiting variable gel-forming pH regions by simple 
mixing of tri-PCG-COOH and tri-PCG-NH2 solutions. 
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Figure 16. Agarose gel electrophoresis of tri-PCG(2.0k), tri-PCG-COOH, tri-PCG-NH2 
and mixtures of tri-PCG-COOH and tri-PCG-NH2 (A/C = 0.2–2.0) in PB (pH = 7.4) at 25 
ºC before and after heating (37 °C, 30 min). Lanes 1 and 2: tri-PCG(2.0k); Lanes 3 and 
4: tri-PCG-COOH; Lanes 5 and 6: tri-PCG-NH2; Lanes 7 and 8: mixture A/C = 2.0; Lanes 
9 and 10: A/C = 1.0; Lanes 11 and 12: A/C = 0.5; Lanes 13 and 14: A/C = 0.2. Odd Lanes: 
before heating; Even Lanes: after heating at 37 °C for 30 min. 
 
5.4 Conclusions 
   For fail-safe reasons, dual (temperature and pH) stimuli-responsive systems have 
been desired. To apply dual stimuli-responsive IP systems to tissues and organs with 
different physiological pHs, however, temperature-responsive IPs exhibiting different 
gel-forming pH regions must be synthesized for each case since it is difficult to alternate 
gel-forming pH regions of IP systems. In this study, we succeeded in preparing a novel 
IP system exhibiting variable gel-forming pH regions. PCGA-b-PEG-b-PCGA (tri-PCG) 
having carboxylic acid groups or primary amine groups on both termini, tri-PCG-COOH 
and tri-PCG-NH2, were successfully synthesized. Using these triblock copolymers having 
negatively charged and positively charged termini, we could prepare dual stimuli 
(temperature and pH) responsive biodegradable injectable polymer systems. This system 
has great advantages because the gel-forming pH region can be easily controlled by just 
changing the mixing ratio of tri-PCG-COOH and tri-PCG-NH2. This system can provide 
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wide variety and specific gel-forming pH regions by simple mixing of two stock solutions 
of tri-PCG-COOH and tri-PCG-NH2. The gel-forming pH region could be altered from 
pH 2.0–4.0 to pH 7.4–9.0. This system can provide a fail-safe dual-stimuli-responsive IP, 
which is compatible with different tissues and organs having different physiological pHs, 
and is expected to be applied in clinical trials for drug delivery systems, regenerative 
medicine and anti-adhesive materials, etc. 
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poly(depsipeptide-co-lactide)-g-PEG 
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6.1 Introduction 
   Thermo-gelling polymers have gained much attention in the past two decades as 
implantable medical materials. In particular, biodegradable thermo-gelling polymers with 
a sol-to-gel transition point (Tgel) between room temperature and body temperature are 
expected to be useful for injectable polymer (IP) systems 1-5 Injectable biodegradable 
hydrogels have been widely investigated for biomedical applications, such as drug or cell 
delivery and tissue engineering. It is of particular interest that such hydrogels can easily 
entrap drugs, proteins, and cells by mixing them into the polymer solutions prior to 
administration 6-12. As the insertion of IP hydrogels into the body is done simply by 
injection and does not require surgical procedures, such IP systems are expected to help 
provide minimally invasive therapy. 
   IPs exhibiting a temperature-responsive sol-to-gel transition in aqueous solution 
should possess amphiphilicity with a delicate balance of hydrophilicity and 
hydrophobicity 13. As such, most IPs consist of both hydrophilic and hydrophobic 
segments. Poly(ethylene glycol) (PEG) has frequently been used as the hydrophilic 
segment in IP systems due to its excellent biocompatibility. Water-insoluble 
biodegradable aliphatic polyesters such as poly(L-lactide) (PLLA), poly(D-lactide) 
(PDLA), poly(DL-lactide) (PDLLA), poly(DL-lactide-co-glycolide) (PLGA), poly(ε-
caprolactone), poly(ε-hydroxybutyrate), and their modified polymers have been primarily 
adopted as the hydrophobic segment 13-19. Various types of polymer structures (e.g. linear, 
graft, star-shape, etc) were previously reported for IPs. Linear di- or triblock copolymers 
are the simplest and have been investigated by many researchers. However, the 
mechanical strength of the hydrogels prepared from these linear copolymer solutions was 
not enough for their clinical application as implant materials. Temperature-responsive 
hydrogels of high total molecular weight polymers are logically expected to show higher 
mechanical strengths. However, due to the strong dependence of Tgel on PEG length, 
linear di- and triblock copolymers have limitations in molecular weight. Elongation of 
the PEG chain leads to an increase in Tgel or loss of transition character itself. Jeong et al. 
and Kim et al. reported some graft, multiblock or branched copolymers composed of PEG 
and either PLGA or PLLA to overcome the problems concerning the total molecular 
weight of injectable polymers 20-23. However, the PLGA-g-PEG graft copolymer and 
PEG-PLLA multiblock copolymer in aqueous solutions (25 wt%) did not show high 
enough storage moduli at 37°C. As mentioned above, hydrophobic/hydrophobic balance 
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and the length of hydrophilic segment in IPs affect their sol-to-gel transition behavior 
very much. However, no systematic study for the effects of the hydrophobic/hydrophobic 
balance and the length of the hydrophilic segment on the sol-to-gel transition behavior 
has been carried out.  
   We have previously reported the biodegradable copolymers of depsipeptide and 
PLLA, poly(depsipeptide-co-L-lactide) containing reactive side-chain groups such as 
COOH, NH2, and SH based on the amino acids in depsipeptide unit 24-25. They can adopt 
many functionalities via chemical modification of the functional groups. Recently, we 
synthesized poly(depsipeptide-co-DL-lactide)-graft-PEG (P(DG-DL-LA)-g-PEG) as a 
graft-type IP 26. An aqueous solution of P(DG-DL-LA)-g-PEG (20 wt%) with a certain 
PEG length and composition showed temperature-responsive sol-to-gel transition at 33°C. 
This graft-type molecular architecture allowed for simple modifications in the length and 
amount of PEG chains introduced on P(DG-DL-LA). This system is suitable for a 
systematic study to investigate the effects of hydrophobic/hydrophobic balance and the 
length of hydrophilic segment on the sol-to-gel transition behavior. In this paper, we 
prepared P(DG-DL-LA)-g-PEG copolymers with different amounts and lengths of 
introduced PEG chains, and investigated their sol-to-gel transition behavior. Herein, we 
discuss the relationship between the sol-to-gel transition temperature and molecular 
weight of introduced PEG chains or PEG contents in P(DG-DL-LA)-g-PEG copolymers. 
 
6.2 Experimental section 
6.2.1 Materials 
   Hexaethylene glycol monomethyl ether (MeO-PEG300, Mn: 296 Da) was purchased 
from Tokyo Chemical Industry Co., Ltd. Monomethoxy-poly(ethylene glycol) (MeO-
PEG350, Mn: 350 Da), dicyclohexylcarbodiimide (DCC), N,N-dimethylaminopyridine 
(DMAP) and anhydrous dichloromethane (DCM) were purchased from Wako Pure 
Chemical Industries, Ltd and used without further purification. MeO-PEG550 (Mn: 550 
Da) was purchased from Sigma-Aldrich. Other chemicals were commercial grades, and 
used without further purification. A series of P(GD-DL-LA)s with different depsipeptide 
contents were prepared by a method in the literature 27-28. 
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Scheme 1.  Preparation of P(GD-DL-LA)-g-PEG. 
 
 
6.2.2 Preparation of P(GD-DL-LA)-g-PEG  
   A series of P(GD-DL-LA)-g-PEG copolymers was prepared through coupling 
reactions between the pendant carboxyl groups of PGD-DL-LA and the end hydroxyl 
group of MeO-PEG. In brief, the mixture of P(GD-DL-LA) and MeO-PEG (2 equivalents 
to COOH of P(GD-DL-LA)) was dried and dissolved in 1 mL of anhydrous DCM. DCC 
(1.5 equivalents to COOH of P(GD-DL-LA)) and DMAP (0.5 equivalents to COOH of 
P(GD-DL-LA)) dissolved in anhydrous DCM (1 mL) were added to the solution. The 
obtained mixture solution was stirred at room temperature for 12 h. After removal of 
dicyclohexylurea as a side product by filtration, the filtrate was poured into diethylether 
to remove the excess MeO-PEG to give white precipitates of P(GD-DL-LA)-g-PEG. The 
detailed procedures and results for the prepared copolymers are in the Supporting 
Information. 
 
6.2.3 Characterization 
   1H NMR spectra were recorded on a JNM-GSX-400 (JEOL, 400 MHz) nuclear 
magnetic resonance instrument using CDCl3 as a solvent. The chemical shifts were 
calibrated against tetramethylsilane (TMS) and the solvent signal of CDCl3. The number 
of introduced MeO-PEG, and the composition ratios of the MeO-PEG to P(GD-DL-LA) 
backbone in P(GD-DL-LA)-g-PEG were calculated based on 1H NMR integral ratios. The 
number-average molecular weight (Mn) and the polydispersity index (Mw/Mn) of P(GD-
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DL-LA)-g-PEG copolymers were determined by size exclusion chromatography (SEC) 
(column: TSKgel Multipore HXLM ×2, detector: RI). The measurements were performed 
using dimethylformamide (DMF) as an eluent at a flow rate of 1.0 mL/min at 40°C and a 
series of PEG as standards. 
 
6.2.4 Sol-to-Gel Transition Behavior 
   Sol-to-gel transition behavior of each copolymer aqueous solution was tested by test-
tube inverting method. Each sample of P(GD-DL-LA)-g-PEG copolymers in a 5-mL vial 
was dissolved in phosphate buffer solution (pH = 7.4, ionic strength = 0.14) with 
sonication at 4°C. The vial was immersed in a water bath at desired temperature for 15 
min, removed from the water bath, then inverted repetitively to determine Tgel based on 
the criteria of ‘‘flow’’ (=sol) and ‘‘no flow’’ (=gel) in 30 sec, with a temperature increment 
of 1°C per step. Measurements were repeated three times for each temperature to 
determine the transition temperature in phase diagram. 
 
6.2.5 Rheological Measurements 
   Each sample of P(GD-DL-LA)-g-PEG copolymers was dissolved in phosphate buffer 
solution at 4°C. A temperature dependence measurement of each sample’s physical 
property was performed to allow detailed examination of temperature-responsive sol-to-
gel transition behavior. Measurements were taken with a dynamic rheometer (HAAKE, 
Thermo HAAKE RS600). A solvent trap was used to prevent vaporization of the solvent. 
Each sample solution was placed between parallel plates (25 mm diameter and 1.0 mm 
gap) using a syringe. The plates were then heated at a rate of 0.5°C/min. The data was 
collected under controlled stress (4.0 dyn/cm2) and a frequency of 1.0 rad/s. The hydrogel 
formation behavior of the sample solution was monitored by measuring the shear storage 
modulus (G’) and the loss modulus (G”) at every minute. 
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6.3 Results and discussion 
6.3.1 Preparation of P(GD-DL-LA)-g-PEG copolymers 
   A series of P(GD-DL-LA)-g-PEG copolymers was prepared through coupling 
reactions between the pendant carboxyl groups of P(GD-DL-LA) and the end hydroxyl 
group of MeO-PEG with different molecular weights (300, 350 or 550 Da). Weight 
contents of PEG in the copolymers were intentionally adjusted to around 24, 27, or 30 
wt% to compare the effect of molecular weights of MeO-PEG graft chains on their 
temperature-responsive properties. The results of characterization for P(GD-DL-LA)-g-
PEG copolymers were summarized in Table 1. Here, we use abbreviation codes, XXX-
YY, for each P(GD-DL-LA)-g-PEG copolymer sample. The first three digits (XXX) 
represent the molecular weight of introduced MeO-PEG (Da) and the last two digits (YY) 
represent the weight content of PEG in percent for the P(GD-DL-LA)-g-PEG copolymer. 
For example, the copolymer with 300-24 is P(GD-DL-LA)-g-PEG having 24 wt% of PEG 
content prepared with of MeO-PEG (300 Da). Figure 1 shows SEC profiles for typical 
examples of P(GD-DL-LA) and P(GD-DL-LA)-g-PEG samples. All of the copolymers 
obtained showed unimodal elution profiles. The structure of P(GD-DL-LA)-g-PEG was 
determined from 1H NMR spectrum measured in CDCl3. The spectrum for each P(GD-
DL-LA)-g-PEG sample was given as simple integrations of P(GD-DL-LA) and MeO-PEG. 
The degrees of substitution (DS) of MeO-PEG per carboxylic acid of depsipeptide units 
were estimated to be 100% for all samples. In other words, we carried out the coupling 
reactions until DS became 100%. PEG contents in P(GD-DL-LA)-g-PEG samples were 
determined to be 23-31 wt% based on the integration ratios of methyl proton of LA in 
P(GD-DL-LA) to methyl proton of MeO-PEG. All copolymers obtained had similar 
molecular weights (within 29 000 ± 3 000), different molecular weights of MeO-PEG 
(300, 350 and 550), and PEG contents (about 24, 27, and 30 wt%). The copolymers were 
sticky pastes that were difficult to dissolve in water or phosphate buffer solution for those 
over 5 wt%. It took at least 5 h for copolymers to be dissolved in aqueous solution by 
stirring. A homogeneous transparent micelle suspension (colloidal solution) could be 
obtained by sonication in an ultrasound bath for 1 h at 10°C. 
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Table 1. Characterization of P(GD-DL-LA)-g-PEG 
code Mn 
×10-3 a) 
x 
[mol%] b) 
# of 
PEGc) 
PEG content 
[wt%]d) 
Yield 
[%] 
300-24 26 17 20 24 77 
300-27 32 22 30 27 76 
300-30 30 25 31 30 77 
350-23 27 13 18 23 79 
350-27 27 17 20 27 67 
350-31 34 22 30 31 83 
550-23 26 9 11 23 80 
550-28 30 11 16 28 80 
550-30 27 12 15 30 72 
a) Estimated by GPC (eluent : DMF, standard : PS). 
b) Mole fraction of depsipeptide units in P(GD-DL-LA). 
c) Number of MeO-PEG introduced per polymer molecule estimated by 1H NMR 
(solvent : CDCl3). 
d) Weight content of PEG in copolymer estimated by 1H NMR (solvent : CDCl3). 
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Figure 1. 1H NMR spectrum of P(GD-DL-LA)-g-PEG (350-23) in CDCl3. 
 
 
 
Figure 2. Size exclusion chromatograms of (a) P(GD-DL-LA) (Mw =19 000, degree of 
introduction of depsipeptide unit = 17 mol%), (b) 300-24, (c) 350-23, and (d) 550-23.  
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6.3.2 Sol-to-Gel Transition Behavior 
   Temperature-responsive sol-to-gel transition behaviors of P(GD-DL-LA)-g-PEG 
copolymers were observed by the test tube inverting method. As shown in Figure 3, 
P(GD-DL-LA)-g-PEG copolymer suspension was a clear sol below Tgel, but it turned into 
a turbid gel when the temperature was raised above its Tgel. A suspension of 300-24 
showed a sol-to-gel transition for polymer concentrations of 10-20 wt% (Figure 4a). 300-
24 (10 wt%) underwent so-to-gel transition across Tgel at 26°C. Tgel decreased with the 
increase of the polymer concentration for all of the samples tested. This is due to an 
increased possibility of physical cross-linking. Moreover, 10 wt% 300-24 gel underwent 
syneresis with increase in temperature above 44°C. The upper boundary curves gave the 
gel-to-syneresis transition temperature. These temperature-responsive phase transition 
behaviors were found to be reversible: when the temperature of a gel state sample was 
lowered below Tgel, the gel became a transparent sol again. On the other hand, at a 5 wt% 
polymer concentration 300-24 suspension did not show sol-to-gel transition and was 
instead transitioned between sol and turbid sol states. Similar observations were made for 
5 wt% 350-23 and 550-23 (Figure 4b and 4c). Lowest gelation concentrations of these 
three copolymers were similar (10 wt%), although Tgel values at the same concentration 
varied. The lowest Tgel was observed for the copolymer with the shortest MeO-PEG 
chains (300-24) and the highest Tgel was observed for the copolymer with the longest 
MeO-PEG chains (550-23). Among copolymers with the same PEG (hydrophilic 
segment) content, Tgel increased with the increase in the molecular weight of MeO-PEG. 
These results indicate that for P(GD-DL-LA)-g-PEG copolymers of similar PEG content, 
the introduction of short PEG chains is more effective in decreasing Tgel than the 
introduction of long PEG chains. This should be because the shorter PEG chain is more 
likely to be dehydrated upon heating compared with the longer one.  
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Figure 3.  Photographs of (a) sol and (b) gel states for P(GD-DL-LA)-g-PEG copolymer 
(350-23) in test tube inverting experiment. 
 
 
Figure 4.  Phase diagrams of (a) 300-24, (b) 350-23, and (c) 550-23 in phosphate buffer 
solution at various concentrations and temperatures. 
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   To discuss the effects of PEG content and chain length of PEG on the sol-to-gel 
transition behavior, Tgel and PEG content for all P(GD-DL-LA)-g-PEG copolymers (20 
wt% polymer concentration) are summarized in Figure 5. As mentioned above, the trend 
that Tgel of P(GD-DL-LA)-g-PEG copolymers increased with increase in the molecular 
weight of MeO-PEG graft-chains was observed for all series of the copolymers with PEG 
contents of about 24, 27, and 30 wt%. On the other hand, Tgel increased with increase in 
the PEG content among the series of P(GD-DL-LA)-g-PEG prepared from MeO-PEG300 
(300-24, 300-27, and 300-30). It is a natural tendency that more hydrophilic copolymer 
micelles are more stable in aqueous solution, and it needs higher temperature to form a 
crosslink by dehydration of PEG chain in the copolymers. The same trend was observed 
for series of P(GD-DL-LA)-g-PEG copolymers prepared from MeO-PEG350 (350-23, 
350-27, 350-31) and MeO-PEG550 (550-23, 550-28, 550-30). 
   These results provide vital information useful for controlling Tgel and rational design 
of amphiphilic copolymers exhibiting sol-to-gel transition at desired temperature. For 
instance, biomedical uses of polymers as an injectable drug delivery system require Tgel 
to be between room temperature and body temperatures. Among the copolymers 
synthesized in this study, 300-27, 300-30, and 350-23 showed Tgel at 31, 28, and 32ºC, 
respectively, and are suitable for injectable biomaterials. 
 
 
Figure 5. Plots of Tgel vs. PEG content for P(GD-DL-LA)-g-PEG copolymers prepared 
with MeO-PEG300 (●), MeO-PEG350 (▲), and MeO-PEG550 (■) in phosphate buffer 
solution. 
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6.3.3 Rheological Measurements 
   To investigate the effects of molecular weight of PEG graft chains on the physical 
properties of the obtained hydrogel, the storage modulus (G’) and loss modulus (G”) in 
the gelation process were investigated by dynamic mechanical analysis. Figure 5 shows 
the temperature dependence of G’ and G” for 300-24, 350-23, and 550-23 in phosphate 
buffer solution at 20 wt%. In addition to the test tube inverting method, Tgel can be 
determined by a dynamic mechanical analysis: Tgel is defined as temperature at which G’ 
and G’’ intersect. Tgel of 300-24, 350-23, and 550-23 were observed to be 28.7, 33.3, and 
39.8°C, respectively. Although these values were not the same as the values obtained by 
the test tube inverting method (Figure 5), the results were within similar range. The 
maximum G’ values of 300-24, 350-23, and 550-23 systems (20 wt%) were 672, 840, and 
894 Pa at 38.4ºC, 42.4°C, and 46.9°C, respectively. These values are relatively high 
compared with the values for linear di- or tri-block copolymers previously reported. The 
differences in these maximum G’ values were not so significant. These results 
demonstrate that the length of PEG graft chain of the P(GD-DL-LA)-g-PEG copolymers 
has no significant influence on the physical strength of hydrogel obtained.  
 
 
Figure 5.  Storage modulus G’ (solid symbols) and loss modulus G” (open symbols) as 
a function of temperature for P(GD-DL-LA)-g-PEG copolymers (20 wt%) in phosphate 
buffer solution. (●) 300-24, (▲) 350-23, and (■) 550-23. 
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6.4 Conclusions 
   We prepared P(DG-DL-LA)-g-PEG copolymers with similar total molecular weight, 
different length of PEG graft chains and different PEG contents. The effects of the length 
of PEG graft chains and PEG contents on the temperature-responsive sol-to-gel transition 
behavior of the copolymers in phosphate buffer solution were investigated. Sol-to-gel 
transition temperatures of P(GD-DL-LA)-g-PEG copolymers with the same PEG content 
increased with increase in the molecular weight of PEG side chains. This should be 
because shorter PEG chain is likely to be dehydrated at lower temperature. On the other 
hand, the length of the PEG graft chain did not have a significant influence on physical 
properties of hydrogels upon heating. Although the effects of total molecular weight of 
the graft copolymers were not investigated in this work, the information obtained in this 
work should be useful for providing strategies on rational design of amphiphilic 
biodegradable polymer exhibiting temperature-responsive sol-to-gel transition at desired 
temperature. These results also suggest that the graft-type amphiphilic copolymer system 
is a highly convenient category of polymer architecture for control of sol-to-gel transition 
temperature, and useful for biomedical application as biodegradable injectable polymers. 
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7.1 Introduction 
   In the last few decades, much attention has been directed toward biodegradable 
thermo-gelling polymers that exhibit sol-to-gel transitions between room temperature and 
body temperature for their usage as injectable polymers (IPs) 1-5. Aqueous solutions of 
such IPs can be administered by simple syringe injection into the body, become hydrogels 
at body temperature, and be degraded after a certain period of time. They have been 
widely studied for biomedical applications, such as drug delivery systems (DDS) and 
scaffolds for tissue engineering. Such hydrogels entrapping drugs, proteins or cells can 
easily be prepared by simply adding them into polymer solutions prior to administration 
6-12. Importantly, since the insertion of an IP hydrogel into the body does not require 
surgical procedures, such an IP system should be a minimally invasive therapeutic system.  
   Biodegradable IPs usually have amphiphilic structures with a delicate balance of 
hydrophilicity and hydrophobicity to exhibit a temperature-responsive sol-to-gel 
transition in aqueous solution 13. They typically are constructed from both hydrophilic 
and hydrophobic segments. Poly(ethylene glycol) (PEG) has been frequently used as a 
hydrophilic segment due to its biocompatibility. Biodegradable aliphatic polyesters such 
as poly(L-lactide) (PLLA), poly(DL-lactide) (PDLLA), poly(DL-lactide-co-glycolide) 
(PLGA), poly(ε-caprolactone) (PCL), poly(β-hydroxybutyrate) (PHB), and their 
modified copolymers have been primarily adopted as hydrophobic segments 13-19. The 
most popular molecular structures for IPs consisting of PEG and an aliphatic polyester 
are linear block (AB, ABA, BAB or multi) type architectures, but some other types of 
molecular structures having branched structures such as graft-type or star-shaped IPs have 
also been reported 20-23. We also previously reported several graft-type and star-shaped 
biodegradable IP systems 24-27. Among them, a graft-copolymer system consisting of a 
hydrophobic aliphatic polyester copolymer main chain and PEG graft chains had some 
advantages compared to block copolymer systems 26,27. The sol-to-gel transition behavior 
of IPs strongly depends on the length of the PEG segments, with longer PEG chains in 
block copolymer systems leading to an increase in the sol-to-gel transition temperature 
(Tgel) or a loss of the transition character itself. Therefore, typical block copolymer-type 
IPs have limitations in the length of PEG segments and total molecular weight, which 
may be obstacles to achieving higher physical properties in the gel state. On the other 
hand, using graft-copolymer architecture, the total molecular weight of the polymer can 
be changed independently of the length of the PEG graft chain while retaining the sol-to-
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gel transition behavior. Therefore, it is possible to produce higher-molecular-weight IPs 
by employing graft-type architecture. Higher molecular weights and branched structures 
of graft copolymer-type IPs are favorable for exhibiting higher physical strength in the 
gel state 26-27. 
   IP thermogel systems have been widely used for drug delivery systems 1-5. Several 
factors influence the release rate of drugs from hydrogels, including 
hydrophilicity/hydrophobicity and molecular weight of the drug, degradation rate of the 
hydrogel, and diffusion constant of the drug in the hydrogel. For example, Kim et al. 
reported the sustained release of hydrophobic and hydrophilic drugs from a PEG-b-
PLGA-b-PEG triblock copolymer thermogel 28. The hydrophilic ketoprofen and 
hydrophobic spironolactone were released for two weeks and two months, respectively. 
Liu et al. also demonstrated the release of indomethacin and 5-fluorouracil from PLGA-
b-PEG-b-PLGA thermogel systems 29. Hydrophilic 5-fluorouracil and hydrophobic 
indomethacin were secreted from the hydrogel over five days and one month, respectively. 
Drug release rates depend on the structures and degradation rates of the copolymers that 
comprise the hydrogels 30. However, the release rates of water-soluble hydrophilic low-
molecular-weight drugs are generally faster than hydrophobic and/or high-molecular-
weight drugs, because the apparent pore sizes of the hydrogel networks are much larger 
than the size of low-molecular-weight drugs and the diffusion constants of such water-
soluble drugs are relatively high. Thus, it is not easy to achieve long-term sustained 
release of relatively water-soluble low-molecular-weight drugs. In an ideal system, the 
release of drugs from IP hydrogels would be controlled independently by the 
hydrophilicity/hydrophobicity and molecular weights of the drugs.  
   Alternatively, a macromolecular prodrug is a category of prodrug system used in DDS, 
where low-molecular-weight drugs are covalently attached to water-soluble polymers 31. 
We previously reported some macromolecular prodrug systems of antitumor drugs using 
biodegradable polymers as carriers 32-33. For example, covalent attachments of anticancer 
drugs to biocompatible water-soluble polymers were effective in delivering the drugs to 
the tumor site and better in vivo antitumor activity was realized due to enhancement 
permeability and retention (EPR) effects 34-35 and reduction of the side effects of the drugs 
from their escape from the distribution site to unfavorable sites in the body. Usually the 
drugs are inactive and non-toxic while they remain attached to the backbone polymers, 
but they become active by conversion to the parent drugs upon hydrolytic release from 
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the backbone polymer. Therefore, these release and activation mechanisms of 
macromolecular prodrug systems can provide similar effects as the sustained release of a 
drug. The release rates of drugs from the backbone polymer can be controlled by the 
hydrolysis rate of the covalent bond between the drug and backbone polymer, the 
attachment manner (type of chemical bonds), and the structure of spacer groups 
(hydrophilicity/hydrophobicity). 
   Polydepsipeptides are copolymers of amino acids and hydroxyl acids. Previously, we 
reported the synthesis of biodegradable copolymers of depsipeptide and lactide, 
poly(depsipeptide-co-lactide), with reactive side-chain groups such as COOH, NH2, OH 
and SH, by ring-opening polymerization of cyclodepsipeptides consisting of the 
corresponding amino acids and glycolic acid 36-39. Using the functionality of the side-
chain group of these copolymers, various chemical modifications can be installed to 
provide functional biodegradable materials. Recently, we synthesized an amphiphilic 
graft copolymer of poly(depsipeptide-co-DL-lactide) with PEG, poly[(glycolic acid-alt-
L-aspartic acid)-co-DL-lactide]-g-PEG [P(GD-DL-LA)-g-PEG], by the coupling reaction 
of carboxylic acid groups of P(GD-DL-LA) with monomethoxy-PEG (MeO-PEG). An 
aqueous solution of P(GD-DL-LA)-g-PEG (20 wt%) with certain lengths and 
compositions of PEG showed temperature-responsive sol-to-gel transitions at 33-51 °C 
depending on the PEG length and composition 26. Using this system, the unreacted 
residual carboxylic acid groups can be used for further functionalization of the thermo-
gelling polymer system, e.g., for drug immobilization. 
   In this paper, we propose a new type of IP system, which can act as a macromolecular 
prodrug, that exhibits sustained release of water-soluble low-molecular-weight drugs. 
Water-soluble antibiotic levofloxacin (LEV) with pH-dependent solubility in the range 
30-300 mg/mL 40-41 was chosen as a model of a relatively hydrophilic low-molecular-
weight drug, because it has a reactive carboxylic acid group and easily detectable UV-
absorption. The LEV was attached to P(GD-DL-LA)-g-PEG to give a P(GD-DL-LA)-g-
PEG/LEV conjugate. Temperature-responsive sol-to-gel transition behavior of the 
conjugate in aqueous solution and the release behavior of LEV from the hydrogel were 
investigated.  
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7.2 Experimental section 
7.2.1 Materials 
   Monomethoxy-poly(ethylene glycol) (Mn = 350 Da) (MeO-PEG350), dicyclohexyl 
carbodiimide (DCC), N,N-dimethylaminopyridine (DMAP) and dry methylene chloride 
(DCM) were purchased from Wako Pure Chemical Ind., Ltd. Levofloxacin (LEV), N-
tert-butoxycarbonyl(Boc)-ethanolamine and N-hydroxysuccinimide (NHS) were 
purchased from Aldrich. Other reagents were commercial grade and used without further 
purification. P(GD-DL-LA) was prepared by literature methods 26, 42. An amino derivative 
of LEV, LEV-ethyl-NH3+Br-, was synthesized by the coupling reaction of LEV with N-
Boc-ethanolamine using DCC as a condensing reagent and subsequent deprotection using 
TFA. PLGA-b-PEG-b-PLGA triblock copolymer (Mn of PEG = 1,500 Da, Mn of a PLGA 
segment = 1,800 Da, degree of polymerization (DP) of LA and GA = 9.4 and 4.0, 
respectively) was synthesized according to the literature 15 and used as a control thermo-
gelling polymer. The sol-to-gel transition temperature of the polymer solution (20 wt%) 
was 33 °C. 
 
 
 
Scheme 1. Synthesis of P(GD-DL-LA)-g-PEG/LEV conjugate. 
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7.2.2 Measurements 
   1H NMR spectra were recorded on a JNM-GSX-400 (JEOL, 400 MHz) nuclear 
magnetic resonance instrument using deuterated chloroform (CDCl3) as solvent. The 
chemical shifts were calibrated against TMS and solvent signal of CDCl3. The number of 
introduced MeO-PEG units and the composition of MeO-PEG in the conjugate (wt%) 
were calculated based on 1H NMR integral ratios in the spectra of P(GD-DL-LA)-g-PEG. 
The number average-molecular weight (Mn) and polydispersity index (Mw/Mn) for 
P(GD-DL-LA)-g-PEG and P(GD-DL-LA)-g-PEG/LEV conjugate were determined by 
size exclusion chromatography (SEC) (Column: TSKgel Multipore HXLM × 2; detector: 
refractive index) using DMF as an eluent at a flow rate of 1.0 mL/min at 40 °C and a 
series of PEG as standards. The number of introduced LEV molecules in the conjugate 
was determined by UV-vis absorption spectra in DMSO using a spectrophotometer 
(Shimadzu UV-2400PC). The amounts of parent LEV and LEV attached on P(GD-DL-
LA)-g-PEG hydrolysates released to the medium were determined by high performance 
liquid chromatography (HPLC) analysis [Column: LiChrospher 100RP-18e; detector: 
photodiode array (PDA)] of the supernatant using the ammonium formate 
buffer/acetonitrile gradient system as an eluent at a flow rate of 0.5 mL/min at room 
temperature. The gradient solutions were 50 mM ammonium formate buffer (A solution) 
and 50 mM ammonium formate buffer/acetonitrile (1:1, B solution), respectively, where 
the A/B ratio in gradient solution was changed from 95/5 to 60/40 for the initial 3 min, 
and then to 0/100 for the next 12 min. 
 
7.2.3 Synthesis of P(GD-DL-LA)-g-PEG/LEV conjugate 
   P(GD-DL-LA) (Mn = 2.3 × 104 Da, content of depsipeptide unit = 16.0 mol%, 1.50 g, 
65.2 µmol, COOH: 1.50 mmol) was dried and dissolved in anhydrous DMF (10 mL). 
LEV-ethyl-NH3+Br- (146 mg, 0.300 mmol), DCC (62 mg, 0.300 mmol), NHS (30 mg, 
0.300 mmol) and DMAP (73 mg, 0.600 mmol) dissolved in anhydrous DMF solution (5 
mL) were added to the polymer solution and the mixture was stirred at room temperature 
for 24 h. Next, the anhydrous DMF solution (1 mL) containing MeO-PEG350 (945 mg, 
2.70 mmol) and DCC (464 mg, 2.25 mmol) was added into the reaction mixture, which 
was stirred at room temperature for 12 h. The reaction mixture was filtered to remove the 
decyclohexylurea side product. The unreacted MeO-PEG350 and LEV derivative were 
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removed by reprecipitation using diethylether/methanol (7/4, v/v) to give a white 
precipitate of the P(GD-DL-LA)-g-PEG/LEV conjugate (yield: 83%). 
 
7.2.4 Sol-to-gel transition 
   The sol-to-gel transition behavior of P(GD-DL-LA)-g-PEG/LEV conjugate and 
P(GD-DL-LA)-g-PEG aqueous solution were investigated by the test tube inversion 
method as follows 24. Each sample was dissolved in phosphate buffer (PB) solution (pH 
= 7.4, ionic strength = 0.14) in a 5-mL vial at a given concentration with sonication at 
room temperature. The vial was then immersed in a water bath at the desired temperature 
for 15 min. After the vial was inverted, the sol-to-gel transition temperature was 
determined based on the criteria of ‘‘flow’’ (=sol) and ‘‘no flow’’ (=gel) in 30 sec with a 
temperature increment of 1 °C per step. Measurements were repeated three times at each 
temperature to determine the transition temperature in the phase diagram. 
 
7.2.5 Rheological measurements 
   P(GD-DL-LA)-g-PEG/LEV conjugate or P(GD-DL-LA)-g-PEG solution (20 wt%) 
was prepared by dissolving each sample in PB solution at room temperature. The 
temperature-dependent rheological properties of the solution on the temperature-
responsive sol-to-gel transition were measured by using a dynamic rheometer (HAAKE, 
Thermo HAAKE RS600). A solvent trap was used to prevent vaporization of the solvent. 
Each sample was injected into the 1.0 mm space between parallel plates of 25 mm 
diameter using a syringe. The data were collected under controlled stress (4.0 dyn/cm2) 
and a frequency of 1.0 rad/s, and the plates were heated at a rate of 0.5 °C/min. The 
hydrogel formation behavior of the sample solution was monitored by measuring the 
shear storage modulus (G’) and the loss modulus (G”) at every point.  
 
7.2.6 Swelling and degradation test 
   The swelling and in vitro degradation behavior of copolymer hydrogels in PB solution 
at 37 °C was investigated. The hydrogels (20 wt%) prepared in a 5-mL vial were fully 
soaked in 80 mL of PB solution, and incubated at 37 °C with gentle stirring. After 
predetermined periods, the supernatant was removed from the swollen hydrogels, and the 
resulting hydrogels were weighed. The medium solution was freshly replaced after every 
weight measurement. The percentage of weight change of these hydrogels was calculated 
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using the following equation, where W0 is the initial weight just after preparation of the 
hydrogel and Wt is the weight after incubation in PB: 
Gel weight change (%) = (Wt/W0) × 100 
 
7.2.7 In vitro LEV release 
   The in vitro release of LEV from the P(GD-DL-LA)-g-PEG/LEV hydrogel was 
investigated in PB solution and compared with P(GD-DL-LA)-g-PEG and PLGA-b-PEG-
b-PLGA hydrogels that physically entrapped LEV molecules. P(GD-DL-LA)-g-PEG and 
PLGA-b-PEG-b-PLGA hydrogels that physically entrapped LEV molecules were 
prepared by dissolving a mixture of each polymer and the LEV molecule at the same 
weight ratio as existed in the P(GD-DL-LA)-g-PEG/LEV conjugate. The hydrogels were 
prepared by heating the sample solution (20 wt%) to 37 °C in a 5-mL vial. The opened 
vials containing the hydrogels were fully soaked in 80 mL of PB solution, and incubated 
at 37 °C with gentle stirring. After predetermined periods, 1 mL of supernatant solution 
was collected from the mother supernatant, and evaporated to remove water. The residue 
was dissolved in DMSO, and the absorbance at 287 nm was measured on a UV-vis 
spectrophotometer. The same amount (1 mL) of fresh PB solution was added to the 
supernatant after every sampling, and the vial was continuously incubated at 37 °C. The 
amounts of LEV and LEV attached to fragments of released P(GD-DL-LA)-g-PEG 
hydrolysates were determined from the corresponding peak areas in the HPLC elution 
profiles using a calibration curve from a standard solution of LEV. 
 
7.3 Results and discussion 
7.3.1 Synthesis of the conjugate 
   P(GD-DL-LA)-g-PEG/LEV conjugate was successfully synthesized and isolated in 
83% yield. The number-average molecular weight (Mn) for the P(GD-DL-LA)-g-
PEG/LEV conjugate was estimated to be 2.7 ´ 104 Da by SEC measurement (Table 1 and 
Figure 1). The structure of the conjugate was characterized by 1H NMR spectroscopy in 
CDCl3 (Figure 2). The spectrum was given as a simple integration of P(GD-DL-LA), 
MeO-PEG and LEV derivative. The number of grafted MeO-PEG units was calculated to 
be 21 per P(GD-DL-LA) molecule. The number of introduced LEV units was determined 
to be 2.0 per P(GD-DL-LA) molecule based on the absorbance at 287 nm. Since the 
number of COOH groups in P(GD-DL-LA) was 23, these values indicate that almost no 
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free COOH existed on the P(GD-DL-LA)-g-PEG/LEV conjugate. The weight content of 
PEG in the P(GD-DL-LA)-g-PEG/LEV conjugate was determined to be 23 wt% based on 
the integration values of the methyl proton of the lactide unit and the methyl proton of 
MeO-PEG. The control sample, P(GD-DL-LA)-g-PEG, was prepared by the same 
synthetic route without LEV using the same P(GD-DL-LA) and MeO-PEG350. The 
number of grafted MeO-PEG units for P(GD-DL-LA)-g-PEG was 23. This means that all 
of the COOH groups of P(GD-DL-LA) were converted into MeO-PEG graft chains. 
 
Figure 1. Gel permeation chromatograms of a) P(GD-DL-LA)-g-PEG/LEV, b) P(GD-DL-
LA)-g-PEG, and c) P(GD-DL-LA). 
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Figure 2.  1H NMR spectrum of P(GD-DL-LA)-g-PEG/LEV in CDCl3. 
 
Table 1. Characterization of P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-LA)-g-
PEG 
 Mn 
×104 a) 
# of 
GD units b) 
# of 
PEGc) 
# of 
LEVd) 
PEG content 
[wt%]c) 
Yield 
[%] 
P(GD-DL-LA)-g-PEG/LEV 2.7 23 21 2.0 23 83 
P(GD-DL-LA)-g-PEG 2.6 23 23 - 25 87 
a) Estimated by GPC (eluent: DMF; standard: polystyrene) 
b) Number of GD (Glc-Asp) units in P(GD-DL-LA) 
c) Estimated by 1H NMR (solvent: CDCl3) 
d) Estimated by UV-vis spectra (solvent: DMSO) 
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7.3.2 Sol-to-gel transition behavior 
   Temperature-responsive sol-to-gel transition behavior of P(GD-DL-LA)-g-PEG/LEV 
conjugate and P(GD-DL-LA)-g-PEG solution was investigated by the test tube inversion 
method. Figure 1 shows photographs of the sol and gel states for 20 wt% solutions of 
P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-LA)-g-PEG. Both P(GD-DL-LA)-g-
PEG/LEV conjugate and P(GD-DL-LA)-g-PEG PB solutions were in the sol state at room 
temperature (Figure 3a, c), and transitioned to the gel state at 37 °C (Figure 3b, d). These 
results indicate that the introduction of LEV into P(GD-DL-LA)-g-PEG had no significant 
influence on the gelation behavior. For biomedical use, the sol-to-gel transition 
temperature (Tgel) of IP is desired to be between room temperature (ca. 25 °C) and body 
temperature (37 °C). Therefore, the P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-
LA)-g-PEG would be applicable for biomedical use. Figures 4a and 4b show phase 
diagrams for P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-LA)-g-PEG in PB 
solution, respectively, at various concentrations and temperatures. For example, as the 
temperature increased from room temperature, the 10 wt% solution of P(GD-DL-LA)-g-
PEG/LEV conjugate underwent gelation at 33 °C (Tgel). Tgel, shown as the lower boundary 
curves in the phase diagram, decreased with increasing polymer concentration. This is 
due to the increase in probability of physical cross-linking by micelle aggregation. 
Moreover, the gel state of 10 wt% P(GD-DL-LA)-g-PEG/LEV conjugate solution 
underwent syneresis at 43 °C. The higher boundary curve of the phase diagram gives the 
gel-to-syneresis transition temperature, which increased with increasing polymer 
concentration. The temperature-responsive phase transitions were reversible: when the 
temperature was lowered below Tgel, the solution changed again into a translucent sol 
state. P(GD-DL-LA)-g-PEG/LEV conjugate solutions of lower concentrations (5-10 wt%) 
did not show gelation upon heating, and only showed clear sol-to-turbid sol-to-syneresis 
transitions as the temperature increased. P(GD-DL-LA)-g-PEG without LEV also 
exhibited a similar trend in that the critical gelation concentration was around 10 wt% 
(Figure 4b). We previously revealed that P(GD-DL-LA)-g-PEG having a larger number 
of PEG units showed higher Tgel than P(GD-DL-LA)-g-PEG having a smaller number of 
PEG units of the same length 26,27. Tgel’s of 10 wt% P(GD-DL-LA)-g-PEG/LEV conjugate 
and P(GD-DL-LA)-g-PEG solution were 33 and 35 °C, respectively, and the 20 wt% 
solutions of these samples showed Tgel at 29 and 31 °C, respectively. P(GD-DL-LA)-g-
PEG/LEV conjugate solution showed slightly lower Tgel (about 2 °C) than P(GD-DL-LA)-
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g-PEG solution in the concentration range tested. This is because the PEG content of 
P(GD-DL-LA)-g-PEG was higher than that of the P(GD-DL-LA)-g-PEG/LEV conjugate, 
and showed good consistency with the previous finding that Tgel depended on PEG 
content of P(GD-DL-LA)-g-PEG copolymers 26, 27. Functional groups and molecules 
besides PEG graft chains should also have influence on the temperature-responsive phase 
transition behavior. Introduction of hydrophilic or hydrophobic groups can be predicted 
to increase or decrease Tgel, respectively. In this case, because the hydrophilic carboxylic 
acid group of LEV was converted to an ester bond for attachment of LEV to the P(GD-
DL-LA) backbone, the introduction LEV might enhance the hydrophobicity and decrease 
the Tgel value. However, the decrease in the Tgel value for P(GD-DL-LA)-g-PEG/LEV 
compared with P(GD-DL-LA)-g-PEG was small. The main reason for the slight decrease 
in Tgel value should be the lower amount of PEG introduced, and the effect of LEV on the 
sol-to-gel transition was almost negligible compared with the effect of the amount of PEG. 
To reveal the precise influence of the introduction of LEV, we should prepare P(GD-DL-
LA)-g-PEG/LEV and P(GD-DL-LA)-g-PEG having the exact same amount of PEG. 
However, at this time, we have been unable to produce these samples. 
 
 
 
Figure 3. Photographs of 20 wt% solutions for P(GD-DL-LA)-g-PEG/LEV conjugate 
and P(GD-DL-LA)-g-PEG at room temperature (a) and (c), and at 37 °C (b) and (d), 
respectively. 
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Figure 4. The state diagrams of a) P(GD-DL-LA)-g-PEG/LEV conjugate and b) P(GD-
DL-LA)-g-PEG in PB solution at various concentrations and temperatures. 
 
7.3.3 Physical properties of the hydrogels 
   The storage modulus (G’) and loss modulus (G”) in the gelation processes were 
observed by dynamic mechanical analysis. The temperature dependence of G’ and G” for 
P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-LA)-g-PEG PB solution (20 wt%) 
are shown in Figure 5. In this measurement, Tgel can be defined as the temperature where 
G’ passes over G’’. Tgel values for P(GD-DL-LA)-g-PEG/LEV conjugate and P(GD-DL-
LA)-g-PEG were 28.8 °C and 29.7 °C, respectively. These results support the 
aforementioned trend observed in the test tube inversion method (Figure 4). The 
copolymer solutions did not show significant change in G’ and G’’ values at temperature 
ranges below Tgel (20-27 °C), but these values increased drastically around Tgel. The G’ 
values at 37 °C were 1,553 and 1,259 Pa for P(GD-DL-LA)-g-PEG/LEV and P(GD-DL-
LA)-g-PEG hydrogels, respectively. Maximum G’ values of P(GD-DL-LA)-g-PEG/LEV 
and P(GD-DL-LA)-g-PEG were 1,610 (at 37.5 °C) and 1,484 (at 38.4 °C) Pa, respectively. 
According to our experience, such differences observed in G’ values of P(GD-DL-LA)-g-
PEG/LEV and P(GD-DL-LA)-g-PEG hydrogels are not significant based on the 
rheological measurement deviation of the instrument used. These values are relatively 
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higher than those of typical linear biodegradable thermo-gelling polymers such as PLGA-
b-PEG-b-PLGA 15 due to the branched architecture of the graft copolymer as reported in 
our previous work 26. 
 
 
Figure 5. Storage modulus G’ (solid symbols) and loss modulus G” (open symbols) as a 
function of temperature for (a) P(GD-DL-LA)-g-PEG/LEV conjugate and (b) P(GD-DL-
LA)-g-PEG (20 wt%) in PB solution. 
 
7.3.4 Swelling and degradation of the hydrogels 
   To study the hydrolytic profiles of the hydrogels prepared from P(GD-DL-LA)-g-
PEG/LEV conjugate and P(GD-DL-LA)-g-PEG PB solution (20 wt%), the hydrogels 
formed were incubated at 37 °C for 11 weeks. At every point, weights of the swollen 
hydrogels were measured. Figure 4 shows the time course of weight change of the 
hydrogels. P(GD-DL-LA)-g-PEG/LEV hydrogel displayed a gradual increase in weight 
by swelling for 2.3 weeks. This swelling behavior can be interpreted by a decrease in 
physical cross-linking points due to partial hydrolysis of the polymer chains. Erosion of 
the hydrogel and partial dissolution of the hydrolyzed polymer occurred gradually for 10 
weeks, and after 11 weeks the hydrogel disappeared completely. P(GD-DL-LA)-g-PEG 
hydrogel exhibited similar swelling and erosion/dissolution behavior: swelling up to 2.6 
weeks and erosion for 10 weeks. The introduction of LEV molecules had almost no effect 
on the hydrolytic swelling and erosion behavior of the hydrogels. These results suggest 
that the introduction of small amounts of model drug molecules did not have significant 
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influence on the degradation of P(GD-DL-LA)-g-PEG. The slow erosion and relatively 
long degradation time of P(GD-DL-LA)-g-PEG hydrogels render them suitable for use as 
injectable drug delivery devices, as they are expected to allow sustained release of 
entrapped pharmaceutical agents. 
 
 
Figure 6. Swelling and degradation profiles of 20 wt% P(GD-DL-LA)-g-PEG/LEV (●) 
and P(GD-DL-LA)-g-PEG (▲) hydrogels in PB solution at 37 °C. 
 
7.3.5 Release behavior of LEV 
   Figure 7a shows the cumulative release of LEV (including LEV derivatives) from the 
hydrogels. P(GD-DL-LA)-g-PEG and PLGA-b-PEG-b-PLGA hydrogels that physically 
entrapped LEV were used as controls. P(GD-DL-LA)-g-PEG/LEV hydrogel showed 
gradual and continuous release of LEV derivatives for 11 weeks. This was almost equal 
to the swelling and degradation period (Figure 6). The released LEV derivatives 
contained both parent LEV molecules and LEV attached to P(GD-DL-LA)-g-PEG 
hydrolysates, a prodrug form, because hydrolyzable ester bonds existed not only at 
attachment sites of LEV on P(GD-DL-LA) but also in the backbone polymer itself. To 
determine the precise amount of parent LEV molecules released at each point, we carried 
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out HPLC analysis of the supernatant of the release test on separate parent LEV and LEV 
derivatives for the first 10 days. The amounts of LEV and total LEV derivatives released 
were calculated from the corresponding peak areas of the HPLC elution profiles (Figure 
5b). The amount of parent LEV molecules was about 2% of total LEV in the system after 
10 days. This amount corresponds to about 10% of LEV derivatives released in 10 days. 
On the other hand, the release rate of the parent LEV molecule from P(GD-DL-LA)-g-
PEG hydrogel that physically entrapped LEV was significantly faster than that from the 
P(GD-DL-LA)-g-PEG/LEV hydrogel. The release of LEV from P(GD-DL-LA)-g-PEG 
hydrogel was almost completed in 3 weeks. The release rate of LEV derivatives from 
P(GD-DL-LA)-g-PEG/LEV hydrogel was three or four times slower compared with that 
from P(GD-DL-LA)-g-PEG hydrogel in the initial 3 weeks. Moreover, we investigated 
the release of LEV from PLGA-b-PEG-b-PLGA hydrogel as a control of linear type IP, 
and compared that with the release behavior from P(GD-DL-LA)-g-PEG and P(GD-DL-
LA)-g-PEG/LEV hydrogels. The release rate of LEV from PLGA-b-PEG-b-PLGA 
hydrogel was faster than that from P(GD-DL-LA)-g-PEG hydrogel. The release rate of 
low-molecular-weight compounds from hydrogels should depend on their diffusion 
constants. The difference observed in the release rates between PLGA-b-PEG-b-PLGA 
and P(GD-DL-LA)-g-PEG hydrogels should be due to the difference in sizes of hydrogel 
networks, and degradation rates of the copolymers, based on the polymer structures 
(linear block or graft). Thus, it was revealed that the release rate of a water-soluble model 
drug (LEV) from IP hydrogel could be sustained by using a graft-type thermo-gelling 
polymer [P(GD-DL-LA)-g-PEG], and further suppressed by covalent immobilization to 
the polymer backbone.  
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Figure 7. (a) Time course in vitro release of LEV derivatives from the hydrogels in PB 
solution at 37 °C: P(GD-DL-LA)-g-PEG/LEV (●), P(GD-DL-LA)-g-PEG (▲), and 
PLGA-b-PEG-b-PLGA (■); (b) Time course release amounts of parent LEV (◆) and 
LEV derivatives (●) from P(GD-DL-LA)-g-PEG/LEV hydrogel. 
 
7.4 Conclusions 
   We developed a macromolecular prodrug-type IP system using a biodegradable graft-
type thermo-gelling polymer, P(DG-DL-LA)-g-PEG. Covalent attachment of a model 
drug (LEV) to the polymer was carried out utilizing the reactive carboxylic acid groups 
on P(DG-DL-LA)-g-PEG. The obtained P(DG-DL-LA)-g-PEG/LEV conjugate exhibited 
temperature-responsive sol-to-gel transition behavior in PB solution between room 
temperature and body temperature similar to P(DG-DL-LA)-g-PEG. P(DG-DL-LA)-g-
PEG/LEV conjugate showed slightly lower Tgel compared with P(DG-DL-LA)-g-PEG 
which had a slightly larger content of PEG. The introduction of LEV molecules onto 
P(DG-DL-LA)-g-PEG did not have a significant influence on the sol-to-gel transition 
behavior, physical properties, or in vitro degradation rates of the hydrogel. P(DG-DL-
LA)-g-PEG/LEV hydrogel showed swelling and degradation for 11 weeks, and the 
release of LEV derivative from the hydrogel was observed continuously during the same 
period. The release rate of LEV from P(DG-DL-LA)-g-PEG/LEV hydrogel was much 
slower than that from P(DG-DL-LA)-g-PEG and PLGA-b-PEG-b-PLGA hydrogels 
physically entrapping LEV molecules. The release of the model drug from the physical 
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entrapping system is mainly governed by diffusion, but the release from the prodrug-type 
IP system can be controlled by the degradation rate of the backbone polymer itself as well 
as the covalent linkages between the drug moiety and polymer. Moreover, most of the 
LEV derivatives released were in the prodrug form, LEV attached to P(GD-DL-LA)-g-
PEG hydrolysates, which can then act as a drug after further hydrolysis. The amount of 
parent LEV was about 10% of all LEV derivatives released. These results suggest that the 
covalent attachment strategy is effective for achieving sustained release of water-soluble 
low-molecular-weight drugs in IP systems, and can be applied to drug delivery devices 
for highly bioactive molecules. 
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   This thesis summarizes the results of basic studies on thermo-gelling polymers with 
certain properties and functions as a minimally invasive implantable system. 
 
   In chapter 2, a very quick preparative method at r.t. for aqueous IP solution was 
described. The effects of various water-soluble additives on the dispersion time of freeze-
dried tri-PCG and sol-to-gel transition behavior of the copolymers were investigated. We 
found that some of the best formulations composed of tri-PCG and PEG as additives could 
be dispersed in PBS to give suspension within 20 sec at r.t. The obtained suspension could 
be sucked by syringe and exhibited temperature-responsive sol-gel transition between r.t. 
and body temperature. Therefore, this system should be convenient for instant preparation 
at clinical scene.  
 
  In chapter 3, new biodegradable injectable polymer system forming chemically cross-
linked hydrogel in response to temperature change to overcome duration time of gel state 
was described. Tri-PCG and tri-PCG-SA-OSu were synthesized. The micelle solution of 
mixture of tri-PCG and tri-PCG-SA-OSu was further mixed with a solution of water-
soluble polyamine, such as poly-L-Lysine (PLys), which can form covalent bonds with 
the succinimide ester groups on the triblock copolymer termini. The obtained formulation 
showed temperature-responsive irreversible gelation and longer duration of gel state in 
vitro and in vivo. Furthermore, the hydrogel showed longer and controllable duration time 
of gel state by mixing ratio of NH2 and OSu groups. 
 
   In chapter 4, temperature-responsive biodegradable injectable polymer systems 
forming covalently cross-linked hydrogel by Michael-addition type thiol-ene reaction 
was described. Tri-PCG-Acryl was synthesized. Tri-PCG-Acryl micelle solution was 
mixed with tri-PCG micelle entrapping DPMP. The mixture micelle solution (Molar ratio 
of tri-PCG and tri-PCG-Acryl = 1 : 1, content rate of tri-PCG-Acryl = 50%, code: 50%-
S) exhibited sol-to-gel transition as increasing temperature, and then did not become a sol 
state after cooling at 4°C. This is due to that chemically cross-linking points were 
generated by Michael-addition type thiol-ene reaction. Moreover, we prepared freeze-
dried-sample of PEG, tri-PCG/DPMP micelles, and tri-PCG-Acryl micelles. The obtained 
powdery sample could be dispersed within 30 sec in PBS at r.t. The obtained 
homogeneous suspension (50%-D) also showed irreversible sol-to-gel transition in 
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response to temperature similar with 50%-S. Furthermore, the obtained hydrogel with 
various contents of tri-PCG-Acryl showed longer duration time of the gel state in vitro 
and in vivo, and the duration time can be controlled by changing mixing ratio of tri-PCG-
Acryl (16-50%). Therefore, this system should be convenient use in clinical scene. 
 
   In chapter 5, conventional control method of gel-forming pH region of biodegradable 
temperature-responsive injectable polymers was described. Carboxylic acid-terminated 
tri-PCG (tri-PCG-COOH) and amine-terminated tri-PCG (tri-PCG-NH2) were 
synthesized by reaction of tri-PCG and succinic anhydride or coupling reaction and 
deprotection of Boc-Gly and tri-PCG. We investigated sol-gel transition behavior of tri-
PCG-COOH, tri-PCG-NH2 and their mixture solution as functions of pH and temperature. 
Tri-PCG-COOH solution did not exhibit sol-gel transition behavior under the whole pH 
and temperature region investigated. Tri-PCG-NH2 solution exhibited sol-gel transition 
behavior under pH = 7-9. Sol-gel transition of the mixture solution of tri-PCG-COOH 
and tri-PCG-NH2 with various anion and cation ratio (A/C = 0.2-1.0) were investigated. 
The mixture solution (A/C = 1) exhibited sol-gel transition behavior under pH = 2-5 as 
increasing temperature. The pH region showing sol-gel transition could be changed by 
A/C ratio.  
 
   In chapter 6, the effects of length of PEG graft chains and PEG contents on the 
temperature-responsive sol-to-gel transition behavior of the copolymers was described. 
P(GD-DL-LA)-g-PEG copolymers having similar total weight, different length of PEG, 
and different PEG contents were synthesized. Sol-gel transition temperature of P(GD-DL-
LA)-g-PEG with higher molecular weight of PEG increased compared with the 
copolymers with lower molecular weight of PEG. The length of the PEG graft chain did 
not have negative effects on physical properties of hydrogels with elevating temperatures. 
 
   In chapter 7, a macromolecular prodrug-type biodegradable injectable polymer 
system of sustained release for low-molecular water-soluble drug was described. A P(GD-
DL-LA)-g-PEG were synthesized by the coupling reaction of carboxy acid groups of 
P(GD-DL-LA) with monomethoxy-PEG (MeO-PEG). Then, unreacted residual carboxy 
acid groups were used for immobilization of water-soluble low-molecular weight drugs 
(LEV). P(GD-DL-LA)-g-PEG and P(GD-DL-LA)-g-PEG/LEV solutions exhibited sol-to-
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gel transition between r.t. and body temperature. The immobilization of LEV onto P(GD-
DL-LA)-g-PEG had no negative effect on the sol-to-gel transition behavior, mechanical 
strengths and degradation behavior of the hydrogel. The LEV release from obtained 
hydrogel were observed continued and sustained release of LEV for 11 weeks in vitro.  
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